BASAL,DUE,INSULIN,MRI,TOLERANCE
ANALYSING,STRUCTURAL
169,COPYRIGHT,NEURONS,SCIENCE,SOMATIC
EVALUATION,MAXIMAL,METASTASES
AFTER,CHOROID,DYSPHONIA
CROATIA,DEPARTMENT,ENT,GENERAL,METASTATIC,RENAL,SURGERY,ZADAR
BACKGROUND,EARLY,GAMMA,HUNGARY,LABEL,METHODS,OBJECTIVE,PATIENT,PERSISTING,PURPOSE,RESULTS,SELECTION
ARGUMENTS,DESPITE,HOWEVER,HUNGARY,WHILE
177,AIM,ATTENTION,CONCLUSION,EMOTIONAL,ERROR,LABEL,METHODS,NETWORK,OBJECTIVE,QOL,RESULTS
BASED,DETECTING,HEMIFIELD
CHEST
AUXILIARY,CONCLUSION,JANUARY,LABEL,METHODS,NATAL,NORTE,OBJECTIVE,OCTOBER,RESULTS,RIO,THERE
ALONG,EEG
288,MRI,THEREFORE
000MG,178,BASED,FDG,FOLLOWING,HOWEVER,MALIGNANT,PET,SINCE
OTHERWISE,TARGETABLE
BACKGROUND,CYTOLOGIC,CYTOPLASMS,DEPENDING,MEDULLARY,MEN
002,151,169,COPYRIGHT,COX,DELAY,INC,LABEL,LOCAL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SRS
169,ANATOMICAL,COPYRIGHT,DTI,FIFTY,FRACTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
019,024,048,169,AGE,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SEVEN,SEVENTY,SIX,SIXTEEN,THESE,THREE
011,028,032,033,102,108,109,118,138,169,170,172,201,260,303,ACT,BETWEEN,CONTINUED,COPYRIGHT,CSI,EBT,FVC,INC,IQR,LABEL,MARCH,METHODS,OBJECTIVE,PFT,PULMONARY,PURPOSE,RESULTS,THERE,THESE,TLC
216,270,282,284,350,566,604,ALK,AMONG,IHC,III,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VENTANA
177,ACADEMY,CHINESE,COLLEGE,CONCLUSION,DEC,FEDERATION,GYNECOLOGY,IB1,IB2,IIA,JAN,JUL,LABEL,MEDICAL,METHODS,NECUC,OBJECTIVE,OBSTETRICS,PATHOLOGIC,PFS,RECURRENT,RESULTS,TEN,UNION
000,114,398,456,580,649,933,974,APRIL,CIS,COCHRAN,ECM,GALBR,HOWEVER,III,ORS,POTENTIAL,SIX,SMD,STUDIES
946,BRAIN,CD3,CD4,CD5,CD8,DESPITE,FURTHER,GADOLINIUM,HOWEVER,IIE,ISH,TAI,TCR,TIA
CD151,CONCLUSION,DETECTING,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
001,002,009,078,169,CHO,CONCLUSION,GLX,GUA,HOWEVER,LABEL,LIPID,METABOLITE,METHODS,MRS,OBJECTIVE,PURPOSE,RESULTS,ROC,THRESHOLD,WHITNEY
169,BASED,CCM,GRE,IMAGING,ITALIAN,LITERATURE,MRI,RESONANCE,SWI,THREE
169,BACKGROUND,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,ROI,SIX,SMA
169
169,LITERATURE
HODGKIN,PNETS,SECONDARY,THESE
145,169,CD133,CONVERSELY,CR208,GBM,GSC,IE1,IES,OVERALL,SIMILARLY,TOWNE,UL123
PALLIATIVE,THERE
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,VARYING
AFTER,MRI,THREE
CARLO,CHANGES,HOWEVER,MONTE,MRI,NON
177,DIFFERENT,FDG,PANCREATIC,PET,THEREFORE
160,163,169,CONCERN,COPYRIGHT,EZZAT,INC,PATHOLOGY,PUBLISHED,SOCIETY
CERTAIN,HOWEVER,RADIATION,SOCIETY
EASTERN,FIFTY,GRADE,GROUP,III,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS,SEVENTEEN,SHORT,THESE,THREE
169,COPYRIGHT,INC,PCM,PGT,THESE
009,015,045,169,183,920,AROMATASE,BACKGROUND,COPYRIGHT,COUNCIL,EARLY,FUNDING,GROUP,INTENTION,LABEL,LTD,MEDICAL,METHODS,PRIMARY,PUBLISHED,RESULTS,RRS,THERE,TRIALISTS
002,004,169,183,206,766,767,AMONG,BACKGROUND,COPYRIGHT,COUNCIL,EARLY,FUNDING,GROUP,INTENTION,LABEL,LTD,MEDICAL,METHODS,OVERALL,PRIMARY,PUBLISHED,RESULTS,RRS,TRIALISTS
169,COPYRIGHT,LTD,PCI,SMALL
169,ADRIAMYCIN,ADX,ATP,CALCEIN,CASPASE,COPYRIGHT,DESPITE,GBM,INCREASING,IRELAND,LTD,MOLECULAR,TAKEN,THREE,TMZ,USING
BLOOD,ICH,VTE
169,CNS,COPYRIGHT,DIFFUSE,DIPGS,HOWEVER,INC,MUTATIONS,THESE
BLASTIC,BPDCN,CD4,ELDERLY
113,AIM,INSTITUTE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,ROMANIA
001,006,008,013,029,039,046,150,400,750,ADC,ADCHIGH,CONCLUSION,DIXON,DWI,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PERFUSION,RESULTS,THERE,THESE
AIM,ANXIETY,CONCLUSION,DEPRESSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PROVIDING,RESULTS,SCALE,SHORT
MRI
169,945,946,955,COPYRIGHT,IFN,III,INC,SNP,VIRAL
000,250,AFTER,CAP,FEC,LAP,TZB,WHILE,WHOLE
CLINICIANS,PCI,TKI
DYSPHAGIA,PALATAL,REGAINING,THEREFORE
160,169,652,ADVERSE,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS
160,APRIL,EVALUATION,GBM,GROUP,HDACI,INC,INSTITUTE,LABEL,MATERIALS,METHODS,MORBIDITY,OBJECTIVE,PFS,PROGRAM,PUBLISHED,PURPOSE,RADIATION,RESULTS,RPA,SCORING,THERAPY,TMZ,TREATMENT,VPA,YOUNGER
137,160,169,177,AMONG,ASSESSMENT,BATTERY,COPYRIGHT,EVENT,HIT,HOWEVER,INC,KAUFMAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PIQ,PNET4,PSI,PURPOSE,RAVEN,RESULTS,THEREFORE,USING,VIQ,WMI
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PARTNER,PUBLISHED,RESULTS,SOCIETY,THERE,URBAN
169,AKT,BAX,BCL,CASPASE,COPYRIGHT,GBM,HOWEVER,INHIBITION,IRELAND,LTD,NVP,THESE,TMZ
AMONG,CONCLUSION,FDG,FURTHER,LABEL,MRI,PET,RELATED,UNLABELLED
135,169,COPYRIGHT,LABEL,METHODS,NUCLEAR,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY
169,739,765,954,APAF1,COPYRIGHT,ECTOPIC,KAISO,POK,PREVIOUSLY,THESE,WHILE
FIRST,THEREFORE
169,CNS,COPYRIGHT,DELTA,HOWEVER,INC,NOTCH,THESE,VEGFR
CNS,REPORTS
BACKGROUND,BRAIN,EXCLUSION,LABEL,MATERIALS,METHODS,MRI,OTHER,RESULTS
169,183,ACADEMY,ALZHEIMER,EIGHT,LABEL,METHODS,NEUROLOGY,OBJECTIVE,RESULTS
BACKGROUND,BLOOD,DIFFUSE,DOL,LABEL,METHODS,METICULOUS,SIGNS
AFTER,ALZHEIMER,HOWEVER,TBI,TRAUMATIC
169,19Q,COPYRIGHT,INC,NEWLY
169,956,AFTER,BACKGROUND,BRITISH,IMAGING,JOURNAL,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,THESE,TRIAL,UNIVERSITY
AKT,COA,GBM,GLUCOSE,REMARKABLY,THESE
239,ALCOHOL,DROSOPHILA,RAS
SOL,SUBSEQUENT,WEGENER
CRUDE,DCM,FUNGI,HOWEVER,MTT,PISOLITHUS,RKO
169,ASD,CCCTC,COPYRIGHT,EPIGENETIC,GIVEN,INC,NOTABLY,PUBLISHED,SOCIETY,THESE,USING
774,CPEB4,HOWEVER,IHC,PCR,WESTERN
FURTHER,LSD,MYC,OLIG2,POU,SRY
FURTHER,GBM,III,PET,PHASE,TMZ
124,177,GAMMA,KNIFE,PERFEXION
BASED,ENGLISH,EXTRACTION,ICU,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,SOURCES,SYNTHESIS
COH,FSH,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,GBM,INC,ISSUE,MYC,SPECIAL,TARGETING
169,CNS,COPYRIGHT,LTD,NEURO
12A,956,ABC,ABCB1,ABCC1,ABCG2,ATP,GOVERNMENT,HOWEVER,IMAGING,KO143,THESE
169,177,945,AUTHORS,CONCLUSION,COPYRIGHT,DISEASE,FASTING,GERIATRICS,IFG,JOURNAL,LABEL,METHODS,NFG,OBJECTIVE,OBJECTIVES,ORS,POPULATION,RESULTS,SETTING,SOCIETY,WORLD
GRADE
HYPERHAES,WHILE
1990S,ALA,ALASENS,BACKGROUND,BASED,DEPARTMENT,HOWEVER,INSTITUTE,LABEL,METABOLIC,METHODS,NEUROLOGY,RESULTS
DESPITE
169,204,COPYRIGHT,FINALLY,IMR32,LAN,SNP,THEREFORE,UTR
169,ALK,COPYRIGHT,FINALLY,INC,THESE
169,COPYRIGHT,GBM,INC,MICRORNAS,PDCD4,PROGRAMMED
174,177,2012A,956,CARLO,CONCLUSION,CTV,GBM,KNOWLEDGE,LABEL,MATHWORKS,MEP,METHODS,MONTE,OBJECTIVE,RESULTS,SFS

BCL,EMA,MIB,NAB2EX6,SFT,STAT6,STAT6EX16,THEIR,THESE,USING
174,AFTER,BRAINPATH,GERMANY,SEVERAL,STORZ,TUTTLINGEN,VITOM
174,ADVERSE,AES,APRIL,BACKGROUND,CONCLUSION,CTCAE,GLIADEL,HOWEVER,JANUARY,JAPAN,LABEL,METHODS,RESULTS,SEPTEMBER,SEVERAL,THEIR,THERE
102,160,215,224,300,354,GENOMIC,GIVEN,HOWEVER,MENDELIAN,SIMILAR,SINCE
005,169,215,BED,COPYRIGHT,GBM,INC,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THESE
ANAPLASTIC,BACKGROUND,CONCLUSION,IMAGING,LABEL,METHODS,VIDEO
CONCLUSION,EXCELLENT,FORTY,GTN,IRB,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SIX,STATISTICS
10877,967,BACKGROUND,III,LABEL,METHODS,RESULTS,THERE,THEREFORE,TTFIELD,USING
004,100,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THREE
144,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS
001,005,009,023,028,169,309,540,580,AIM,ANTICANCER,BACKGROUND,CDKN2,CGG,CGT,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,REGARDING,RESULTS,THESE,USING
GIVEN,THERE,TRM
169,231,233,ALK,COPYRIGHT,HOWEVER,HSP,INHIBITORS,INTERGROUP,NON,NSCLC,PFS,PROTEIN,PUBLI,PUBLISHED,SAS,SHOCK,SMALL,STRATEGIES,THESE
169,946,C2C12,COPYRIGHT,FMK,GFP,GFP11,GPA,IBS008738,INC,MOUSE,MYOGENESIS,RAC,VAD
174,BETWEEN,COHORTS,CONCLUSION,DLT,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,PHASE,PURPOSE,RESULTS
947,BECAUSE,DIPG1,DIPGS,JHH,JQ1,NOTCH,SHORT,TREATMENT
140,169,BECAUSE,CONCLUSION,FMISO,IMAGING,INC,LABEL,MEIER,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,TBMAX,UNLABELLED
BET,CONTAINING,CONVERSELY,GBM,HELICOS,HOWEVER,HOX,MULTIFORME,SMALL,TREATMENT
005,702,852,864,893,AUC,CONCLUSION,DSC,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,ROC,VARIATION
169,CSC,GBM,LABORATORY,PRESS,PUBLISHED,TISSUES
002,169,COPYRIGHT,DWI,GTV,HCV,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PDV,PFS,PRE,PURPOSE,RADIATION,RESULTS
102,169,177,945,CONCLUSION,HISTOLOGIC,INCREASED,INDUCTION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RELAPSE,RESULTS,SIXTY,SOCIETY

ALZHEIMER,CONCLUSION,LABEL,PEARSON,RESULTS,UNLABELLED
AFTER,AUTOPSY,BECAUSE,GBM
177,956,963,GBQ,PET,SMALL,THESE,TREATMENT
018,15Q21,169,215,746,AFRICAN,AMERICANS,BACKGROUND,CDC5L,COMPASS,CONSORTIUM,ELTD1,HDAC9,HEART,IL1RN,INC,LABEL,METAL,METASTROKE,METHODS,NOMINAL,OBJECTIVE,PITX2,POPULATION,PTPRG,PURPOSE,RESULTS,STUDIES,USING,WDFY4,ZFHX3
169,384,BMI,HIT,LABEL,METHODS,NAFLD,OBJECTIVE,RESULTS,SOCIETY
001,DISCOVERY,OBJECTIVE
001,005,4TH,CNS,DFS,THEREFORE
10878,BACKGROUND,CARCINOMA,CONCLUSION,CONSORTIUM,EASTERN,FINAL,GROUP,LABEL,METASTATIC,METHODS,OBJECTIVE,PFS,RENAL,RESULTS
169,BIOLOGY,CONVERSELY,DEPLETION,FINALLY,FOXM1,HOWEVER,INC,MOLECULAR,SOCIETY,THESE
DESPITE,FGFR1,FIBROBLAST,K656E,ONCOGENIC,PAS,THESE,THREE
945,956,GBM,HIF,HYPOXIA,ORTHOTOPIC
001,010,031,AGE,CONCLUSION,INS,KNOWLEDGE,LABEL,METHODS,NAA,OBJECTIVE,POINT,RESULTS
5XFAD,945,946,947,ALZHEIMER,AMYLOID,APP,CONVERSELY,PEROXISOME,PPARA,SDS,SEQUENTIAL,THEREFORE,THESE
947,C53,NUCLEOLAR,THESE
ANATOMICAL,MRI,PNC,RESULTS,WHILE
160,ATTENUATED,CSH,EMT,ESRP1,FURTHER,IGF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
GRADE,MELATONIN,MULTIFORME,OCTREOTIDE,RETINOIDS,VIT,VITAMIN
131,169,500MG,BACKGROUND,BETWEEN,COPYRIGHT,DOVITINIB,JANUARY,LABEL,LTD,METHODS,OCTOBER,PFS,RESULTS,SECONDARY,THERE,VEGFR
169,BRAIN,CHC22,CONGENITAL,E330K,GUARANTORS,PRESS,PUBLISHED,SIMILARLY,THESE,UNIVERSITY
169,COPYRIGHT,INC,PAPILLARY,SEVENTEEN
169,COPYRIGHT,EPIGENETIC,LTD
169,ASSESSMENT,BRAIN,CNS,COPYRIGHT,LTD,METASTASES,NEURO
DESPITE,FINALLY,N10
169,ANALYZING,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FIRST,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SRT,TCP
125,150,BACKGROUND,BBT,IMAGING,INCLUSION,IRINOTECAN,LABEL,LGG,MANAGEMENT,METHODS,PROCEDURE,RESULTS,SEVEN,SIXTEEN,THREE,TREATMENT
169,BIOLOGY,FINALLY,INC,MOLECULAR,SOCIETY
169,AUTHORS,BACKGROUND,BLOOD,BTS,CNS,CONCLUSION,INC,LABEL,METHODS,PEDIATRIC,RESULTS,SURVIVORS,THESE,WILEY
169,COPYRIGHT,IL8,IRELAND,LTD,MARIMASTAT,MMP,MMP14,MT1
100,457,551,553,ACCORDING,BASED,BESIDES,MMP
160,293,757,CNS,COMPETING,CONCLUSION,COX,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE
100,169,945,BACKGROUND,BESIDES,CNP,COPYRIGHT,GFP,GIC,HOWEVER,IRELAND,LABEL,LTD,METHODS,NG2,PCR,PDGFR,PRIMARY,RED,RESULTS,RFP,SU3,U87
169,509,555,ABSTRACTS,CIS,EFFECTS,HEMATOLOGY,MEDLINE,REVIEWS,SCALE,SOCIETY,STUDIES,TEN,THERAPY,WORKING
000,169,700,956,ALZHEIMER,COPYRIGHT,INC,PARKINSON,PRINCETON,SLC11A2,TFR
169,COPYRIGHT,IMAGING,INC
169,945,DCA,MRS,NHA,NOTABLY,PDH,REDUCED,TAKEN,U87,USING
141,BACKGROUND,BELOB,CEC,CONCLUSION,LABEL,METHODS,RESULTS
001,169,349,AUC,BACKGROUND,BASAL,BOX,CONCLUSION,DIAGNOSIS,FOXC1,GEM,IHC,LABEL,METHODS,PAM50,PCR,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,ALTOGETHER,AUTOPHAGY,CERTAIN,COPYRIGHT,HCC,HEP3B,HEPG2,INC,PEPCK
APOPTOSIS,CREATED,REDUCED
90O,OAR,PHILIPS,PINNACLE3,PTV50,PTV66,TPS,TREATMENT
174,CONCLUSION,FFF,KNOWLEDGE,LABEL,MEDICAL,METHODS,MUS,OAR,OBJECTIVE,PHANTOM,PTV,RESULTS,SYSTEMS
KREITER
946,BECAUSE,CERTAIN,CLR01,LYS,THEREFORE
10P12,10Q21,13Q12,215,542,620,771,788,CHINESE,HAN,PITUITARY,SNP
169,COPYRIGHT,DESPITE,EXPRESSION,FEDERATION,INHIBITION,MG132,PUBLISHED,SEVERAL,SOCIETIES,THEREFORE
001,006,033,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RCC,RENAL,RESULTS,SRS
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MENINGIOMA,METHODS,OBJECTIVE,PATIENT,RESULTS
001,149,169,261,287,AIM,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,END,HODGKIN,INSTITUTE,JANUARY,LABEL,MCL,METHODS,NHL,NON,OBJECTIVE,RESULTS,SIR,SPM,THERE
143,145,169,174,AIM,ANTICANCER,ANTISENSE,BACKGROUND,CONCLUSION,COPYRIGHT,GBM,IM3,INSTITUTE,LABEL,MATERIALS,METHODS,NOVEL,OBJECTIVE,RESULTS,RHO,U87
001,003,006,160,169,183,500,956,ACUTE,ASL,BRAIN,COPYRIGHT,FIFTY,HGG,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TLC,TMZ,V25GY
0MM,169,5MM,BACKGROUND,CONCLUSION,COPYRIGHT,DSC,EIGHT,ICD,IRELAND,LABEL,LTD,MATERIALS,METHODS,NPC,OAR,OBJECTIVE,PCM,PURPOSE,RESULTS,TMJ
002,ASSESSMENT,BACKGROUND,BIOMARKERS,CONCLUSION,DISCUSSION,III,LABEL,METHODS,PFS,R132H,RESULTS,THESE,TMZ
001,AMERICANS,ETHNICITY,ITALY,THROUGH
336,945,BACKGROUND,COX,ELISA,HOWEVER,LABEL,MEIER,METHODS,PBMCS,PCR,PFS,RESULTS,STRATIFIED
SELLA,SEVERAL
ENGLISH,HOWEVER,INDEX,SURVIVORS,UTILITIES
ACCORDING,III,KARNOFSKY
007,009,018,021,022,029,033,036,037,042,169,245,489,PBT,PRESS,PUBLISHED,RTEL1,STRATIFIED,THEREFORE,UNIVERSITY
001,100,169,AVAGLIO,C30,CONCLUSION,HRQOL,III,LABEL,METHODS,OBJECTIVE,PURPOSE,QUALITY,RAW,RESULTS,SOCIETY,TABLE,TMZ,TREATMENT
000,100,169,235,305,350,439,450,519,520,550,607,764,787,966,AVASTIN,CONCLUSION,GBM,LABEL,METHODS,OBJECTIVE,PURPOSE,QALYS,RESULTS,SOCIETY,VALUE
100,192,201,434,458,723,893,BMI,HOWEVER
BACKGROUND,BRAIN,CONCLUSION,EOC,LABEL,METHODS,MRI,OUTLINE,PROGNOSIS
CRT,DMEAN,FFF,FLATTENING,MUS,NSCLC,OCTOBER,THERE
ULTRASOUND,WHILE
BRAIN,MRI,NMO,THESE
100,BESIDES,ELOVL,HAPLOTYPE,IMPORTANCE,L168F,LABEL,METHODS,OBJECTIVE,RELEVANCE,RESULTS,SCA,SCA34,SETTING,USING,W246G
BMJ,GROUP,LABEL,LIMITED,MENINGITIS,METHODS,MINIRIN,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,THERE,TOTAL
169,AIF,APOPTOSIS,COPYRIGHT,DEPLETION,INC,THESE
160,169,947,COPYRIGHT,INC,PEROXISOME,PUBLISHED,RE1,REST4,RESULTS
169,MANAGEMENT,OAB,SINCE,SMALL,THESE,TRAUMATIC,URINARY,WHITE,WMD
169,ABCA1,ATP,AUTHORS,COPYRIGHT,GBM,GLYBURIDE,INC,INHIBITION,MEMBERS,PUBLISHED,S1P,SILENCING,SPT,SUBUNIT,U87MG
157,169,276,2DG,CNS,COPYRIGHT,MALDI,PROTEOMICS,TOF
169,ACIDS,NOTABLY,NUCLEIC,PRESS,PUBLISHED,THESE,UNIVERSITY,WHEREAS
002,169,2CM,5CM,600MU,8CM,BACKGROUND,CONCLUSION,COPYRIGHT,GAMMA,IRELAND,KNIFE,KRUSKAL,LABEL,LINAC,LTD,MATERIALS,METHODS,OBJECTIVE,PADDICK,PURPOSE,RESULTS,SIMILAR,SRS
169,200,946,956,BACKGROUND,CATENIN,COPYRIGHT,EASTERN,GBM,INC,LABEL,MATERIALS,METHODS,MTS,RESULTS,TREATMENT,U87,WNT
169,760,BIOLOGY,FINALLY,GBM,HIPPO,INC,MOLECULAR,S760A,S760E,SER,SIMILAR,SOCIETY,UTILIZING,YAP
100,169,BACKGROUND,BASEL,BRAIN,CONCLUSION,III,INTRADURAL,LABEL,METHODS,THESE,UNDER
AFTER,MCG,MRI,MULTIFOCAL,PET,THROUGH
CHANGES,GROWING,IDO
169,ADVANTAGES,ALK,COPYRIGHT,LTD,NSCLC,TKI
BACKGROUND,CONCLUSION,GCT,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY
001,169,552,AFTER,CONCLUSION,COX,GPA,HOWEVER,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURSIVE,RESULTS,SEVERAL,SOCIETY
001,104,153,169,189,293,HEMATOLOGY,LOG,OVERALL,SOCIETY,THERE
SEX,THESE
GBM,GSC,HOWEVER
156,217,OVERALL
132,169,946,COPYRIGHT,HOWEVER,INC,MIR,SMAD7,TAKEN,TGF,THESE,UTR
169,946,COPYRIGHT,INC,KNOCKDOWN,LDH,U87,WNT,XBP1S
001,004,011,028,169,188,911,933,ASSESSMENT,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PREDICTION,PRESS,PROGNOSTIC,PUBLISHED,RESULTS,SIXTY,UNIVERSITY
169,231,233,COPYRIGHT,ENDOCRINE,GONADAL,PUBLISHED,SAS
100,AFTERWARD,AUTHORS,CONTINUOUS,GROSS,IOM,LABEL,MEP,METHODS,OBJECTIVE,RESECTION,RESULTS,TRANSIENT
118,1ST,435,AMONG,BRAIN,CALCULATED,CASES,COX,CUMULATIVE,EXCLUDING,GAMMA,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SRS,UNIVARIATE
002,265,FSE,LABEL,METHODS,OBJECTIVE,READERS,RESULTS,THREE,WIS
FEW,MONRO,SIMILARLY,TSC
100,177,946,CD133,FCM,III,LABEL,METHODS,NG2,OBJECTIVE,PRIMARY,RESULTS,SHG139S
001,002,010,016,027,103,169,BACKGROUND,COX,HOWEVER,KARNOFSKY,LABEL,LEV,METHODS,PFS,RESULTS,SOCIETY
169,CD4,COPYRIGHT,INC,THESE,USING
169,183,228,456,508,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PATHOLOGY,RESULTS,SOCIETY
169,CAPON,COPYRIGHT,EXF,GTPASES,PDZ,PSD95,TAT
003,009,169,177,611,947,BACKGROUND,FIBRINOGEN,GBM,GL261,LABEL,MDSCS,METHODS,NOD,NSG,PEARSON,PRESS,PROTEIN,PUBLISHED,RESULTS,TREGS,UNIVERSITY
AFTER,BALANCING,FOLLOWING,HBA1C,HBALC,LABEL,MAY,METHODS,MRI,UNLABELLED
010,169,BACKGROUND,BDIXS,BMD,DECREASED,ENDOCRINE,INC,LABEL,METHODS,PROCEDURES,RESULTS,THERE,WILEY
150,169,178,610,AUC,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,MONDAYS,OBJECTIVE,PURPOSE,RESULTS,TUESDAY
169,500,CNS,COPYRIGHT,EPENDYMAL,INC,REGARDING,WORLD
169,CHOROID,COPYRIGHT,CPC,INC,TAF12,USING
169,COPYRIGHT,HOWEVER,INC,MBM,METASTATIC
ALZHEIMER,ARG,ASP,H3O,HV1,THEIR
000,102,151,169,500,750,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FORTY,FURTHER,INSTITUTE,LABEL,METHODS,NEITHER,OBJECTIVE,OVERALL,RESULTS,SRS,SRT
056,169,177,ANTICANCER,BACKGROUND,CHOROID,CONCLUSION,COPYRIGHT,CPC,INSTITUTE,LABEL,LFS,MATERIALS,MEIER,METHODS,OVERALL,RESULTS
001,021,023,045,049,093,110,169,354,AIM,AMONG,ANTICANCER,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,CYCLE,DESPITE,GRADE,IMPACTS,INSTITUTE,LABEL,METHODS,OBJECTIVE,PCV,PFS,RESULTS
169,854,ANTICANCER,BACKGROUND,COMPARING,CONCLUSION,COPYRIGHT,GEC,GIVEN,INSTITUTE,LABEL,MATERIALS,METHODS,PATHWAY,RESULTS
030,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EMT,EPITHELIAL,FRESH,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PITUITARY,RESULTS,THERE,THESE,TWIST
AFTER,CNS,CRANIOTOMY,III,RESTAGING
144,169,177,178,215,334,544,595,694,ADC,BACKGROUND,BOARD,CONCLUSION,DIFFUSION,DWI,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMITIVE,RESULTS,SEVERAL
169,231,233,COPYRIGHT,EARLY,FINALLY,HYPOSIALIA,ONCOLOGIC,PUBLISHED,SAS,TASTE,THESE
120,135,GLASGOW
AKT,EVALUATION,INDUCTION,KANK3,SULF2,THESE
215,365,809,ABCA1,ACOT4,AFRICAN,AMERICANS,BLOOD,DISCOVERY,ESP,EXOME,HEART,IMPORTANCE,INSTITUTE,JANUARY,LABEL,METHODS,NHLBI,OBJECTIVE,PDE4DIP,PROJECT,RELEVANCE,RESULTS,SEQUENCING,SETTING,THESE,ZFHX3
169,AML,BACKGROUND,COA,COPYRIGHT,EARLY,GENERAL,LABEL,MAJOR,METHODS,NADPH,R132H,SCOPE,SINCE,WHILE
CELLS,HTRA1,HYPOXIA,IGF,IGF2BP3,INS,LABEL,METHODS,OBJECTIVE,RESULTS,U87,U87GLIOMA
160,169,172,307,508,ACIDS,AMONG,BASED,ENRICHMENT,FOLDING,NOTABLY,NUCLEIC,OVERLAP,PRESS,PUBLISHED,QDH,UNIVERSITY
169,946,AUTHORS,BMP,COPYRIGHT,INVERSELY,MEMBERS,PUBLISHED,TGF,THESE
169,COLLEGE,COPYRIGHT,LTD,MRI,PUBLISHED,ROYAL
BRITISH,CERTAIN,DIFFUSION,DIG,DIT,GBM,METHODS,MRI,RESULTS
169,COPYRIGHT,EXPRESSION,PRIMARY,SCIENCE,THESE,TISSUES,VARIATION
ALK
169,COPYRIGHT,INC,PERFUSION
BRAIN,HOWEVER,THERAPIES
ALA,BACKGROUND,CONCLUSION,HOWEVER,IMPORTANCE,LABEL,METHODS,MRI
169,950,COPYRIGHT,FURTHER,NGL,PAR,PDZ,PKC,THESE
169,558,CNS,CONCLUSION,DESPITE,DUE,FULLY,GERMANY,HODGKIN,LABEL,METHODS,NHL,OBJECTIVE,OVERALL,RESULTS,SCHLESWIG,SOCIETY,THESE,THYROID
145,431,473,BACKGROUND,CONTEXT,INCREASED,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SMR,SWEDISH,THERE,WOMEN
215,BACKGROUND,DISCUSSION,INCIDENTAL,LABEL,METHODS,SINCE
DESPITE,THESE
169,384,ARF,AUC,BACKGROUND,COPYRIGHT,DVT,INC,INPATIENT,LABEL,METHODS,NIS,OVERALL,PREDICTIVE,REGULATORY,RESULTS
169,ACBD3,ADP,AUTHORS,COA,ERK,GOLGI,LIMITED,NAD,PARP1,PRESS,TAKEN
169,947,AUTHORS,ERK,HDAC3,HDACS,HISTONE,HOWEVER,LTD,MMP,NOTABLY,PTY,PUBLISHING,SCIENCE,TAKEN,U87MG,WILEY
169,945,AKT,BIOLOGY,GD2,GD3,HOWEVER,INC,MOLECULAR,PDGFR,SOCIETY,SRC,THERE,YES
120,169,DMB,HDC,INC,INFANTS,MOLECULAR,PTCH1,UTR,WES,WHILE,WHOLE,WILEY
DIFFUSE,GSK
001,008,010,169,475,ADVERSE,APRIL,CAS,CEA,COPYRIGHT,END,INC,LABEL,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,SURGERY,VULNERABLE
128,BACKGROUND,COLLEGE,CURRICULAR,INC,LABEL,MATERIALS,METHODS,PUBLISHED,RESULTS
001,005,017,164,169,284,BACKGROUND,CONCLUSION,COPYRIGHT,EOR,GTR,INC,IOMRI,LABEL,METHODS,OBJECTIVE,OVERALL,PATIENT,PERMANENT,RESULTS,YET
001,169,COPYRIGHT,CTV,FIFTEEN,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PGI,PTV,PURPOSE,RESULTS,RGI,TCP
169,BASED,COPYRIGHT,INC,VARIOUSLY
169,COPYRIGHT,FURTHER,HEPG2,INC,PERIFOSINE,USING
BLOOD,CHOROID,CPC,GREAT,ICE,METHODS,RESULTS,SPECIAL,TEN,THEREFORE,TORONTO
169,292,839,BACKGROUND,BLOOD,COX,ELISA,HEART,HOWEVER,IMUBIND,INC,ITALY,LABEL,LABORATORY,METHODS,MILAN,NUTRITION,OBJECTIVE,PURPOSE,RESULTS,USING
001,01206,03128,131,150,181,200,2GY,AFTER,AMONG,BACKGROUND,CHT,COX,DFS,GBM,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RTH,SURGERY
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS

169,BACKGROUND,BLOOD,DOSES,INC,LABEL,METHODS,RESULTS,SEGAS,THROUGH,TOTAL,TREATMENT,TSC,WILEY
1451A,160,556,700,BACKGROUND,COATS,H484P,INDIA,LABEL,METHODS,NOTCH,TEK,UTR,WES
252,CONCLUSION,DOSIMETRIC,HOWEVER,HWB,KNOWLEDGE,LABEL,LWB,MALIGNANT,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,EXPRESSION,IMI,STG
169,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RCC,RESULTS
169,19P13,BAH,CUSHING,GENOMIC,LABEL,METHODS,MOLECULAR,OBJECTIVE,RESULTS,SOCIETY
169,BRAIN,MRI,NPV,PPV
169,THERE
169,AFTER,HIV,MRI,NON,PCNSL,RITUXIMAB
002,082,100,169,177,BEV,CBF,EVALUATION,FIFTY,GBM,LABEL,MCA,UNLABELLED
169,911,AUC,BACKGROUND,CONTEXT,GRADE,III,LABEL,MACHINE,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,ROC,THREE
ACROMEGALY,EXCESSIVE,IGF,STUDIES,THERE
169,BACKGROUND,COX,FINLAND,FINNISH,HEART,HISTORICAL,INC,LABEL,MEIER,METHODS,OBJECTIVE,POSTSTROKE,PURPOSE,RESULTS,STATISTICS,YOUNG
169,954,COPYRIGHT,IRELAND,LTD,MMP
001,10Q,169,19Q,210,26882,26951,426,636,CONCLUSION,EORTC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,VALIDATION
104,169,212,249,459,920,AMONG,ASSESSMENT,CONCLUSION,EVALUATION,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PEDIQUEST,PRO,PURPOSE,QUALITY,RESULTS,SCALE,SOCIETY,STRATEGIES,SYMPTOM,TECHNOLOGY,THOUSANDS
169,COPYRIGHT,INC,RCC,RENAL
169,ACADEMY,CONCLUSION,DISTANT,FOUNDATION,HNSCC,INTERGROUP,LABEL,METHODS,MULTI,OBJECTIVE,OPSCC,RESULTS,SETTING,SURGERY,THESE
169,231,233,AUTHORS,COPYRIGHT,PRINCIPAL,PUBLISHED,SAS,TREATMENT,USA
110,120,230,BLOOD,CONCLUSION,HCG,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PITUITARY,RESULTS
160,169,211,ASN,AUTHORS,GOLGI,LIMITED,PRESS,WHEREAS
128,FURTHER,MICRORNAS
LMX1A,LMX1B,NOTABLY,PARKINSON
169,APC,COPYRIGHT,ENDOGENOUS,INC,LTD,THESE
169,COPYRIGHT,GBM,INC,MUTATIONS,NGS,OVERALL,USING
10A,10B,169,BASED,BRAIN,GUARANTORS,PRESS,PUBLISHED,THESE,TNF,TRAIL,UNIVERSITY,USING
AFTER,BECAUSE,CPP,CURRENTLY,GRADE,MRI,TEN
100,248,611,ASA,AWAKE,BASED,CALIFORNIA,CLASS,FIFTY,FRANCISCO,KARNOFSKY,KPS,LABEL,LARYNGEAL,MAPPING,METHODS,OBJECTIVE,OPERATIONS,RESULTS,SAN,SIXTY,SOCIETY,UNIVERSITY,WASHINGTON
598,ADVERSE,ANY,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONFERENCE,CONTROLLED,DUE,FACTORS,FIFTEEN,FURTHER,HOWEVER,INDEX,ISSUE,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OPIOIDS,RESULTS,SCIENCE,SELECTION,SEPTEMBER,WEB
GTN,PLACENTAL,PRIMARY,PSTTS
BACKGROUND,LABEL,METHODS,MRI,STAGING,ULTRASOUND
169,AKT,ECTOPIC,RAS
169,BRITAIN,COPYRIGHT,EMT,FINALLY,GREAT,IRELAND,LTD,NSCLC,PUBLISHED,SOCIETY,WILEY
169,APMIS,FINALLY,HOWEVER,LTD,NUCLEAR,PUBLISHED,UCN,WILEY
169,COPYRIGHT,HLA,THESE
001,169,177,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MONITORING,OBJECTIVE,PHMEP,RESULTS
10878,138,148,169,BACKGROUND,BELOB,C30,COPYRIGHT,EORTC,HRQOL,LABEL,LTD,METHODS,QLQ,RESULTS,TREATMENT
001,002,006,007,018,019,169,177,301,AED,FACTORS,LABEL,METHODS,NPA,OBJECTIVE,REDUCTION,RESULTS,START,TIMETOSTOP,TTS
001,004,007,016,027,169,198,AFTER,CONCLUSION,LABEL,METHODS,NEUROTOXIC,OBJECTIVE,PRIOR,PURPOSE,RESULTS,SOCIETY,TREATMENT
CONVERSELY,MULTIPLEX,V600E
169,945,AKT,C9ORF10,FAK,FAM120A,FINALLY,IL13R,SRC,TRAIL
SPHERICAL
DESPITE
GSC,HOWEVER,REGARDLESS
RADIATION

AFTER,CENTRAL,CNS,FURTHER,NERVOUS
GLIOMAS
945,CCL19,CCL21,IFN,IL4
169,304,488,ALLOGENEIC,DISEASE,GVT,INC,MAC,MRD,WILEY
169,213,313,COPYRIGHT,INC,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,PARTNER,PUBLISHED,SOCIETY,URBAN,USUALLY
169,ACR,ACRYLAMIDE,CERTAIN,COPYRIGHT,LTD,WILEY
BASED,MEDULLARY,MRI
100,DCS,LABEL,METHODS,MRI,NPV,OBJECTIVE,RESULTS,THEREFORE,YET
001,012,024,053,125,261,300,352,446,613,876,900,905,913,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THESE
003,169,177,180,271,451,ACADEMY,CLINICIANS,CONCLUSION,FOUNDATION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,SITES,SURGERY,THERE
169,COPYRIGHT,DETECTION,INHERITING,LTD,LYNCH,MMR,THEREFORE
001,004,033,038,125,169,183,259,ASCL1,BACKGROUND,C17,COPYRIGHT,COX,DORON,DUCKMAN,EXPRESSION,FUNDING,INTEGRATED,LABEL,LTD,METHODS,NETWORK,NOTCH,RESULTS,SMARCB1,TAL
169,174,BRAIN,GUARANTORS,HOWEVER,MRI,PRESS,PUBLISHED,SEVERAL,THEREFORE,UNIVERSITY
169,231,233,AFTER,COPYRIGHT,PEDIATRIC,PUBLISHED,SAS
2008B,945,CNS,CONVERSELY,ERG,ETS,GBM,HBS,SMA
ALZHEIMER,BACKGROUND,CONCLUSION,CSF,LABEL,NFT,P301L,RESULTS,TAU,THERE,TOTAL,USING
100,139,24H,BIOCHIP,CD133,CLUSTER,GLIAL,GSC,ISOCITRATE,LABEL,METHODS,MICRO,MIRNA,NG2,NUCLCAR,OBJECTIVE,PRIMARY,RESULTS,SHG,SHG139S,VEGFR
169,BASED,COPYRIGHT,EBOLA,GPC,IMPORTANCE,LABEL,LASSA,MARBURG,OBJECTIVE,SOCIETY,UNLABELLED,VESICULAR,VSV
169,946,AKT,EGF,FINALLY,NOTABLY,PARK2,WNT
000,AFTER,HOWEVER,MRI,THESE
804,AUTHORS,BACKGROUND,CBT,CENTRAL,COLLECTION,CONTROLLED,DATABASES,DUE,FIRST,GRADE,HOWEVER,IBD,ISSUE,LABEL,MEDLINE,METHODS,MST,OBJECTIVE,OBJECTIVES,PST,RESULTS,SECONDARY,SELECTION,SMD,TBI,THERE
102,169,385,396,BACKGROUND,BARTHEL,CHINA,EIGHT,HEART,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TRC,TRIAL,URL
169,COPYRIGHT,DIAGNOSIS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,PATHOLOGY,RESULTS,RMS,SOCIETY
BMJ,BRITAIN,COX,CVD,FURTHER,GREAT,GROUP,IHD,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR
000,100,107,169,260,ACT,AMENDMENT,BACKGROUND,BLACK,BRAIN,DIAGNOSTIC,END,GREATER,LABEL,LAW,METHODS,PREDICTORS,PROGRAM,REGISTRIES,RESULTS,SOCIETY
169,ASSESSMENT,BACKGROUND,COPYRIGHT,ETV,INC,LABEL,METHODS,PRACTICAL,RESULTS
AUGER,INSERTION,LOW,PEPTIDE
169,176,177,231,233,CONCLUSION,COPYRIGHT,CURRENTLY,GUSTAVE,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SAS,SERVICE,THESE
169,BACKGROUND,CENTRAL,CONCLUSION,COPYRIGHT,INC,KARNOFSKY,LABEL,METHODS,MRI,OBJECTIVE,OPTIMAL,RESULTS,SCORE,SEVEN,SRS
CAVERNOUS,SURGERY
CHADC,DERMOID,EPIDERMOID,MRI,TYPICAL
CNS,CURRENT,ULTRASMALL
945,946,AFTER,BACKGROUND,CHORIONIC,CONTEXT,GSU,HCG,LABEL,METHODS,OBJECTIVE,P453T,PITUITARY,RESISTANCE,RESULTS,RTH,THYROID,TSH,TSHOMAS
169,231,233,COPYRIGHT,PUBLISHED,SAS
P53
HOPES,MEDLINE,PROGNOSIS,RADIATION

169,667,BOARD,COPYRIGHT,HMH,HOUSTON,INC,JANUARY,LABEL,MEDICAL,METHODIST,METHODS,MRA,MRI,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,TEN
001,169,311,ALLERGY,BACKGROUND,COLLEGE,CONCLUSION,COPYRIGHT,CURRENT,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THESE
169,CBA,COPYRIGHT,USING
169,BCL,BIRC3,GBM,MNGCS,PRESS,PUBLISHED,SASPS,TAKEN,THEREFORE,THESE,UNIVERSITY,Y15
169,ANTICANCER,COPYRIGHT,ENGLISH,FDG,HISTOLOGIC,INSTITUTE,QUADRUPLE,SUBSEQUENT,SUV
169,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,GROSS,INC,LABEL,METHODS,MRI,OTA,PRIMARY,RESULTS,WORLD
169,915,972,APRIL,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FACTORS,IQR,IRELAND,JANUARY,LABEL,LTD,METHODS,NHS,OVERALL,PUBLISHED,RESULTS
AKT,GII,HIF,LOW,P53
BRAIN,MRI,THERE
100,CHOROID,CPP,CSF,METHODS,MRI,RESULTS,STANLEY,THERE,UNIVERSITY
169,AUTHORS,COPYRIGHT,HOWEVER,INC,NOTABLY,PUBLISHED,SOMATIC,THESE
143,AIM,BACKGROUND,DISTANT,LABEL,METHODS,NODAL,OBJECTIVE,PET,RESULTS,SIXTY,TOMOGRAPHY,VALUE
177,CRANIAL,DAILY,IQR,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SCALE,SIXTY,THERE
LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,THESE
100,169,177,BACKGROUND,CONCLUSION,INC,INITIAL,LABEL,METHODS,OPG,OPTIC,OUTCOME,PROCEDURE,RESULTS,SUFFICIENT,VOLUMETRIC,WHILE,WILEY
169,COPYRIGHT,FINNISH,INC,NF2,SHH,SMARCB1,SMARCE1,SNF,SWI
169,BEHAVIORAL,COPYRIGHT,DESPITE,INC,RESULTS,SEVERAL
GBM
SHMT2
169,18F,CHOLINE,FEC,FLUROETHYL,INC,MRI,NGGCT,PET,WILEY
169,DESPITE,END,FIFTY,INC,LABEL,METHODS,NON,OBJECTIVE,RESULTS,SURVIVORS,WILEY
1P19Q,AFTER,ANAPLASIA,IDH,III,LOWER,MOLECULAR,THESE,WORLD
CD124,GBM,MDSCS,MYELOID,THESE
141,608,945,946,94E,ANXA1,GBM,INGENUITY,ITGA5,LN229,OVERALL,PATHWAY,U87MG
CERTAIN,MONOCYTES
MALIGNANT,THESE
145,171,AFTER,ANXIETY,BACKGROUND,CONCLUSION,DEPRESSION,EPWORTH,INDEX,LABEL,METHODS,PITTSBURGH,QUALITY,RESULTS,SCALE,SLEEP,SLEEPINESS
002,004,007,008,011,028,045,169,177,AMSTERDAM,ANT,BACKGROUND,CONCLUSION,CSF,DISEASE,DTI,ICARS,INC,LABEL,METHODS,PROCEDURES,RESULTS,SCALE,TASKS,TESLA,TREATMENT,WILEY
DESPITE,EXTENSIVE,GRADE,III,MUTATIONS
AMONG,APRIL,BECAUSE,DNT,JANUARY,RESECTION
169,945,CHB,CHRONIC,COPYRIGHT,FINALLY,FURTHER,HBV,HCC,INC,STUDIES,UNIVERSAL
169,799,ASIAN,BACKGROUND,C228T,C250T,CHINESE,COPYRIGHT,FUNCTIONAL,LABEL,LARGE,LTD,METHODS,RESULTS,SEVERAL,THESE
169,AKT,BRCA1,COPYRIGHT,ERCC1,HOWEVER,INC,SRC,STAT3,THEREFORE
169,177,2MM,3MM,7MM,AFTER,CARLO,CONCLUSION,COPYRIGHT,DUE,FLUKA,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MONTE,OBJECTIVE,OVERALL,PET,PTV,PURPOSE,RESULTS
100,177,CIVIL,CONCLUSION,DEPARTMENT,DOW,INTRA,KARACHI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,UNIVERSITY
160,169,COPYRIGHT,HOWEVER,III,LOCALLY,METASTATIC,PUBLISHED,SAS
169,COPYRIGHT,INC,PRIMARY,PUBLISHED,SOCIETY
001,007,169,AFTER,AHR,COMPARISON,COPYRIGHT,COX,HRT,INC,KARNOFSKY,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OLDER,PURPOSE,RESULTS,SRT,TMZ
001,002,006,019,024,169,515,COPYRIGHT,DFS,INC,THESE
169,215,AC133,CD133,CD3,CD8,CSC,GBM,SCS
169,AUTHORS,BACKGROUND,COPYRIGHT,EVALUATION,GENERALLY,III,LABEL,LTD,METHODS,PFS,PUBLISHED,RESULTS,SEVERAL,SOLID,TESTING,TUMOURS
001,014,025,039,044,061,100,177,DESPITE,END,ENDONASAL,LABEL,MEIER,METHODS,OBJECTIVE,PITUITARY,PREDICTORS,QOL,RESULTS,SEM,SINONASAL,SURGERY
032,144,289,CSF,ELDERLY,ENDOSCOPIC,FIFTY,FORTALEZA,GENERAL,LABEL,MAY,METHODS,OBJECTIVE,PAS,RESULTS,SOCIETY
100,FALSE,GTR,HOWEVER,LABEL,MARGINS,METHODS,MRI,OBJECTIVE,RESULTS,SEVERAL,U87
169,BACKGROUND,COPYRIGHT,GIVEN,HOWEVER,INC,LABEL,METHODS,OWING,PUBLISHED,RADIATION,RESULTS
169,182,945,BBB,BCL2L12,BTB,GBM,GIC,HIF2A,KOURI,LABORATORY,MET,PRESS,PUBLISHED,REPRESSION
169,ALZHEIMER,APP,DR6,LABORATORY,PRESS,PUBLISHED
169,244,BRAIN,DEPRESSION,INCREASED,INVENTORY,LABEL,METHODS,OBJECTIVE,RESULTS
RADIATION,THEREFORE
HOWEVER,JANUARY,OCTOBER
DECREASED,GLASGOW,INCREASED,SCALE,VEP
026,100,116,139,169,374,704,ASSESSMENT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSI,SIXTY,THESE
169,BIOLOGY,EGF,GBM,GENOMIC,INC,MOLECULAR,SOCIETY,THESE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,OVERALL,SUBSEQUENT
169,231,233,COPYRIGHT,PREVENTION,PUBLISHED,SAS,USING
177,BACKGROUND,BLACK,CHARLOTTE,CHBAH,CHRIS,CMJAH,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOTHO
CAVERNOUS,MEDULLARY,MRI
101,160,169,COPYRIGHT,GBM,III,INC,LABEL,MATERIALS,MEIER,METHODS,MGD,MTD,OBJECTIVE,PFS,PHASE,PUBLISHED,PURPOSE,RESULTS,TMZ,TREATMENT
2TV,DYNAMIC,LOGAN,MA1,PET,THESE
169,946,ATLAS,FOXM1,FURTHER,GBM,GSC,PDGFA,STAT3
AVERAGE,BACKGROUND,CONCLUSION,GALEN,LABEL,METHODS,OBJECTIVE,RESULTS
169,484,BIOLOGY,CHROMATIN,FOS,HOWEVER,INC,KV1,MOLECULAR,NUCLEAR,SELECTIVE,SNU,SOCIETY,SP1,THESE,WESTERN
169,946,APC,CBC,MYC,PRESS,PUBLISHED,SNF,SWI,UNIVERSITY
240,344,QDS,THREE,USING
169,16P13,BRAIN,CLEC16A,GUARANTORS,HOWEVER,KNOCKDOWN,PRESS,PUBLISHED,THESE,TREATMENT,UNIVERSITY
169,BACKGROUND,CTCAE,DISTANT,INC,LABEL,MEIER,METHODS,RADIATION,RESULTS,TIMES,TOXICITIES,WILEY
001,169,ATROPHY,BRAIN,DIFFERENT,FRIEDREICH,FUNCTIONAL,GUARANTORS,PRESS,PUBLISHED,THERE,UNIVERSITY,WHEREAS
169,AMONG,COPYRIGHT,FEMALES,INC
169,ALTERATION,BECAUSE,FORMATION,GTP,SOCIETY,WHILE
021,029,169,18K322A,AGE,COPYRIGHT,GD2,INC,LABEL,MANAGEMENT,METHODS,MYDRIASIS,OBJECTIVE,PEDIATRIC,PUBLISHED,PURPOSE,RESULTS,STRABISMUS,THESE
169,340,CONFIRMING,COPYRIGHT,FURTHER,INC
169,AAS,COPYRIGHT,CRE,INC,LOX,MCRS1,RAS,THESE,WHEREAS
AFTER,BROCA,DIFFUSION,DTI,FAT,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
106,182,186,335,517,CONSORTIUM,FACTORS,GAMMA,KARNOFSKY,KNIFE,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS,SIX,SRS,VHL
CSF,EBX,ETV,FOLLOWING,GRADE,JANUARY,LABEL,LESIONS,METHODS,OBJECTIVE,RESULTS,SINCE,SIX,THESE
BETWEEN,ESTIMATED,EWING,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,RFS,THERE,THESE,TOKYO,UNIVERSITY

CSF,METHODS,RESULTS,THERE,USING
169,COLORECTAL,COPYRIGHT,CRNDE,EXPRESSED,HOWEVER,IRELAND,LTD,NEOPLASIA,PUBLISHED,RAPAMYCIN
100,945,AFTER,OVERALL,RCC
177,267,271,ALZHEIMER,ASSOC,BACKGROUND,BEHAVIORAL,CSF,DIS,JAKOB,LABEL,METHODS,OBJECTIVE,PCNSL,RESULTS,RPD,THERE,WHITE
TBARS
LABEL,METHODS,OBJECTIVE,ODD,ODE,OPTIC,PURPOSE,REPORTS
RESPONSES,RESULTS
102,169,225,720,956,CONTROL,HYPOCCS,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SOCIETY,STUDIES,THERE,USING
169,600,ATIII,BACKGROUND,CNS,CSF,III,INC,INHIBITOR,LABEL,METHODS,RESULTS,THROMBOSIS,WILEY
169,DESPITE,EPIDERMAL,HOWEVER,USING
169,CDC20,INC,SIXTY,WEBGESTALT,WILEY
946,CHEST,HCG,HISTOLOGY,PATIENT,THERE
169,HOWEVER,SOCIETY
169,945,946,947,BIOLOGY,CONSISTENT,ERR,EXPRESSION,INC,MCF,MOLECULAR,SOCIETY,THESE,USING
002,004,300,AIM,CONCLUSION,FIFTY,III,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
BACKGROUND,CONCLUSION,LABEL,METHODS
BACKGROUND,IIA,IIB,ITALY,LABEL,METHODS,POPULATION,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
169,EVS,GBM,GSC,PROTEOMIC
001,169,1ST,230,3RD,6TH,745,9TH,ANXIETY,COPYRIGHT,DEPRESSION,DEPRESSIVE,DIMENSION,DISCUSSION,HOWEVER,HUNDRED,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE
945,EXPRESSION,GBM,GLS,THESE
169,200,946,CD4,COPYRIGHT,ENV,HIV,INC,MACROPHAGE,THESE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,MRI,PRIMARY,THEREFORE
169,AFTER,BBB,CNS,COPYRIGHT,HOWEVER,THERE
169,AKT,COPYRIGHT,DESPITE,GBM,IRELAND,LTD,THEREFORE,WNT
169,321,351,672,ALZHEIMER,CHINESE,COPYRIGHT,CYP,FURTHER,HAN,INCREASING,IRELAND,LTD,MALDI,TOF
001,003,011,036,037,048,AFFILIATED,BETWEEN,DEPARTMENT,PROVINCIAL,THERE,UNIVERSITY
001,007,018,025,177,329,PRL
008,021,187,BMS,BRAIN,EIGHT,ESTIMATED,MPNST,SEVEN,STS,THERE,UNIVERSITY
169,19Q,CIC,COPYRIGHT,ERK,FUBP1,FURTHER,H3F3A,HOWEVER,III,INC,NOTABLY,OVERALL,PCR,PEDIATRIC,THESE,TKD
007,AMONG,BRAIN,DISCHARGE,HOWEVER,KARNOFSKY,KPS,METHODS,RESULTS,SCALE,SIXTY,TEXAS,THERE,UNIVERSITY
169,945,BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,PRL,RESULTS,SOCIETY
169,177,247,757,DEPARTMENT,DEPRESSION,DRESDEN,ENDOCRINE,GENERAL,INDEX,INSTITUTE,INVENTORY,LABEL,MAX,METHODS,OBJECTIVE,OBJECTIVES,OUTPATIENT,PITTSBURGH,PSYCHIATRY,PSYCHOLOGY,QOL,QUALITY,RESULTS,SCREENING,SETTING,SEVERAL,SLEEP,SOCIETY,TECHNICAL,THESE,UNIVERSITY,VAS
169,ALZHEIMER,COPYRIGHT,INCREASING,LTD,MISFOLDED,MODULATION
169,BACKGROUND,CCM,DELTA,HBEGF,HEART,INC,LABEL,METHODS,NG2,NOTCH,OBJECTIVE,PDGFRB2,PERICYTES,PURPOSE,RESULTS,S1P,TGFB1,TRANSGENIC
215,AFTER,FIFTEEN,GIANT,LIMITED
169,AML,INC,LOH,WILEY,WILMS
119,169,AMONG,BACKGROUND,BECAUSE,CONCLUSION,INC,LABEL,METHODS,OVERALL,PARTIAL,PROCEDURE,RESULTS,SCALE,SEVEN,THERE,THREE,WILEY
CUSHING,FOLLOWING
100,APC,CRC,FBXW7,SMAD4,SOMATIC,SYNE1
8G7G3,SPT24,TTF
169,COPYRIGHT,INC
169,CNS,COPYRIGHT,IMAGING,INC,MRI,TODAY
160,169,224,BAK,COPYRIGHT,COX,HOWEVER,INC,MEIER,MIR,MTT,PCR
169,531,AFRICAN,AMERICANS,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THESE
001,005,006,050,072,169,180,206,304,310,403,416,446,550,710,738,804,883,965,AII,BACKGROUND,COPYRIGHT,COX,INC,ISOCITRATE,LABEL,METHODS,PATIENT,PFS,RADIOLOGY,RESULTS,THESE,WORLD
345,954,DESPITE,MAP,NOD,RIPK2
67KDA,CURRENT,DUSPS,HOWEVER,KIT,LABEL,MAPKS,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,THEREFORE,WESTERN
177,3DCRT,CONCLUSION,CTV,DMEAN,DVH,GROSS,GTV,LABEL,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS
CALCIUM,CD318,CDCP1,CUB,FUNCTIONAL,ORAI1,STIM1,STOCS,THESE,TRASK
500,946,EIGHT,H1299,ITGB3BP,SHC,SRPK1,USING
169,767,867,CHANGES,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,SIXTEEN,THERE
169,ABCG1,AUTHORS,CD133,COPYRIGHT,GSC,INC,LEVERAGING,LGG,NF1,PUBLISHED,USING
109,151,169,414,470,ANNOTATION,BENJAMINI,CONCLUSION,COPYRIGHT,DFLAT,FUNCTIONAL,INC,IPA,LABEL,METHODS,OBJECTIVE,OMICS,OUTPUTS,RESULTS,T21,TRISOMY,TUFTS,USING
160,SEVEN,WILMS
169,945,946,COPYRIGHT,INC,NOTUM,ORGANIZER,THESE,WNT,XENOPUS
106,169,ABOUT,AIM,BRAIN,CNS,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNLABELLED
109,116,169,BECAUSE,BROADENING,CARLO,COPYRIGHT,DESPITE,INC,LABEL,MATERIALS,METHODS,MEV,MONTE,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,LTD
169,ALZHEIMER,COPYRIGHT,FINALLY,ISSUE,NEUROLOGY,NGS,SPECIAL
169,COPYRIGHT,INC,THESE
169,BACKGROUND,COEXISTING,CONCLUSION,COPYRIGHT,DIFFUSION,DTI,INC,LABEL,METHODS,RESULTS,THREE
CENTRAL,MRI,SOUTH,TRANS,UNIVERSITY,XIANGYA
169,ATAXIN1,ATXN1,COPYRIGHT,INC,SEEKING,THESE
185,BECAUSE,BRAIN,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,TREATMENT
169,HEART,INC,UNTIL
169,392,946,BIOLOGY,ERK,INC,MH2,MOLECULAR,R175H,SER,SILENCING,SMAD2,SMAD3,SMAD4,SOCIETY,TGF
154,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,ENGLAND,FIFTY,LABEL,LTD,MATERIALS,MAY,METHODS,MRI,NETWORK,OBJECTIVE,PUBLISHED,RESPONSES,RESULTS,ROYAL,THERE
169,CNS,IOC,SOCIETY
169,AWARENESS,COPYRIGHT,FACTORS,INC,LABEL,METHODS,OBJECTIVE,PREVIOUSLY,RESULTS,SCALP,SPREADING
169,COPYRIGHT,LTD,THERE
013,018,027,063,160,177,215,BACKGROUND,DOSIMETRY,FFF,FLATTENING,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS,THEREFORE,THREE,U87
ENDONASAL,TSS
AFTER,DCS,WHILE
LYG
AKT,AMONG,COMPARING,EXPRESSION,GBM,HOWEVER,KARNOFSKY,MICRORNAS,PCR,SCALE,TGF,THREE
BBB,HOWEVER,PARKINSON,THESE
ANCHORAGE,H2009,SIMILAR
003,008,013,035,113,150,169,ADVERSE,BMS,CONCLUSION,CONCURRENT,COPYRIGHT,COX,FIFTEEN,GRADE,INC,IPI,IPILIMUMAB,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SRS
602,MIA,MMP,PAPILLARY,PTC,SIMILARLY,SV1,THYROID
169,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,DETECTION,GPA,INC,LABEL,LTS,METHODS,PRESENTING,PROGNOSTIC,QOL,RESULTS,RPA,SRS
169,945,946,CONCLUSION,COPYRIGHT,CSC,DCC,DLQ,FITTING,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLQ,SMALLER
108,169,370,495,BASED,COPYRIGHT,DIR,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
169,359,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SASKATOON,SEVENTY
043,169,364,389,AUTHORS,COPYRIGHT,HRS,INC,IPD,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,RPA,SRS,THREE
ADDITIONAL,AIM,ASIAN,BACKGROUND,BURKITT,CASES,CD3,CONCLUSION,DLBCL,EXCLUSION,GCB,HODGKIN,INCLUSION,INDIA,LABEL,MATERIALS,METHODS,MIB,NON,OBJECTIVE,PCNSL,PRIMARY,RESULTS,SOUTH,THERE
MONRO
001,015,049,120,130,177,225,ANOVA,BACKGROUND,CONCLUSION,COX,FRONTAL,GROUP,HOWEVER,LABEL,MATERIALS,MBT,MEIER,METHODS,OVERALL,RESULTS
001,002,130,169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GBM,INSTITUTE,LABEL,METHODS,PFS,RESULTS,TREATMENT
169,ANTICANCER,COPYRIGHT,GBM,INSTITUTE,LN229,P53,THERE,U87,WHILE
169,ANTICANCER,COPYRIGHT,GBM,HOWEVER,III,INSTITUTE,PFS,PHASE
169,945,946,947,BIOLOGY,HOWEVER,INC,LYSOSOMES,MOLECULAR,SOCIETY
HOWEVER,KNOCKDOWN,NF2,YES
000,150,800,900,CORRECTED,COSTS,GAMMA,HODGKIN,LABEL,METHODS,OBJECTIVE,PER,RESULTS,ZEALAND
100,169,170,AFTER,BACKGROUND,COPYRIGHT,CRUDE,GTR,INC,LABEL,LIMITED,METHODS,OVERALL,PAPILLARY,RESULTS,WORLD
009,100,169,ADC,ASSIGNMENT,BSC,CONCLUSION,CONTINUOUS,COPYRIGHT,CST,DTI,FAS,FIBER,FRACTIONAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WHITE
160,169,COPYRIGHT,EMF,INC,NUMBERS,PREVIOUSLY,SAR,SINCE
160,169,BIOLOGY,COPYRIGHT,INC,PERIOSTIN,POSTN
001,169,847,903,AUC,BACKGROUND,CONCLUSION,COPYRIGHT,FET,III,IRELAND,JANUARY,KARNOFSKY,LABEL,LTD,MAY,METHODS,MRI,PET,REGARDING,RESULTS,ROC,SCALE,VOI
GADOLINIUM,HOWEVER,INITIALLY,THEREAFTER
RESECTION
AFTER,CONTROL,HOWEVER,METASTATIC
169,405,624,COPYRIGHT,INC,INDIVIDUAL
160,169,19Q13,C19MC,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN
169,894,BACKGROUND,COPYRIGHT,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,RESULTS,THERE
108,194,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WORLD
300,CPS,DCS,ERS,ERT,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PTI,REPETITIVE,RESULTS,YET
177,AFTER,AUGMENTED,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
122,CNS,CONVERSELY,GRADE,III,LABEL,LARGE,METHODS,MRI,MRS,OBJECTIVE,RESULTS,USING
169,BACKGROUND,COPYRIGHT,CROWN,INC,LABEL,METHODS,OIT,PATHOLOGIC,PUBLISHED,THESE
BESIDES,HDACI,HDACS
177,956,AFTER,METHODS,RESULTS,THERE
132,169,CONCLUSION,FDG,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
BRAIN,EVENTUALLY,HOWEVER,MRI
CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,UNLABELLED
735,BACKGROUND,CHILDHOOD,LABEL,METHODS,RAS,RASOPATHY,RESULTS,SIR,SOMATIC,THESE
001,008,252,291,CLEVELAND,DETAILS,DISTANT,HOWEVER,HPV,III,IMPORTANCE,IMPORTANT,IVB,JANUARY,LABEL,METHODS,OBJECTIVE,OPSCC,RELEVANCE,RESULTS,SECONDARY,SETTING
001,169,954,BACKGROUND,BONFERRONI,COX,GBM,HOWEVER,LABEL,MEIER,METHODS,PFS,PRESS,PUBLISHED,RESULTS,STUDENT,SURGICALLY,UNIVERSITY
AKT,GBM,GIVEN,HGG,NTV,PDGFB
001,169,APHASIA,BACKGROUND,COX,HEART,INC,INSTITUTES,LABEL,METHODS,OBJECTIVE,PNEUMONIA,PURPOSE,RECURRENCE,RECURRENT,RESULTS,SCALE,TIA
169,DEPLETION,LABORATORY,PRESS,PUBLISHED,THESE,UNKEMPT
169,ALLEN,ATLAS,BRAIN,CNS,COPYRIGHT,GERMINOMAS,HOWEVER,INC,KIT,THEREFORE
03012,169,945,ABCB1,ABCG2,AUTHORS,BIP,DECREASED,ERBB1,FGF,GBM,GRP78,HSP70,HSP90,HSPA5,INC,INHIBITION,JOURNAL,OSU,PHYSIOLOGY,PUBLISHED,SILDENAFIL,TREATMENT,WILEY
169,BRITISH,JOURNAL,PRESS,PUBLISHED,TULVING,UNIVERSITY
169,BACKGROUND,CLINICALLY,LABEL,MEDICAL,METHODS,RESULTS,SOCIETY,USING
139,FACTORS,IBS,IMPORTANCE,IRRITABLE,LABEL,MANAGEMENT,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,REVIEWS,SYSTEMATIC,VARIOUS
645,749,AMONG,BACKGROUND,CRUDE,DIAGNOSIS,HODGKIN,LABEL,METHODS,RESULTS,SIMILARLY
SBP,THERE
169,231,233,COPYRIGHT,III,LARGE,PUBLISHED,SAS,WESTERN
144,169,320,COPYRIGHT,HOWEVER,INC,INITIAL,KNOSP,LABEL,METHODS,OBJECTIVE,RESULTS
AMP,BRAIN,BTICS,CAMK2,DOWNSTREAM,GLUT3,TARGETING
110,147,169,530,764,COPYRIGHT,FIRST,GOLDENGATE,HNSCC,SNP,UTR
169,368,452,ASA,CESSATION,COPYRIGHT,FLORIDA,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,UNIVERSITY
169,ANY,HOWEVER,LESIONS
ABDOMINAL,BRAIN,FINALLY,FSH,MRI,PROLACTIN
169,ABCG2,BIOMARKERS,CD271,COPYRIGHT,IRELAND,JARID1B,LTD,MMP,RESISTANT,V600E
169,ABL,ATP,COPYRIGHT,DDX3X,G302V,G325E,LTD,MUTANTS,NMR,PUBLISHED,TAKEN,THESE
169,946,ALZHEIMER,BIOLOGY,CLASSICAL,IGG,INC,MOLECULAR,SOCIETY
169,ALCOHOL,COPYRIGHT,DISORDERS,EFFECTIVE,FOCUS,HARMFUL,IRELAND,LTD,PUBLISHED
001,003,028,063,169,200,252,452,CAUCASIANS,CHINESE,COX,GLEASON,LABEL,MEIER,METHODS,OBJECTIVE,POTENTIAL,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
148,160,177,407,CD1,ECF,THEREFORE,THESE
100,AFTER,BACKGROUND,CONTEXT,LABEL,METHODS,MIB,OBJECTIVE,RESULTS
130,AFTER,BECAUSE,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,130,131,135,319,AFTER,FURTHER,LABEL,LOWER,METHODS,OBJECTIVE,OUTCOME,PEDIATRIC,RAPID,RESULTS,THESE
CENTRAL,CHESTER,ECD,ERDHEIM,LANGERHANS,MENINGEAL
AFTER,DOPPLER,ICA,ICG,LABEL,METHODS,OBJECTIVE,RESULTS
CSF,EEA,GROSS,HOWEVER,LABEL,LEAKAGE,METHODS,OBJECTIVE,RESULTS,TVC
181,AED,FLAIR,HOWEVER,LABEL,LGG,METHODS,MRI,OBJECTIVE,RESULTS,THERE,THESE,TOTAL
169,CONCLUSION,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PARAMETRIC,PET,PK11195,RESULTS,SOCIETY,UNLABELLED
169,AKT,BRAIN,GUARANTORS,IIA,PRESS,PUBLISHED,SEQUENCING,UNIVERSITY,WHILE
143,175,427,700,AUDIT,AUSTRALIAN,CONCLUSION,DONATELIFE,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,POTENTIAL,RESULTS,SETTING,SEVENTY,SIX,TEN,THESE
001,191,954,ABORIGINAL,AFTER,CONCLUSION,CROSS,LABEL,MEASURE,METHODS,NSW,OBJECTIVE,OUTCOME,OVERALL,RESULTS,RRR,SETTING,SOUTH,WALES
001,003,034,169,320,410,ACADEMY,CLASS,CNS,CONCLUSION,HDMTX,III,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PCNSL,PFS,RESULTS
160,956,ABCB1,BBB,FDG,PET
001,120,125,169,190,ACADEMY,CHART,CROSS,FOUNDATION,LABEL,METHODS,NASOSEPTAL,OBJECTIVE,OBJECTIVES,PEDIATRIC,RESULTS,SETTING,SURGERY
000,20000,ALA,BACKGROUND,CONCLUSION,EXTENSIVE,LABEL,METHODS,NOVEL,OBJECTIVE,PORTUGUESE,RESULTS,SERVICE,TRANSITION,UTILITY
169,GBM,HOWEVER,III,SOCIETY,THESE,TREATMENT
169,AKT,GBM,GSC

BECAUSE,EVERY
BMJ,GROUP,IDC,LIMITED,METASTATIC,OESTROGEN,PUBLISHED,PUBLISHING
179,BACKGROUND,CONCLUSION,DOPPLER,IAS,JANUARY,LABEL,METHODS,OBJECTIVE,RECORDS,RESULTS,SCD
160,169,AMONG,AUTHORS,COPYRIGHT,EGF,INC,P14,PP2,PRIMARY,PUBLISHED,RMS,S1386,S1416,SIGNALS,SILENCING,SRC,THESE,Y1764,Y1798
188,215,217,484,727,901,CACNA1A,JAPAN,LOXL1,SNP,XFS
009,017,055,169,177,AGGRESSIVE,BACKGROUND,CENTRAL,FOLLOWING,GROUP,INC,LABEL,METHODS,NPSPNET,PFS,PNETS,PROCEDURE,RESULTS,THERE,WILEY
003,BACKGROUND,BEV,CBDCA,FORTY,GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SECONDARY,THESE
IRINOTECAN
SRS
ACVR1,OTHERWISE,PEDIATRIC,SURGERY,THESE
169,946,COPYRIGHT,SMAD2,TGF
169,ANATOMICAL,COPYRIGHT,IMAGING,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESONANCE,RESULTS,TOMOGRAPHY
169,ATTENTION,COPYRIGHT,FIFTEEN,GKS,HOWEVER,INC,INITIAL,LABEL,METHODS,NFPAS,OBJECTIVE,RESULTS
169,177,BACKGROUND,CONCLUSION,COPYRIGHT,EOR,INC,LABEL,METHODS,MRI,PFS,RESULTS,SIX,TEN,THERE
169,ALS,COPYRIGHT,SCIENCE,SEVERAL,THESE
AFTER,CRANIAL,GCA,MRI,THREE
150,177,574,DAI,GIVEN,GLASGOW,LABEL,LEVEL,MEDICAL,METHODS,MRI,OBJECTIVE,RADIOLOGY,RESULTS,SCALE,SCORE,STATA,THI,TRAUMATIC
AMONG,CRT,GIVEN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,TEN,THREE
11Q23,169,BCP,HOWEVER,MLL,MOLECULAR,OVERALL
111,169,177,296,AROMATASE,CONCLUSION,IMAGING,INC,LABEL,LIVER,MBQ,MEN,METHODS,MOLECULAR,NUCLEAR,ORGAN,PET,RESULTS,SOCIETY,SUV,UNLABELLED,YOUNG

169,BRAINSTEM,CEREBELLAR,COPYRIGHT,EOR,FORTY,INC,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
CNS,CSF,ELISA,III,SERUM
19Q13,C19MC,EMBRYONAL,HISTOLOGY
169,HEMATOLOGY,HOWEVER,RBC,SOCIETY
169,ACADEMY,BRAIN,HOWEVER,MRI,NEUROLOGY,NMO,NMOSD,SINCE,THEREFORE
168,ADDITIONAL,BACKGROUND,CONCLUSION,CONTEXT,IGF,LABEL,METHODS,PAS,PHEOS,PRL,RESULTS,SDH,USING
169,16P11,CNV,COPYRIGHT,INC,RECURRENT
140,154,207,347,609,611,618,620,C611Y,C618R,C618S,C620F,C620G,C620R,IRANIAN,MEDULLARY,MEN2A,MEN2B,MTC,PCR,REARRANGED,RET,THYROID
CHINA,CONCLUSION,JANUARY,LABEL,MATERIALS,MEDICAL,METHODS,MRI,OBJECTIVE,PROVINCIAL,RESULTS,THESE,WHILE
130,246,AMONG,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,XELOX
BRAIN,FEW,LABEL,METHODS,OBJECTIVE,RESULTS,SIX,THERE,THREE
177,BACKGROUND,BENIN,CONCLUSION,CONTEXT,LABEL,METHODS,OPTIC,RESULTS,THEIR,THERE,UNIVERSITY
001,102,169,400,946,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PITUITARY,PTCH1,RESULTS,SHH,SMO,SOCIETY,SONIC,WNT
111,CONSORTIUM,NIH,ROADMAP
169,BIOLOGY,BRAIN,CLAUDIN,INC,KNOCKDOWN,MOLECULAR,SOCIETY
BRAIN
117,169,865,BACKGROUND,CALIFORNIA,COLLEGE,COPYRIGHT,COX,FRANCISCO,HCC,INC,LABEL,METHODS,MILAN,OVERALL,PUBLISHED,RESULTS,SAN,UNIVERSITY
215,HISTOLOGIC,MRI,NEUROLOGIC,NHP,THESE,THREE
169,BIOLOGY,EG5,ENDOGENOUS,GFP,INC,MOLECULAR,SOCIETY,THR,USING,XENOPUS
169,CA1,GRANULE,USING
DESPITE,HISTOLOGY,POSTNATAL,WORLD
SEVERAL,THESE
100,105,CST,DTI,FAT,HOWEVER,IMAGING,KARNOFSKY,KPS,LOW,MRI,RMT,ROI,SCALE
160,BACKGROUND,BRAIN,CONCLUSION,FUNCTIONAL,IMAGING,LABEL,LIS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
150,26S,300,3T3,945,949,956,CONCLUSION,LABEL,MALDI,MATERIALS,METHODS,NIH,NOC,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,TOF
110,173,CONCLUSION,FURTHER,GROSS,GTR,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TOTAL
BACKGROUND,CCNB3,CIC,FOXO4,GENERALLY,LABEL,METHODS,NEWER,RESISTANCE,THEIR
DLBCL,FDG,HOWEVER,PET,THEREFORE
200,250,400,956,PHENYTOIN,SINCE,THREE
169,ANOTHER,AUTHORS,COPYRIGHT,HOWEVER,INDUCTION,LAMP1,LAMP2,LAMP3,PARKINSON,PREVENTION,PUBLISHED,UPR
169,603,946,CONVERSELY,COPYRIGHT,GLIOMAS,IRELAND,LTD,MICRORNAS,MIR,PEARSON,WNT
169,ALZHEIMER,BRAIN,CHARCOT,COPYRIGHT,ISSUE,MARIE,PARKINSON,PIP,SPECIAL,TOOTH
001,129,169,COPYRIGHT,GROUP,INC,LABEL,LGG,MATERIALS,METHODS,MST,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THREE,TMZ
169,COPYRIGHT,FAK,INC,MEANWHILE,THEREFORE,THESE,TMZ,TSPN8,U87MG
229,ECTOPIC,FINALLY,INTERFERON,TAKEN
138,168,215,LABEL,METHODS,OBJECTIVE,RESULTS
104,234,303,776,BUR,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
002,004,007,010,017,020,027,028,041,045,048,094,158,165,170,177,288,367,789,872,909,922,972,LABEL,METHODS,MRI,OBJECTIVE,RCC,RECURRENCE,RESULTS,SIXTEEN
169,BACKGROUND,BASED,DESPITE,DISCUSSION,EUSTACHIAN,HOWEVER,LABEL,METHODS,RADIOLOGIC,SUBSEQUENT
169,BASEL,COGNITION,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THESE,USING,WOMEN
169,946,947,CD8,COPYRIGHT,IFN,INC,MICRORNAS,TGF,TH1
140,169,180,740,ACUTE,BACKGROUND,BLOOD,HEART,HEMORRHAGE,INC,INTENSIVE,INTERACT2,IVH,LABEL,METHODS,OBJECTIVE,PURPOSE,REDUCTION,RESULTS,SCALE,TRIAL,URL
18F,AMONG,BESIDES,FDG,PET
THROUGH
947,948,HOWEVER
169,946,CEDIRANIB,COPYRIGHT,CXCR4,DESPITE,GBM,HGF,IRELAND,LTD,MET,TGF,VANDETANIB,VEGFR
AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TOXICITIES
99MTC,AHX,BRAIN,GLU,LYS,MDP,PET
201,273,355,781,810,817,831,FDG,FIFTY,III,PET,SPECT,SUVRMAX,THEIR,TURMEAN
001,177,ELF,HOWEVER,MFS,ROBOTIC,WHITNEY
500,COX,DDD,HOWEVER,INSURANCE,LOE
4TH,ENGLISH,IEAES,THEREAFTER
AFTER,CD117,MRI
CD271,FURTHER,HOWEVER,METASTASES,PRIMARY
ASSESSMENT,HOWEVER,MIB,PIS,THEREFORE
001,012,021,022,026,032,143,960,GST,MNSOD,PRIMARY,ROS,TXNIP,UNIVARIATE
001,014,027,037,196,19Q,1P19Q,CLINICALLY,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
000,001,026,100,102,19Q,AFFILIATED,CHROMOSOME,CONCLUSION,COX,FIRST,LABEL,LOH,MEDICAL,MEIER,METHODS,OBJECTIVE,RESULTS,SOX17,UNIVERSITY
584,COMPELLING,LUCIFERASE,MICRORNAS,PTTG1IP,THESE,U87
TERATOMAS
160,215,224,339,BMI,METABOCHIP,OBESITY,PATHWAY
160,215,224,459,BMI,PATHWAY
CENTRAL,CNS,EIGHT,GTR,KARNOFSKY,KPS,SIX,STR,VPS
155,FURTHER,HMG,PEARSON,SILENCING,TAKEN,UTR,WNT
233,2CM,JAPAN,MRI,SCALE,WORLD
CONSORTIUM,HOWEVER,JAPAN,MAGIC,MOLECULAR,SHH,THESE,WNT
169,873,BIOLOGY,GBM,IGF2BP1,INC,MOLECULAR,SOCIETY,THESE
169,BIOLOGISTS,COMPANY,CRH,LTD,PUBLISHED,THESE
BMJ,BRAIN,GRADE,GROUP,HOWEVER,LTD,MRI,PUBLISHING
169,BRAIN,COPYRIGHT,INC,THERE
239,BBB,DESPITE,FINALLY,HSA,LOCAL,THESE,VARIOUS
BESIDES,SEGAS,THYROID,TSC,TTF
169,BBB,BRAIN,CNS,HOWEVER,SOCIETY
169,250,635,BACKGROUND,CAUSE,COX,DIETARY,HEART,INC,INPATIENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SWEDISH,THESE,TRIAL,URL
CNS,HOWEVER,IGG,NMO
19Q,272,945,ACCORDING,IDH,III,MOLECULAR,REMARKABLY,WORLD
169,AIM,ANTICANCER,CNS,CONCLUSION,COPYRIGHT,CSF,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,PPS,RESULTS,T790M,TKI
001,125,169,182,198,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DFS,INSTITUTE,LABEL,METHODS,OBJECTIVE,RAS,RESULTS,SERUM,SMS
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,EASTERN,GROUP,HOWEVER,INSTITUTE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PITUITARY,RESULTS
169,18F,215,803,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FLT,III,INSTITUTE,LABEL,LSO,MBQ,METHODS,OBJECTIVE,PET,PRE,RESULTS,SAMPLES
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,INSTITUTE,LABEL,METHODS,MRI,PREVIOUSLY,STATE,TOTAL
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EDU,EMT,HOWEVER,INSTITUTE,LABEL,MATERIALS,METASTATIC,METHODS,MTT,RESULTS
169,ANTICANCER,COPYRIGHT,CURRENT,GRADE,INSTITUTE,THERE
001,024,169,177,886,CGH,CONCLUSION,EXOME,HGG,LABEL,METHODS,OBJECTIVE,PLGGS,PURPOSE,RESULTS,SOCIETY,V600E
001,004,169,BRAIN,CONCLUSION,HRQOL,LABEL,LGG,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SHORT,SOCIETY,TREATMENT
169,COPYRIGHT,MELATONIN,MRI,PARTNER,PUBLISHED,SCN,SIX,SOCIETY,URBAN
001,166,169,177,258,268,424,579,CONCLUSION,COPYRIGHT,LABEL,METHODS,NEUTROPHIL,PARTNER,PUBLISHED,RESULTS,ROC,SOCIETY,UNLABELLED,URBAN
169,291,335,CONCLUSION,COPYRIGHT,GRADE,LABEL,MEIER,METHODS,OBJECTIVE,PARTNER,PFS,PUBLISHED,RESULTS,SOCIETY,URBAN
169,231,233,COPYRIGHT,PUBLISHED,SAS
BMJ,EDH,GROUP,LTD,MULTIFOCAL,PUBLISHING
BMJ,GROUP,LTD,MRI,PUBLISHING
169,BRAIN,GUARANTORS,HAYLING,LESIONS,OVERALL,PRESS,PUBLISHED,THERE,UNIVERSITY
215,238,ACYP2,THESE
19Q,ADULT,FGFR1,LGG,LOW,PEDIATRIC,THESE
256,AFTER,BACKGROUND,CURRENT,HOWEVER,LABEL,METHODS,NODAL,OBJECTIVE,OUTCOME,PATIENT,RESULTS
HOWEVER,SMALL,THESE
421,466,894,ART,BACKGROUND,CONCLUSION,CONTEXT,ELDERLY,GBM,KARNOFSKY,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,RECIPIENTS,RESULTS,SCORE,SRT
181,321,401,479,583,BACKGROUND,DESPITE,FORTY,FURTHER,GBM,HOWEVER,JANUARY,LABEL,LMS,METHODS,MTX,PREDICTION,PROXIMITY,RESULTS,TREATMENT,YOUNGER
169,183,300,340,341,517,559,ARG145GLN,BACKGROUND,CIS,COPYRIGHT,CULTURE,DISEASE,DISORDERS,EDUCATION,FOUNDATION,FUNDING,FURTHER,JAPAN,LABEL,LTD,METHODS,PARKINSON,PROMOTION,RELATED,RESULTS,SCIENCE,SCIENTIFIC,SOCIETY,TECHNOLOGY,THREE,TOKYO,UNIVERSITY,WELFARE
169,AUHCR,BACKGROUND,CHOROID,CONCLUSION,CPC,CURRENTLY,INC,LABEL,METHODS,PROCEDURE,RESULTS,SEVEN,START,TEN,THREE,WILEY
169,231,233,COPYRIGHT,PUBLISHED,SAS,THESE
169,231,233,COPYRIGHT,HOWEVER,PUBLISHED,SAS,WHOLE
BMJ,FAILING,GROUP,LTD,PUBLISHING
169,BRAIN,COPYRIGHT,INC,SIXTY,THESE
ANOVA,BACKGROUND,BMJ,BRONCHIAL,GROUP,HEALTHCARE,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,SAMPLES
000,100,169,743,AGE,AUTHORS,COPYRIGHT,ENGLAND,EPISODE,GBM,HOWEVER,INCIDENCE,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERVICE,STATISTICS,THERE
169,BRAIN,COPYRIGHT,INHERITED,ISSUE,SPECIAL,THEIR,THESE
GLI,PATCHED,SEVERAL,SMO
169,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,MICRORNAS,THBS1,THESE,USING
047,115,169,992,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,LOCAL,METHODS,NSCLC,RESULTS,SRS
001,003,023,111,386,AGGREGATE,GAMMA,KNIFE,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS,THEREFORE
001,026,643,AVM,BROCA,HOWEVER,METHODS,MRI,RESULTS,RIGHT
001,356,CALIFORNIA,DATABASES,FLORIDA,HEALTHCARE,ICD,IMPORTANT,INPATIENT,LABEL,METHODS,OBJECTIVE,QUALITY,RESULTS,STATE,THESE
001,002,137,GRADE,GTR,METHODS,MRI,RESULTS
177,LABEL,METHODS,OBJECTIVE,RESULTS
BECAUSE,KNOWN,MRI,SRS
169,BIOLOGICAL,COPYRIGHT,D10,EFFICIENCY,IRELAND,LTD,SF2
169,231,233,ALK,COPYRIGHT,PUBLISHED,SAS,SEVERAL
160,169,231,233,COPYRIGHT,CTLA4,MEK,MELANOMAS,PD1,PUBLISHED,RAF,SAS,STUDIES,UNTIL
001,160,169,979,AGE,COPYRIGHT,INC,INDEX,JANUARY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SIMPSON,VARIABLES
100,875,879,886,CHINA,EPIDERMAL,FURTHER,JANUARY,LDA,NSCLC,PRIMARY,SOUTHWEST,SVM,USING
102,106,127,135,169,AFTER,COPYRIGHT,HOWEVER,STG,SUBSEQUENT,THERE,THESE
BACKGROUND,CMF,EARLY,EVD,KEY,LABEL,METHODS
169,AUTHORS,HOWEVER
HOWEVER,LABEL,METHODS,MRE,OBJECTIVE,PURPOSE,REASONABLE,RESULTS
CARLO,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,SPATIAL
215,256,448,992,998,CURRENT,IMAGE,LABEL,METHODS,MRI,NKS,OBJECTIVE,PURPOSE,RESULTS
ASIDE,BACKGROUND,BEHAVIORAL,CAUCASIAN,CONCLUSION,LABEL,METHODS,SINCE,THREE
BECAUSE,COMBINING,HOWEVER
000,003,021,103,105,163,169,177,BMI,CRP,INITIAL,LABEL,METHODS,OBJECTIVE,PEDIATRIC,PFS,RESULTS,SOCIETY,USING
003,008,169,BACKGROUND,GAMITRINIB,GBM,LABEL,MECHANISMS,METHODS,NOVEL,PI3KI,PRESS,PUBLISHED,RESULTS,SER,SER31,SMALL,THR,UNIVERSITY
002,028,169,361,929,945,BACKGROUND,COX,FIFTEEN,HEART,HOWEVER,INC,LABEL,METHODS,MODEL,OBJECTIVE,PREMATURE,PURPOSE,RESULTS,SEVERAL,WILLEBRAND
169,BRAIN,COPYRIGHT,PUBLISHED,SAS
169,COPYRIGHT,FLAIR,MRI,PET,PUBLISHED,SAS
169,FERTILITY,OVARIAN,SOCIETY,STUDIES
169,288,BACKGROUND,BIALLELIC,BRAIN,COLORECTAL,CONCLUSION,EAN,HEREDITARY,LABEL,LYNCH,METHODS,MMR,OBJECTIVE,PRIMARY,PURPOSE,R132H,RESULTS
ALZHEIMER,AMONG,BIO,POC,SENSORS
1GENE,AFTER,FIFTEEN,ICE,INI,LABEL,MAXIMAL,MEDICAL,MEIER,METHODS,MIB,MRI,OBJECTIVE,OVERALL,PRESENTING,RESULTS,THERE,UNIVARIATE,VAC,YOUNG
100,ANOTHER,CONTEXT,LABEL,LAPTS,LOCALLY,METHODS,MSH,OBJECTIVE,OUTCOME,PARTIAL,PRL,RESULTS,SETTING,THREE,TMZ
169,DESPITE,MSC,PRESS,THEIR
003,169,215,232,259,328,378,591,945,COMPARING,HOWEVER,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,S100B,THEREFORE,UNIVERSITY
169,177,742,BACKGROUND,CIS,CONCLUSION,COX,HOWEVER,HRS,LABEL,METHODS,NUTRITION,OBJECTIVE,RESULTS,SOCIETY
169,ARGONAUTE,BIOLOGY,FINALLY,GDF15,INC,MOLECULAR,SF3B2,SOCIETY
169,180,956,ACCORDING,DOPAC,DOPAL,DOPET,ENDOGENOUS,MECHANISMS,NAD,PARKINSON,SOCIETY,VESICULAR
169,177,COPYRIGHT,DCA,HOWEVER,INC,PUBLISHED,SRS,SRT,V12GY
CHRONIC,NMDAR,REMOVAL
AKT,BACKGROUND,CNS,ERK,HOWEVER,LABEL,MEK,METHODS,RAF,RAS,RESULTS,U0126,USING,VZS,ZEBRAFISH
000,001,003,027,169,187,285,328,344,441,526,680,775,876,APRIL,CHB,CONCLUSION,CUMULATIVE,EARLY,HCC,LABEL,LIVER,SCC,UNLABELLED
169,AKT,CHM,COPYRIGHT,FURTHER,GBM,GBM8401,IGF,IRELAND,LTD,PDGFR
000,250,600,603,948,SEQUENTIAL
169,BACKGROUND,COSTING,LABEL,METHODS,RESULTS,SOCIETY,TOOLS
160,169,510,900,CHINA,COPYRIGHT,ELISA,GENOMIC,HOWEVER,IGG,IRELAND,LTD,PCR,PREVALENCE,THREE,TOXOPLASMA
169,AUTHORS,FURTHER,G3H,GFP,HGF,HOWEVER,LTD,MET,PTY,PUBLISHING,SCIENCE,SMALL,THEREFORE,THESE,WILEY
160,169,AUTHORS,BECAUSE,COPYRIGHT,HOWEVER,INC,PUBLISHED
158,956,AFTER,BACKGROUND,DDP,EXPRESSION,LABEL,MACC1,MATERIALS,METHODS,MTT,PCR,RESULTS,SILENCING,THERE,WESTERN
000,100,109,112,138,150,684,999,BACKGROUND,FAO,HOUSEHOLD,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,SHATT,THESE
128GY,13PTS,169,176,182GY,18PTS,43PTS,48PTS,51GYE,52PTS,618ML,ACC,AUTHORS,BACKGROUND,BED,C12,CONCLUSION,COPYRIGHT,CTC,DESPITE,III,IRELAND,LABEL,LTD,METHODS,NCI,OBJECTIVE,PTS,PUBLISHED,RESULTS,TREATMENT
000,169,250,ABCG2,ALA,ATP,HOWEVER,INC,PDD,PDT,PRIMARY
169,ABC,ATP,CNS,INC,TARGETING,THESE
169,ABC,ABCB1,ABCG2,ATP,INC,THESE
169,231,233,ANTICANCER,BRAIN,COPYRIGHT,CURRENTLY,DIFFERENT,PUBLISHED,SAS,SUPPORTIVE,THESE
169,COPYRIGHT,FINALLY,GIVEN,HOWEVER,III,PUBLISHED,SAS,SELECTION
169,1MM,COPYRIGHT,MRI,PUBLISHED,SAS
946,948,GSK
510,CORRECT,CSS,CUSHING,HOWEVER,METHODS,MRI,RESULTS
169,ASTROCYTES,BRITAIN,COPYRIGHT,GREAT,HOWEVER,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
BACKGROUND,CONCLUSION,LABEL,LFS,METHODS,THEIR
001,122,131,BRAIN,COX,EFFECTS,LOCAL,MEIER,SRS
007,111,169,19Q,AFTER,ANAPLASTIC,AOA,CODELETED,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCV,PFS,PURPOSE,RESULTS,TMZ
169,7TM,FASEB,LY2940680,MRT,SMO,SMOOTHENED,USING
169,231,233,ASSESSMENT,COPYRIGHT,PROGNOSTIC,PUBLISHED,SAS,THESE
169,231,233,COPYRIGHT,PUBLISHED,SAS,SEVERAL,THESE
METASTATIC,SEVERAL
CUSHING,DUE,THESE
FORTY,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS,TRANSIENT
18F,BACKGROUND,BESIDES,FDG,LABEL,METHODS,PET,RESULTS,SPM,UNIVERSITY,ZHENGZHOU
AMONG,HENCE,HOWEVER,JXG,LANGERHANS,LCH
169,AIF,COPYRIGHT,ENDOSOMAL,FOLLOWING,LRP,PAI,REVERSIBLE,SOCIETY
169,ECM,GBM,ORTHOTOPIC,RHO,TIC,TRANSWELL,VIRTUALLY
DIAGNOSING
001,CHINESE,MEDICAL,OLFACTORY,OUTCOME,SHORT,SINONASAL
185,BRAIN,PET

169,ATM,BIOLOGY,BRAT1,FOLLOWING,HOWEVER,INC,MOLECULAR,NEDD4,SOCIETY,THESE,UNDER,WITHOUT
600,800,BRAIN,CO2,DESPITE,EARTH,HYPOTHESIS
451,BVS,EFFECTIVE
007,BACKGROUND,BIO,KNS42,LABEL,METHODS,PAEDIATRIC,RESULTS,SF188,THEIR
BRAIN,HISTOLOGY,NSCLC
169,340,AMONG,GIC,TAKEN
120,169,APRIL,FORTY,LABEL,METHODS,MRI,NFPAS,OBJECTIVE,RESULTS,SIXTY,SOCIETY
BURKITT,CONCLUSION,CONTEXT,EBV,EPSTEIN,FURTHER,HODGKIN,LABEL,METHODS,OBJECTIVE,PCR,PREVALENCE,RESULTS,SETTING
169,29A,29S,COPYRIGHT,EXOGENOUS,IRELAND,LTD,THESE,U87MG
ABDOMINAL,BRAIN,DIAGNOSTIC,HOWEVER,PANCREATIC
400,DILATED,EARLY,NF1,OPG,THERE
001,109,166,169,253,275,888,ALK,AMONG,CONCLUSION,CRIZOTINIB,DCR,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PROFILE,PURPOSE,RESULTS,SOCIETY,TTP
145,157,ALTOGETHER,AML,BACKGROUND,FORTY,LABEL,LEUKAEMIA,METHODS,OBJECTIVE,RESULTS
110,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THEIR,THERE,TOTAL
169,231BR,BECAUSE,COPYRIGHT,HEPARANASE,HIGHEST,HOWEVER,INC,LAPATINIB,MDA,NEOPLASIA,PRESS,PUBLISHED,THESE
169,BMAL1,CLOCK,COPYRIGHT,HCC,HOWEVER,INC,NEOPLASIA,PRESS,PUBLISHED,STRIKINGLY,TAKEN
177,CONCLUSION,KIM1P,LABEL,LUXOL,METHODS,OBJECTIVE,RESULTS,TDL
177,181,697,729,AFTER,AG490,AKT,ANOVA,BAD,CYTOCHROME,GBM,JAK,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL,STAT3,STAT3SIRNA,THERE,U87,WESTERN
HOWEVER,MARCH,NOVEL,SIX
AWAKE,BACKGROUND,COGNITIVE,COMPARISON,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,WORLD
122,THESE
THESE
169,COPYRIGHT,FINALLY,HENCE,HOWEVER,HTATIP2,INC,PCR,SP1,TAKEN,U87
IP6K2,IP6KS,IP7
12MOPFS,142,149,169,400MG,CONCLUSION,COPYRIGHT,EGF,III,LABEL,LTD,MACDONALD,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
012,078,122,135,172,177,237,313,338,392,404,450,476,528,541,621,633,667,740,842,899,900,903,945,AES,APRIL,BACKGROUND,GLM,HOWEVER,ICD,LABEL,MARKETSCAN,METHODS,OBJECTIVE,RESULTS,THERE,TREATMENTS
177,197,ASSESSMENT,BRM,CNS,GPA,INTRABEAM,KARNOFSKY,LABEL,LOCAL,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SCALE,SIX,SURGERY
643,COLLEGE,CORNELL,CPS,CSF,GROSS,LABEL,MEDICAL,METHODS,OBJECTIVE,PARASELLAR,PATIENT,RCC,RESULTS,THERE,THESE,WEILL,WESTERN
031,169,276,314,361,466,857,915,HOWEVER,III,JANUARY,MSI,MSS,STAGE
001,002,007,008,170,196,343,665,HOWEVER,III
107,18S,28S,395,ADD,AMONG,ANNEXIN,APC,APOPTOSIS,CPG,DENATURING,HOXC8,MDK,MECP2,SAOS2,THERE
169,AKT,BACKGROUND,BASEL,BAY36,CONCLUSION,INHIBITION,LABEL,LDH,METHODS,RESULTS,THESE,TUNEL,U87
BASED,BEX,BRAIN,DUE,EXPRESSED,HOWEVER,THESE
002,003,016,046,108,ADC,CONCLUSION,ETP,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
CESSATION
160,ALTERED,EARLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURFACE
169,ACADEMY,BIOLOGICAL,BTV,CONCLUSION,ENDPOINTS,FET,GBM,INCREASING,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PET,PROGNOSTIC,RCX,RESULTS,SEVENTY,TAC,TMZ
169,945,947,954,ACIDS,KNOCKDOWN,NUCLEIC,PDH,PRESS,PUBLISHED,SP1,TCA,UNIVERSITY,ZBTB2
160,169,231,233,AMONG,COPYRIGHT,CSC,PUBLISHED,SAS
169,COPYRIGHT,RAMAN,SCIENCE,SERRS
CCS,CHILDHOOD,COX,CRT,FIFTEEN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNS,SURVIVORS,TEN,TRANSITION,TURIN
118,129,AMONG,BACKGROUND,DWI,LABEL,METHODS,MRI,MRS,PWI,RESULTS
BACKGROUND,GBM,KIT,LABEL,RB1,RESULTS
FDG,PET
177LU,AFTER,DOTA0
BACKGROUND,GCS,LABEL,METHODS,REDUCED,SMART
CD4,CSF,HIV,IMAGING,LABEL,LUSCHKA,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,TEN
THESE,USING
169,BACKGROUND,CHEMISTRY,CSF,DETECTING,LABEL,METHODS,PCR,RESULTS
169,BACKGROUND,CHEMISTRY,CONTENT,LABEL,NEUROMEDIN,NMU,SUMMARY
169,177,208,976,CCL22,CD4,CLUSTER,COX,DEFECTS,GBM,IDH,IGE,PATIENT,RATIO,SEM
000,163,177,689,99MTC,BACKGROUND,DYNAMIC,LABEL,METHODS,PET,RESULTS,ROI
ACT,AFFORDABLE,BACKGROUND,BECAUSE,CENTERS,CONCLUSION,HAC,HEALTHCARE,INPATIENT,LABEL,METHODS,NATIONWIDE,OBJECTIVE,PATIENT,PROTECTION,PSI,QUALITY,RESULTS
BECAUSE,DIC,LABORATORY
143,INHIBITION,PET
946,AKT,DUE,PAM,SHH,THERE,WNT
000,169,483,600,661,AAV,ATP,CKB,COLORECTAL,COPYRIGHT,INC,THESE
BRAIN,CNS,CPP,HISTOLOGIC,HOWEVER
169,COPYRIGHT,IRELAND,LTD,MULTIMODAL,SHH,WNT
BACKGROUND,CURRENT,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
034,146,19Q,EOR,GIVEN,JANUARY,LGG,MEDICAL,METHODS,MIB,PFS,RESULTS,THERE,TOKYO,UNIVERSITY,WOMEN
THEREFORE,WORLD
176,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,DIFFERENT,LABEL,METHODS,OBJECTIVE,RESULTS,SIGMOID
104,AVERAGE,BACKGROUND,BSCMS,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SCALE
100,800,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NASHVILLE,NORTH,NOVEL,OBJECTIVE,RESULTS,ROBOT,TENNESSEE
BACKGROUND,CONCLUSION,INCREASING,LABEL,METHODS,METRICS,NEUROTOUCH,OBJECTIVE,OPERATING,REGARDLESS,RESULTS,SIX,ULTRASONIC,VALIDATED
001,212,BACKGROUND,CLEVELAND,COMPETING,CONCLUSION,LABEL,LRT,METHODS,OBJECTIVE,RESULTS,SURGERY
169,CHARING,CNS,CONCLUSION,COPYRIGHT,CROSS,EMA,GTN,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TREATMENT
169,AFTER,BACKGROUND,CATHETERS,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,TEXAS,THESE,UNIVERSITY
169,DIPGS,HISTOLOGIC,INC,THEREFORE,WILEY
169,ATLAS,FURTHER,GBM,IDH,PDGXS,SOCIETY,Y1068
CRICK,NUCLEIC,SINCE
130,169,AUTHORS,BACKGROUND,BLOOD,BRIEF,INC,LABEL,METHODS,MRI,PEDIATRIC,PROCEDURE,PUBLISHED,RESULTS,SMALLER,THERE,WILEY
042,169,BACKGROUND,BRAIN,COPYRIGHT,GRONINGEN,IMAGING,IRELAND,LABEL,LTD,MEDICAL,METHODS,MRI,NFA,OBJECTIVE,PURPOSE,RESONANCE,RESULTS,UNIVERSITY
AKT,CD133,GDC,THESE
001,107,COX,ESPECIALLY,FINALLY,HOWEVER,KARNOFSKY,KPS,MEIER,PCR,PFS
169,AUTHORS,COPYRIGHT,GROUP,IAA,IRELAND,LTD,PUBLISHED,RESULTS,THERE
169,ALZHEIMER,CONSISTENT,COPYRIGHT,CYS,GIVEN,NOTABLY,PUBLISHED,SINCE,SOH,STRUCTURAL
169,945,947,AGE,AMP,ATP,BCL,COPYRIGHT,COX,METFORMIN,NRF,THESE,WHILE
169,BIOLOGY,GBM,GLI,MTP53,SHH,SMO,SMOOTHENED,SOCIETY,U87MG,WTP53,ZERUMBONE
16P11,BACKGROUND,BMJ,CGH,GROUP,LABEL,LIMITED,METHODS,PCR,PRRT2,PUBLISHED,PUBLISHING,RESULTS,THESE
122,160,233,BACKGROUND,CONTEXT,ENDOCRINE,ENDOCRINES,LABEL,METHODS,NET,NEURO,OBJECTIVE,OVERALL,RESULTS,SURGERY,TUMEURS,VARIOUS
001,133,173,297,ADVERSE,AFTER,BETWEEN,CLASSES,COX,FIFTY,GAMMA,GBM,III,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,USING,VARIABLES
177,CED,CLEARPOINT,CONVECTIVE,INC,MRI,PARKINSON,PEARSON,PLACEMENT,THERE,THREE
111,137,215,480,CSF,EPIDERMOID,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OPTIMAL,RESULTS,SCALE,SURGERY,THERE,TOTAL
169,ALT,ATR,COPYRIGHT,INHIBITION,RPA,SCIENCE,TERRA
177,585,847,945,946,CONCLUSION,CTCAE,D98,DMEAN,LABEL,LTC,MATERIALS,METASTASES,METHODS,MRI,NCI,OBJECTIVE,PFS,PURPOSE,RESULTS,SIB,SIP
169,COPYRIGHT,HOWEVER,INC
239,514,521,AES,BASEL,CONCLUSION,EAP,EASTERN,EVALUATION,GROUP,ITALIAN,ITALY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RCC,RESULTS,SOLID
169,945,COPYRIGHT,EMT,FURTHER,GBM,GLUT1,IRELAND,LTD,SHRNA,SNB75,U87,YKL40
001,007,103,114,DCS,LABEL,METHODS,MRI,OBJECTIVE,OR2,RESULTS,THERE,THREE
OVERALL,VHL,VON
114,159,BMJ,BRAIN,COMMONEST,EPSCC,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PRIMARY,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,SETTING
STEROID,THESE
183,AUSTRALIA,CONFORMITY,D50,D95,D98,GAMMA,GROSS,GTV,INDEX,ISODOSE,KNIFE,LABEL,LEKSELL,MARCH,MAXIMUM,MEETING,METHODS,NCI,OBJECTIVE,PADDICK,PCI,PIV,POINT,RATIO,RESULTS,SEPTEMBER,SEVERAL,SOCIETY,TAE,THESE,TOLERANCE,TOTAL,TREATED,TTV,TVPIV,V10
169,180,BACKGROUND,COX,EXPRESSION,LABEL,MEIER,METHODS,MOLONEY,P16,RESULTS,SOCIETY,THEREFORE
100,113,169,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIANS,PURPOSE,RESULTS,USING
HOWEVER,IDEALLY
III,PHASE
ASSESSMENT,BASIQ,BRAIN,CONCLUSION,FORTY,FUNCTIONAL,GENERAL,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SYMPTOM
350,CNS,ITALY,NEURO,OCTOBER,TURIN
001,108,164,177,AFTER,AVERAGE,BNP,CARDIAC,CRP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TIC
APLP2,CCI,CONTAINING,FINALLY,FLICE,KNOCKDOWN,LETM1,PROTEIN,RBM,RBM10,SF1,SFS,TBI
169,CDKN2AB,COPYRIGHT,INC,MOLECULAR
169,BACKGROUND,LABEL,METHODS,QOL,RESULTS,SOCIETY,THERE,WORLD
AWAKE,BACKGROUND,BASED,CONCLUSION,DES,HOWEVER,LABEL,METHODS,MIXED,PRE,QMT,QUICK,RESULTS
100,675,BACKGROUND,BNP,LABEL,METHODS,RESULTS,SINCE
122,432,861,BACKGROUND,BETWEEN,CONCLUSION,CSF,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
169,187,BIOLOGY,GCS,INC,INHIBITING,MOLECULAR,RB1,SCF,SINCE,SOCIETY,THESE,THR
004,006,169,AGHDA,CONCLUSION,GHD,GHR,LABEL,METABOLIC,METHODS,OBJECTIVE,PREVALENCE,QOL,RESULTS,SHORT,SOCIETY,TBI
169,363,AES,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS,THERE,TKI,UPFRONT
000,180,240,956,BISPHENOL,BPA,BPS,HOWEVER,STRIKINGLY
ETC,FINALLY,HGG,IMPAIRMENT,KREBS,RAS,THEREFORE
169,543,967,HYPOTHESIS,INC,INPATIENT,LABEL,LEVEL,METHODS,NATIONWIDE,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RATES,RESULTS,SOCIETY,SOUTH,THERE
169,ACIDS,AML,NUCLEIC,PRESS,PUBLISHED,SPARROW,UNIVERSITY
DESPITE,III,INITIAL,PHASE,THERE
GBM,HIF
CSC,GBM,STRATEGIES,THESE
169,A20,A925L,ALK,AUTHORS,LTD,PTY,PUBLISHING,SCIENCE,WILEY
GBM,HOWEVER,IHC,MUTATED,RESULTS,V600E,VE1
BACKGROUND,CONTEXT,LABEL,OBJECTIVE,SECONDARY
945,946,DISRUPTING,GBM,GSC,POSTN,RGD,SILENCING,TAM
177,980,METHODS,MRGLITT,MRI,PAA,PVA,RESULTS,TDE,THERAPY,THERMAL,THROUGH,USING,VISUALASE,VOLUMETRIC
169,APB,COPYRIGHT,INC,INHIBITION,MMG,ORAI1,STIM1,THEREFORE,U87
713,BACKGROUND,CONTROLLED,CURRENT,KNOWLEDGE,LABEL,LIBRARY,METHODS,MST,NSCLC,RESULTS,SBM,SRS,STATA,THERE,WEB
160,HCC,HCV,THEREFORE
152,169,COPYRIGHT,FINALLY,FURTHER,GBM,GREAT,IRELAND,LTD,TAKEN
169,COPYRIGHT,IRELAND,LTD,MAP,MARK4,PTB
169,215,AIM,CALCIFYING,CONCLUSION,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SUBSEQUENT
169,946,BACKGROUND,CONCLUSION,COPYRIGHT,DAS,ELISA,FOLLOWING,GH3,HCS,IRELAND,LABEL,LTD,METHODS,PCR,PRL,RESULTS,SMAD3,TGF,WESTERN
001,002,233,AGE,CCI,INFLUENCE,KARNOFSKY,KPS,LABEL,MAIER,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
169,COPYRIGHT,DESMOID,DTS,THEREFORE
BMJ,GROUP,INDIA,LTD,PUBLISHING
049,BASED,CONCLUSION,IGF,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SRS,SRT
009,169,183,229,APRIL,ASSESSMENT,BACKGROUND,BASED,BETWEEN,COPYRIGHT,EVALUATION,FUNDING,GRADE,GRADING,GROUP,INADEQUATE,JANUARY,LABEL,LTD,METHODS,NEUPSIG,NNT,RESULTS,SPECIAL,STUDIES,THESE,TOPICAL,TRIAL,USING
169,COPYRIGHT,INC,TYPICAL
153,GROUP,HMGA2
947,INHIBITING,NOTCH,PAS,PILOCYTIC,THESE
14Q21,16P13,ADDITIONAL,ARL4A,BESIDES,CHOROID,GENOMIC,LAMB1,MOLECULAR,RSPH9,TARGETS,THESE,TRPM3,VEGFA
ACCEPTANCE,BRAIN,EXCEPTION,FEW,III,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS,SETTING,SEVENTY,TRAUMATIC,TREATMENT
350,456,806,AFTER,BACKGROUND,CONTEXT,CVE,DUTCH,FURTHER,HORMONE,HOWEVER,IRR,LABEL,METHODS,NFPAS,OBJECTIVE,OUTCOME,RESULTS,SETTING,SIXTY,TREATMENT
001,002,255,279,534,LABEL,MAY,METHODS,OBJECTIVE,OVERALL,PHYSICIANS,QUESTIONS,RESULTS,THESE
169,CHEMOBRAIN,COPYRIGHT,HOWEVER,LTD,THERE,THESE
169,COPYRIGHT,DOSIMETRIC,MRI,PUBLISHED,SAS
169,961,CIRCADIAN,CLOCK,HESCS,PER
ACT,AFFORDABLE,DIFFERING,EMERGENCY,INC,PATIENT,PHYSICIANS,PROTECTION,PUBLISHED,RENAL,STATEMENT,THERE
169,CA2,COPYRIGHT,RETICULON,RTN,SEVERAL,THESE
001,020,160,GBM,GRADE,III,IPS,PFS,THERAPY,UNIVARIATE,WORLD
005,160,III,ION,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,OLIVARY,PCF,PURPOSE,RESULTS
169,FDG,HOWEVER,IMAGING,INC,MOLECULAR,NUCLEAR,PET,SOCIETY,SUCCESSFUL,THESE
169,946,ALZHEIMER,CONCLUSION,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,PITTSBURGH,RESULTS,SOCIETY,THK5117,UNLABELLED,USING
215,INTENSE,SKULL
169,AMONG,FOLLOWING,HDC,HEMATOLOGY,KARNOFSKY,MPV,PCNSL,PFS,PRIMARY,SOCIETY,THERE,THOSE
AFTERWARDS,BACKGROUND,BSR,EIGHT,GERMANY,LABEL,METHODS,MRI,RESULTS,SINCE
AIM,BACKGROUND,CONCLUSION,COUNSELING,ECG,LABEL,LIMITATION,METHODS,OBJECTIVE,RESULTS,SCALE,TSC,USG

100,LABEL,LAR,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR
810,CNR,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OFF,PURPOSE,RESULTS,RTP
169,COPYRIGHT,CPP,GBM,HOWEVER,INC,INK4A,THESE,U87MG
239,FURTHER,GBM,GENOMIC,HOWEVER,INDIVIDUAL
169,BORCK,III,LABORATORY,POL,PRESS,PUBLISHED,TAKEN,TBP,WHOLE
169,BBB,COPYRIGHT,NPS,U87MG
169,187,374,CONCLUSION,LABEL,METHODS,MULTIMODAL,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THESE,WML
1970S,ANOTHER,DROSOPHILA,FDA,HOWEVER,PTCH1,SINCE,VISMODEGIB
006,009,014,100,AFTER,BACKGROUND,GRADE,IMAGING,LABEL,LGG,METHODS,MRI,RESULTS,ROC
124,169,946,AUTHORS,CNS,COPYRIGHT,GPCRS,INC,PDZ,PUBLISHED,SIMILAR,WNT,WNT7A,WNT7B
169,CSI,INC,WILEY
001,169,BACKGROUND,COX,EMORY,GBM,HEALTHCARE,LABEL,MEIER,METHODS,PFS,RESULTS,SOCIETY,UNIVARIATE
103,120,157,169,277,380,BACKGROUND,END,LABEL,METHODS,PIC,RESULTS,SOCIETY
169,BRITAIN,COPYRIGHT,FUNCTIONAL,GREAT,HOWEVER,IRELAND,LTD,NR2E1,OVERCOMING,PUBLISHED,RAS,SIRT1,SOCIETY,TLX,WILEY
11C,BACKGROUND,CONCLUSION,GERSTMANN,LABEL,METHODS,MRI,PET
AFTER,BASED,EMERGENCY,HOWEVER
120,169,215,BACKGROUND,BASED,DL1,DL2,DLT,INC,LABEL,METHODS,MTD,PROCEDURE,RESULTS,TOXICITIES,WILEY
160,169,ABSENCE,APMIS,FORTY,HARDY,LTD,PITUITARY,PUBLISHED,SPARC,WILEY
ALECTINIB,ALK,CRIZOTINIB,CSF,FURTHER,MET
CD3,CD4,CD8,FOXP3,GBM,HOWEVER,SCANSCOPE,THESE,TREGS
169,215,2YL,BAX,BCL,COPYRIGHT,H2O,HOWEVER,INC,MTT,SGC7901,WESTERN
APC,IDH1R132H,MHC,PLA
177,AFTER,BETWEEN,CNS,CSI,HIT,LABEL,METHODS,OBJECTIVE,PRIMITIVE,RESULTS,SEPTEMBER
GIVEN,MRI,RCC,TESTING
169,BACKGROUND,COPYRIGHT,GBM,GENERAL,LABEL,METHODS,PKC,RESULTS,THEREFORE,THESE,TMX,TMZ
169,945,954,COPYRIGHT,EGR,INC,LUCIFERASE,SMALL,TNF
CURRENTLY,GBM,GREAT
AFTER,MEMRI,MRI,PET,THERE,THESE
BMJ,BRAIN,COUNTRIES,CURRENT,FIFTY,GROUP,HWL,LABEL,LIMITED,METHODS,MRI,OBJECTIVE,PICTORIAL,PUBLISHED,PUBLISHING,RESULTS
19Q,DISCOVERY,END,GRADE,III,INSTITUTE,LGG,LOW,RESULTS,WORLD
177,AFTER,CLASS,ENGEL,EXCLUDING,GGS,GIVEN,INCOMPLETE,LESIONS,METHODS,MRI,OVERALL,REGARDING,REMNANT,RESULTS,SIXTY,USING
ACCORDING,AFTER,FIFTY,FINALLY,FLAIR,GRADE,HOWEVER,III,LGG,METHODS,MRI,PET,RESULTS,SURGERY
EOR,GREATER,IMAGING,MRI,PROXIMITY,THEREFORE,THROUGH
ATLAS,GBM,HOWEVER,PATIENT,THESE
HDC,SAUDI
121,21MBS,34A,601,ATRTS,BACKGROUND,BASED,BRAIN,CHAIN,CNS,FIRST,LABEL,MBS,METHODS,OVERALL,POLYMERASE,RABDOID,REFERENCE,RESULTS,RTS
AKT,ATP,G161V,K179M,MET
169,250,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,LAPATINIB,MBC,METHODS,ORR,PFS,PLD,RESULTS,SECONDARY
002,004,059,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,INSTITUTE,LABEL,METHODS,OBJECTIVE,REGARDING,RESULTS,SEVEN
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CXCR7,GBM,INSTITUTE,KNOCKDOWN,LABEL,MATERIALS,METHODS,RESULTS,SIMILARLY
AGILENT,BACKGROUND,HISEQ2000,LABEL,MALIGNANT,METHODS,MN1,NF2,NIMBLEGEN,RESULTS,SURESELECT
AMONG,BMX,EFFICIENCY,GBM,GSC,STAT3,THESE,WHILE
177,500,517,760,778,ALA,BACKGROUND,CLR1501,CLR1502,CONCLUSION,EXCITATION,HARVESTED,IMAGING,LABEL,METHODS,OBJECTIVE,RESULTS
001,100,BACKGROUND,CONCLUSION,COX,DBF,FORTY,LABEL,MEIER,METHODS,OBJECTIVE,PRIMARY,RESULTS
125,181,652,AQUATIC,CYTOTOXIC,GH4C1,GLYCOLIPID,MCF,N2A
169,ACADEMY,AFTER,BECAUSE,COPYRIGHT,PEDIATRICS
169,946,ALZHEIMER,BIOLOGY,CONGO,HEPARAN,HEPARANASE,HSPGS,INC,MOLECULAR,SOCIETY,SWE,SWEDISH,THEREFORE,THIOFLAVIN
169,181,BCBMS,BRAIN,CNS,COPYRIGHT,CSF,LAPATINIB,NEITHER,SOCIETY,THESE
313,AIF,ALA,BACKGROUND,HOWEVER,LABEL,METHODS,RESECTION,RESULTS,SEVEN,SIX,THEREFORE
169,COPYRIGHT,DIFFERENT,INC
BACKGROUND,CAUTION,GRADE,LABEL,METHODS
176,186,250,ADVERSE,AUTOLOGOUS,HCT,IMPORTANCE,INSTITUTE,LABEL,METHODS,OBJECTIVE,OVERALL,RELAPSING,RELEVANCE,REMITTING,RESULTS,SCLEROSIS,SETTING,TOXIC,TREATMENT
03012,169,AUTHORS,CMV,EBOLA,GRP58,GRP78,GRP94,HEPATITIS,HSP27,HSP40,HSP60,HSP70,HSP90,INC,INFLUENZA,JOURNAL,LAMP1,LASSA,MARBURG,MEASLES,MUMPS,NTCP1,OSU,PHYSIOLOGY,PRE,PUBLISHED,REC,RSV,RUBELLA,SIMILAR,WILEY
001,13N,177,18F,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,214,229,BACKGROUND,CNS,CSF,FCI,HOWEVER,INC,LABEL,METHODS,PROCEDURE,RESULTS,STOCKHOLM,THERAPY,TREATMENT,UME,WILEY
AKT,CPT,DII,HB1,NDEPT,OVERALL
954,DICER,ERK,GENERALLY,HIV,TAR,THESE,UTR
122,134,ABOUT,CONCLUSION,EDEMA,GAMMA,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN
169,AUTHORS,COPYRIGHT,INC,MMERVK10C,PUBLISHED,THESE
BRAIN,CENTRAL,CHILDHOOD,CNS,DIAGNOSED,FOUNDATION,NERVOUS,OVERALL,PRIMARY,STAND
169,COPYRIGHT,ECM,GBM,HOWEVER,LTD,MINIMIZING
107,169,1CM,3MONTHS,4GY,5MM,COPYRIGHT,CTV,DESPITE,GTV,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PFS,PTV,PURPOSE,RESULTS
169,BECAUSE,BIOLOGY,COPYRIGHT,FEDERATION,INC,MERCIER,PUBLISHED,RESOUND,ULTRASOUND,USING,WORLD
169,BACKGROUND,CONCLUSION,COPYRIGHT,DECISIONS,DISCUSSION,FERRAND,GLIOMAS,LABEL,METHODS,OPTIC,RESULTS,SAS,THROUGH,TREATMENT,UNIVERSITY
002,057,100,169,177,960,CONCLUSION,COPYRIGHT,GAMMA,GKSRS,INC,KNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,PADDICK,PCI,PURPOSE,RESULTS
169,CACL2,COPYRIGHT,EAG,LTD,MUTATIONS,SIMILARLY,THESE,TRUNCATED,VOLTAGE
169,COPYRIGHT,GBM,HIPPO,HOWEVER,INC,MIR,PUBLISHED,TAZ,UTR
169,954,AKT,ATM,AUTOPHAGY,COPYRIGHT,HOWEVER,IRELAND,LTD,OVERALL,STAT3,WHILE
169,945,946,COMBINING,COPYRIGHT,LTD
FMISO,GBM,PET,USING
169,600,CNNM2,COPYRIGHT,MAGNESIUM,MAGT1,SOCIETY,TRPM6
001,100,177,2GY,314,946,947,LITHIUM,SF2,SHH,SINCE,WNT
BACKGROUND,CLINICALLY,CON,DEP,FSH,HOWEVER,LABEL,METHODS,NFPAS,PDQUEST,RESULTS,THESE,THOSE
METASTATIC,SURGERY
126,149,163,169,233,AMONG,CNS,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,POTENTIAL,PUBLISHED,PURPOSE,RESULTS,VII
169,AKT,BIOLOGY,BTICS,CONVERSELY,EGF,ERK,FGF,FURTHER,HOWEVER,INC,MOLECULAR,NGF,NT3,PREVIOUSLY,SOCIETY,TRK
169,174,215,223,348,660,COX,FDR,GBM,INC,LIMITED,THESE,USING,WILEY
FOURIER,PROTEIN,SEP
946,ALZHEIMER,C1Q,LATER,TGF,TNF,WHILE,WNT
102,154,160,171,183,263,362,500,AIM,ASSESSMENT,BMI,LABEL,METHODS,OBJECTIVE,RESULTS,SDS,TEN,THERE
453,AIM,BRAZILIAN,C677T,CONCLUSION,EMBRYONIC,GENOMIC,LABEL,MATERIALS,METHODS,MTHFR,OBJECTIVE,RESULTS,RFC,SAMPLES
002,005,210,233,396,BACKGROUND,EDITORS,FURTHER,HCC,LABEL,METHODS,RESULTS,STAT3,SUMMARY,SYSTEMATIC,TYPICALLY,USING
33342,BT325,FURTHER,HOECHST,TAMOXIFEN,U87
183,AIM,BACKGROUND,CONCLUSION,DTI,GEORG,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,STUTTGART,THREE
946,BACKGROUND,GSK,LABEL,METHODS,PACLITAXEL,RESULTS
BACKGROUND,DESPITE,DLT,GBM,INTRAGO,KARNOFSKY,LABEL,METHODS,MTD,SECONDARY,THEREFORE,TRIAL
BMJ,CNS,EPSTEIN,EXTENSIVE,GROUP,HISTOLOGY,LTD,LYG,PUBLISHING
169,393,ASPIRATOR,COPYRIGHT,DOPPLER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,ULTRASONIC
NETWORK
160,GBM
945,946,ERS,SRC,STEROID,THESE,WHILE
169,CNS,FINALLY,GNA11,PRIMARY,SOCIETY,UNTIL
100,169,956,COPYRIGHT,CPG,ECS,GPR55,INC,OPE,PLD,TAKEN,TRPV1
169,AUTHORS,COPYRIGHT,GBM,INC,NOD,PUBLISHED,SNP,WHOLE
169,ABROGATION,AUTHORS,COPYRIGHT,INC,MYC,P53,PUBLISHED,TRP53
947,BECAUSE,GSH
169,COPYRIGHT,CST,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,ROI,SEEDING,SIMILARLY,WBF,WHOLE
000,001,002,115,168,177,202,ABOUT,AIP,BACKGROUND,BASAL,CONCLUSION,FACTORS,LABEL,METHODS,OBJECTIVE,PITUITARY,PRL,RESULTS
169,BACKGROUND,BASEL,EGGER,LABEL,METHODS,PERTINENT,RESULTS
1270C,1306C,169,266,AMSTERDAM,APC,HNPCC,LEU424VAL,LYNCH,MMR,MUTYH,POLD1,POLD2,POLD3,POLD4,POLE2,POLE3,POLE4,PRO436SER,SCREENING,THEREFORE
169,CNS,COPYRIGHT,HOWEVER,IRELAND,LTD,PUBLISHED
001,018,117,162,270,432,571,GROUP,HOWEVER,JAPAN,TREATMENT
945,954,BACKGROUND,CXC,CXCR4,LABEL,METHODS,P65,PCR,RESULTS,TARGETING,TNF,TRANSWELL,WESTERN
169,COPYRIGHT,DIEGO,INC,LABEL,METHODS,MRI,OBJECTIVE,PITUITARY,RESULTS,SAN,THREE
169,EXPRESSION,IGSF1,N604T,PATHOGENIC,SOCIETY,VARIATIONS
169,CD133,COPYRIGHT,HSC71,HSPA8,INHIBITION,IRELAND,LTD,NANOG,OCT
169,ACADEMY,CLASS,EXPRESSION,KARNOFSKY,LABEL,LAR,METHODS,NEUROLOGY,OBJECTIVE,OCTREOTIDE,PFS,RESULTS,THERE,TREATMENT,WORLD
ADAM9,FISETIN,GBM8401,PCR,U0126,WESTERN
945,946,EMT,FAK,HIF,HOWEVER,INVERSE,KNOCKDOWN,L1CAM,SRC,TWIST,WESTERN
AFTER,BACKGROUND,CAUCASIAN,CLUSTER,CONCLUSION,FURTHER,LABEL,METHODS,SECONDARY
LEUCINE,LRR,LRRC4,NGL
100,ALDH3A2,C20ORF121,CD133,DTL,KIF5C,LOC203547,LOC642489,LOC650152,LOC653308,RPS6KA2,THESE
169,250,COPYRIGHT,DES,DULIP,DUTCH,INC,LINGUISTIC
177,CSI,KNOPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPACE,THERE
100,956,ACTIVATION,ADP,BRAIN,CELLS,DB029,DHA,GAS,LABEL,METHODS,MHBT161,OBJECTIVE,RESULTS,SIMILAR,TAKEN,U87,USING,WESTERN,WST
177,CASPASE,CCK,WESTERN
045,130,143,CSF,GROUP,LABEL,METHODS,OBJECTIVE,PREDICTION,RESULTS,SHH,WHILE,WNT
160,169,ACSS2,COA,COPYRIGHT,INC,NMR,PREVIOUSLY
100,174,400,MAY,MEETING,SCIENTIFIC,SOCIETY,SRS,USA
169,3K27M,COPYRIGHT,SCIENCE
169,177,CONCLUSION,EXPERIENCE,FET,IMAGING,INC,LABEL,MAXIMUM,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTY,SOCIETY,TBR,UNLABELLED
CD133,CELLS,CSC,FINALLY,NANOG,PITX2,PROP1
GBM43,NSC
169,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,MRI,PUBLISHED,RESULTS,TESLA,THERE
035,169,189,222,311,350,577,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LGG,METHODS,PUBLISHED,RESULTS,SEIZURE
CSF,MONRO,SGCTS,SURGERY,TSC
154,169,292,BRACKMANN,CONCLUSION,COPYRIGHT,HOUSE,LABEL,METHODS,OBJECTIVE,RESULTS,VSS
169,COPYRIGHT,CSF,ELISA,ERBB4,FINALLY,HOWEVER,IRELAND,LTD,PARKINSON,THESE,USING
00005,00081,004,172,INC,LABEL,MEIER,METHODS,OBJECTIVE,PEARSON,PUBLISHED,RADIATION,RESULTS,RIMGS,STUDENT,THERE
169,CBD,COPYRIGHT,FURTHER,LTD,SCI
169,ADS,ALT,AST,CAR,COPYRIGHT,ENDOCYTIC,LTD,ONCOLYTIC,PPCBA,RDB,TAKEN,THESE,U87
CONVERSELY,DESPITE,NOTCH,PRRX1
169,GBM,TPC,VX680
BACKGROUND,LABEL,PATHWAY,PID,PUBLISHED,RESULTS,SEQ,THESE
548,BACKGROUND,EDITING,HTS,LABEL,RESULTS,SMALL,THROUGH
169,CDKN2,LTD,NCM,PATHOLOGY,PTY,PUBLISHING,ROBIN,SOCIETY,VIRCHOW,WILEY
169,ACTIVITIES,COPYRIGHT,SOCIETY,UDP,UGT
001,101,116,175,513,673,742,DRUGS,LOW,PERIOSTIN,PFS,THERE
BACKGROUND,HODGKIN,HOWEVER,JANUARY,LABEL,METHODS,REPORTS,RESULTS,THESE
AUSTRIA,BRAIN,CONSORTIUM,KNOWLEDGE,MEETING,NEURO,ROCHESTER,SEPTEMBER,SEVERAL,SOCIETIES,USA
208,398,491,MRI,PEARSON,SPOILED
GREATER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
SEVERAL,THESE
185,HOWEVER,METABOLIC,MRI,PET,ROUTINE,THESE
CUSHING,EARLY,KNOWLEDGE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
INCREASING,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SONIC,SUMMARY
530,650,PARKINSON,SPR,UBIQUITIN,UCH
169,CNR,INC,LABEL,METHODS,MULTI,OBJECTIVE,PURPOSE,RESULTS,SATURATION,WILEY
108,118,169,EXPRESSION,GIVEN,MATCHED,SOCIETY,SSA,SSTR2,SSTR3,SSTR5,SSTRS
174,BACKGROUND,CEPHEID,CONCLUSION,HUICHOL,LABEL,METHODS,MEXICAN,MTB,NEELSEN,RIF,SUNNYVALE,USA,XPERT,ZIEHL
HOWEVER,III,JAGGED1,TAKEN
169,COPYRIGHT,INC,MCC,MCPYV,PYV,SEVERAL
169,252,946,CBP,COPYRIGHT,HDAC1,POK,POKEMON,POZ,PUBLISHED,SMAD2,SMAD4,SMADS,TAKEN,TGF
CPS,TYPICAL,WOMEN
178,179,185,BAT,BMI,CONCLUSION,FDG,FT4,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SERUM,SINCE,THYROXINE,TREATMENT
26S,945,948,III,PKC,RU486,S400A,SILENCING,THESE,TPA,TREATMENT
169,946,CONCLUSION,COPYRIGHT,INC,INFANTILE,LABEL,NADOLOL,OBJECTIVE,PURPOSE,SOCIETY,SUMMARY
003,BASED,CHINESE,COX,HOWEVER,LGG,MEIER,THEREFORE,VLGR1
169,945,COLLAGENS,COPYRIGHT,IRELAND,LTD
169,945,CHINESE,COPYRIGHT,GIVEN,HIF,HOWEVER,IRELAND,LTD
CNS,HOWEVER,NOTABLY,SCLIP,STAT3,TAKEN
001,169,571,574,809,AFTER,HOWEVER,IRR,PERINATAL,THERE,THESE
169,ALTERED,CLINICALLY,FBP,SILENCING
FACTORS,HOWEVER
1P19Q,GLIOMAS,PCV,UNTIL,WORLD
550,666,APRIL,CONCLUSION,COUNCIL,LABEL,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
114,BACKGROUND,BETWEEN,CONCLUSION,CSF,ETV,GAMMA,HOWEVER,KNIFE,LABEL,MAY,METHODS,OCTOBER,RESULTS,TEN,TRANSIENT
946,EMT,FOXM1,GBM,IMPROVING,WNT
169,947,954,APRIL,COPYRIGHT,HOWEVER,IGG,INC
169,BMT,COPYRIGHT,CUNNINGHAM,DIAGNOSIS,MRI,NETWORK,PCR,PML
169,COPYRIGHT,SCIENCE,THESE
169,AFTER,BACKGROUND,CHART,CNS,INC,LABEL,MEIER,METASTASES,METHODS,PROCEDURE,RESULTS,WILEY
169,AKT,BECAUSE,BERBERINE,ERK,GBM,MEK,MKK,RAF,U87
169,946,CHANGES,INHIBITION,JUN,THESE,TRANSWELL
169,DESPITE,PRESS,PUBLISHED,RECURRENT,THEREFORE,UNIVERSITY
AKT,EPIDERMAL,ERK,FINALLY,HOWEVER,IFI27,IFIT1,REGULAR,SHC,TRAIL
ASIDE,HOWEVER,SURGERY,WHEREAS
101,BACKGROUND,BMI,CONCLUSION,DISORDERS,ESI,HIT,IEG,INVENTORY,LABEL,METHODS,RESULTS
946,ACP,SEVERAL,WNT
200,AST,DLT,EGF,GBM,KPS,MTD,SIROLIMUS,TARGETING,TEN,VANDETANIB
107,169,AIM,ANTICANCER,BACKGROUND,CENTRAL,CNS,COPYRIGHT,CSF,DISCUSSION,INSTITUTE,LABEL,METHODS,MRI,NERVOUS,OBJECTIVE,RESULTS,SIXTY,TRB,TRILATERAL
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,RESULTS
030,043,100,169,AIM,ANTICANCER,BASED,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,KPS,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DNETS,INSTITUTE,LABEL,MATERIALS,METHODS,NG2,OBJECTIVE,PAEDIATRIC,RESULTS,WHILE
169,ANTICANCER,BRAIN,COPYRIGHT,INSTITUTE,PALLIATIVE,RADIATION
CNS,COGNITIVE,DIAGNOSIS,HOWEVER,PRE,SIGNS,SIXTY,VITAL
EARLY,EWING,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
ADMET,BBB,CNS,EIGHT,THESE
AAV,AAVRH,AVASTIN,CONCURRENT,ELISA,FOLLOWING,GBM,LOCALIZED,NOD,PCR,STUDIES,THESE,U87MG
ADULT,GBM,HOWEVER,THEIR,THESE
945,AKT,BESIDES,CELLS,FOS,GBM,HIF,JUN,MMP,PCR,TIMPS
AKT,CYR61,FURTHER,GBM,TAKEN
104,220,ATLAS,CHINESE,HSPA6,HSPB1,MMP,MMP19,PEARSON,RAB34
169,CEREBELLAR,COPYRIGHT,DIAGNOSIS,LHERMITTE,SAS,V600E
169,CONVERSELY,COPYRIGHT,FINALLY,HOWEVER,IRELAND,LTD,LYS,OTU,OTUD5,PDCD5,PROGRAMMED
169,297,CCI,COPYRIGHT,INC,INDEX,PUBLISHED,SCALE
169,COA,COPYRIGHT,ERK,FPP,GBM,GTPASES,HMG,LOV,LTD,MEK,POH,RAF,RAS,RHO,U87,WHILE
169,COPYRIGHT,INC,LABEL,OBJECTIVE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS
169,BACKGROUND,BESIDES,CONCERNING,COPYRIGHT,INC,LABEL,METHODS,PITUITARY
169,CONCLUSION,COPYRIGHT,DIFFERENT,ENDONASAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,ALTERNATE,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PRE,RESULTS
102,169,BACKGROUND,CLEFT,COPYRIGHT,CYSTS,INC,LABEL,METHODS,RESULTS,THERE
169,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
001,008,BACKGROUND,CONCLUSION,EASTERN,GROUP,LABEL,METHODS,RESULTS,SINCE,TEN,TREATMENT
CD2N2,CH2N2,DAG,PC3,PTDINSP,TMS,USING
157,177,200,500,AUTOMATED,CNS,EYELINK,III,LABEL,METHODS,OBJECTIVE,RESULTS,SPATIAL,THERE,THESE,THREE
AFTER,BACKGROUND,FURTHER,HOWEVER,LABEL,METHODS,RESULTS
AIP,BACKGROUND,CONTEXT,KNOWN,LABEL,LOH,MAX,METHODS,MUTATIONS,OBJECTIVE,OUTCOME,PGL,PITUITARY,RESULTS,RET,SETTING,TMEM127,VHL
PITUITARY
2ND,BAF47,BECAUSE,RTPS1,RTPS2,SMARCA4,SMARCB1,SNF,SWI
518,ATLAS,FINALLY,GBM,NOTCH,PCR,TAKEN
156,169,AKT,BINDING,BIOLOGY,EBP50,EZRIN,INC,INCREASED,MOLECULAR,PDZ,SOCIETY,THR
BRAIN,MANAGEMENT,NEWER
BRAIN,HEADSMART,STUDIES
169,394,441,477,786,918,AMONG,BACKGROUND,CASES,CRC,LABEL,METHODS,RAS,RESULTS,SOCIETY
169,COPYRIGHT,INC
169,946,COPYRIGHT,FURTHER,HOWEVER,INC,PREVIOUSLY,TAKEN
050,144,224,368,ARCHIVE,ATLAS,CONCLUSION,GBM,HIPAA,IMAGING,INGENUITY,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,PATHWAY,PURPOSE,RESULTS,VOLUMES
160,169,183,BASED,BECAUSE,GEORG,STUTTGART,THEREFORE
169,382,953,AUSTRALIAN,HODGKIN,LABEL,METHODS,OBJECTIVE,READERS,RESULTS
719,BACKGROUND,CONCLUSION,FDG,LABEL,METHODS,MRI,PCNSL,PET,RESULTS,SUV,TEN
169,COM,COPYRIGHT,LTD,UCM
028,035,107,225,954,BVZ,ELISA,GBM,PFS,SNP,THROMBO,VEGFA
178,552,586,BETWEEN,DSC,FOLLOWING,GAMMA,GKS,HOWEVER,INITIAL,MARCH,MRI
CHINESE,EMERGENCY
ADRENAL,AIM,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE
127,169,BACKGROUND,CNS,CSF,GREATER,LABEL,METHODS,OVERALL,PEDIATRIC,PERTINENT,RESULTS,SOCIETY
101,134,169,794,851,COX,DISCUSSION,LABEL,MACHINE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SVM
169,BECAUSE,COPYRIGHT,ENDOSCOPIC,FORTY,HISTOLOGIC,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS
CUSHING,EGF
002,100,169,ACCORDING,COPYRIGHT,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,NCA,NEOPLASTIC,OBJECTIVE,RESULTS,SCHOLAR,SCIENCE,WEB
160,169,5MC,AML,AUTHORS,COPYRIGHT,INC,PUBLISHED,SOMATIC,THESE,WT1
169,852,ABS,BUTADIENE,CONCLUSION,COPYRIGHT,DEVELOP,DUE,LABEL,MATERIALS,METHODS,MHZ,MRI,OBJECTIVE,RESULTS,STYRENE,TESLA
169,246,264,D617EFS,E450X,GLIOMAS,PRESS,PUBLISHED,THESE,UNIVERSITY,USING,VALIDATION
169,946,BBB,BIOLOGICAL,COPYRIGHT,DUE,INC,NIEMANN,PUBLISHED
IMS,MALDI,TOF
BACKGROUND,BESIDES,GBM,LABEL,METHODS,MRI,RESULTS,WORLD
169,231,397,944,COLLEGE,COPYRIGHT,LTD,ONTARIO,OVERALL,PALLIATIVE,PRT,PUBLISHED,ROYAL
210,ABERRANTLY,BACKGROUND,LABEL,MECHANISM,METHODS,MTT,PCR,RESULTS,SIN3A,TARGETSCAN,WESTERN
169,946,AKT,ANNEXIN,BCL,CHINESE,COPYRIGHT,EGF,ERK,GLIOMAS,LTD,MMP,QUERCETIN,RAS,SHG44,THEREFORE,U87,WOUND
AFTER,BACKGROUND,BECAUSE,BRAIN,CONCLUSION,CTA,HOWEVER,LABEL,LERICHE,METHODS,MRI,THERE
143,CHINA,CHINESE,DTRAM,FIFTY,MINOR,SSM
ACTIVATION,BACKGROUND,BAX,BID,INDIVIDUAL,LABEL,METHODS,MMP,RESULTS,THESE,U87MG
001,009,015,027,033,048,131,146,291,386,588,910,BACKGROUND,BESIDES,EUD,GENERAL,KRUSKAL,LABEL,METHODS,PEARSON,PTV,RADIATION,RESULTS,UNIVERSITY
AETIOLOGY,BMJ,CALCIFYING,GROUP,LTD,MRI,PUBLISHING
001,004,177,180,CRH,CUSHING,FDG,IMAGING,MAXIMUM,METHODS,MRI,PET,RESULTS,SUV,TEN,THREE,WHILE
DSRCT,EARLY,EWING,EWS,OTHER,REVERSE,WILMS,WT1
100,177,BENEFIT,BETWEEN,GBI,GLASGOW,INVENTORY,JANUARY,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,SHORT,THEIR,VSS
945,946,CONCLUSION,ECS,FORTY,III,LABEL,METHODS,MVS,OBJECTIVE,OBJECTIVES,RESULTS,SMA
169,COPYRIGHT,GBM,IMAGING,INC
169,COPYRIGHT,INC
169,COPYRIGHT,GBM,IMAGING,INC,MRI,SEVERAL
160,169,BECAUSE,COPYRIGHT,DESPITE,DIAGNOSED,INC
169,COPYRIGHT,EPIGENETIC,INC,PUBLISHED,SCIENTISTS
ACTIVATOR,GBM,STAT3,THESE,TRANSDUCER
044,049,100,169,19Q,ABSENCE,AMP,COPYRIGHT,III,INC,THESE,WESTERN
231,BACKGROUND,CK5,LABEL,LUMINAL,MCF,MDA,METASTATIC,METHODS,RESULTS,SIMILAR,THEIR,WHILE
001,002,003,007,009,473,AKT,BACKGROUND,EXPRESSION,HOWEVER,LABEL,MBS,METHODS,MIB,RESULTS,SER
160,169,183,ADMISSION,DEPARTMENT,DIAGNOSIS,GEORG,HENCE,HGH,HISTORY,LABEL,METHODS,MRI,PSYCHIATRY,RESISTANCE,SERUM,STUTTGART,THYROID,TREATMENT,TRH,TSH
169,AIM,APA,APN,B1LYP,B3LYP,COPYRIGHT,DVIOH,III,INC,NMR,RAS,SOGGA11,THEREFORE
141,ABCG2,CPT,MBL,MDR
ABI,AIM,BENEFIT,BETWEEN,CONCLUSION,LABEL,LIP,MANCHESTER,MARCH,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SEVENTY,USING
DIFFUSE,JMJD3
109,ALTOGETHER,CONVERSELY,EB1,END,GBM,U87,VINCA,VINFLUNINE
100,169,AFFYMETRIX,FURTHER,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SHROOM2,SPHK1,THESE,THREE
001,085,169,327,389,AMONG,CUMULATIVE,END,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,USING,VALIDATED
001,012,028,039,040,041,054,066,AGE,BACKGROUND,EASTERN,FIFTY,GROUP,HOWEVER,LABEL,METHODS,RESULTS
121,177,BACKGROUND,DEPARTMENT,EARLY,INCOMPLETE,LABEL,MARCH,METHODS,RADIATION,RESULTS
PRL
176,HOWEVER,HTP,LABEL,METHODS,MRI,MRIDB,MSD,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SAR,T1W,T2W,THREE
001,100,ACHIEVING,BRAIN,LABEL,METHODS,MEV,OBJECTIVE,PLANS,PURPOSE,RESULTS,SECONDARY,SFO
198,ALEMS,ALTERATION,DMS,THESE
BTB,ECS,KNOCKDOWN,MMP,PD98059,PP2,ROBO4,ROUNDABOUT,SHORT,SLIT2,SRC
AMONG,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TOTAL
169,ACCORDING,BACKGROUND,DCI,DELAYED,HEART,IMAGING,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STRATEGIES,TREAT
C1Q,C5B,DEPOSITION,ELISA,GBM,MBL,MULTIFORME,SERUM,THEREFORE
ADVANCE,HELPING,THERE,WHILE
GBM,THERE,TMZ,TREATMENT

DESPITE
CURRENT,DESPITE,TREATMENT
19Q,26951,ANAPLASTIC,CODEL,CPG,EORTC,IDH,PCV
19Q,ADDITIONAL,EOR,LOW,LOWER,NOVEL,PCV,QOL,TMZ
000,CLEAR,CURRENT,GBM,THESE

19Q,CIC,FUBP1,HOWEVER,IDH,LOW,MAP,PROGNOSTIC,THESE
GLIOMAS
169,COPYRIGHT,DYNAMIC,INC,KMT1E,KMT2A,NRF,THREE
169,BASED,BRATS,COPYRIGHT,LTD,MRI,THEREFORE
169,CNS,COPYRIGHT,EARLY,GRAND,HIV,HOWEVER,LTD,ROUND
001,002,004,016,029,040,121,C30,CNS,EORTC,HRQOL,LGG,QLQ,QOL,QUALITY,RADIATION,TREATMENT,USING
EOR,GBM,INDIVIDUAL,MRI
169,AUTHORS,COPYRIGHT,FRAGILE,FXS,INC,MMP,MUTATIONS,PUBLISHED,THESE,USING
001,ILSSS,KEY,LABEL,LOW,METHODS,NPV,OBJECTIVE,OBJECTIVES,PPV,RESULTS,SWI
13RA2,169,945,946,956,CMV,COPYRIGHT,EPHA2,FOXP3,HIF,PDGFR,STAT3,WP744
169,954,BECAUSE,COPYRIGHT,EXTRACTED,INC,SGP40,SGP65,THESE,TREATMENT
BACKGROUND,BRAIN,EEG,LABEL,METHODS,MRI,RESULTS
7TH,BASED,MODEL,RESILIENCY
160,169,954,AUTHORS,COPYRIGHT,DIFFERENT,DISRUPTION,GSC,INC,NSTCS,PUBLISHED
113,169,AGE,AMONG,AUTHORS,CONCLUSION,COPYRIGHT,III,INC,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,OGM,PUBLISHED,RESULTS,RETRACTION,SIMPSON,WORLD
169,600,APOA1,APOA4,APOA5,APOC3,AZA,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PCR,RESULTS,TC7
169,177,342,422,764,COPYRIGHT,GFS,INC,IPL,IPS,RBS,SCC,THESE
130,169,177,215,916,ANAWETV,COPYRIGHT,GIBBS,HOWEVER,INC,MRI,SNR,TSC
169,COPYRIGHT,SHC
001,006,031,073,124,169,327,456,535,591,783,830,COPYRIGHT,GROSS,KPS,LABEL,METHODS,NON,OBJECTIVE,RESULTS
169,COPYRIGHT,DTT,FUNCTIONAL,GROSS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,SMALL,THERE
169,CASES,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,POSTNATAL,RESULTS,STUDIED,TOP,VAGINAL
169,COPYRIGHT,HOWEVER,IRELAND,LTD,REDUCED,THESE
100,169,CONCLUSION,COPYRIGHT,DEFERRING,LABEL,METHODS,OBJECTIVE,PCNSL,RESULTS,RFS,TOXICITIES
169,ACCORDING,AFTER,CONCLUSION,COPYRIGHT,DSA,FIFTEEN,GAMMA,KNIFE,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS,REVIEWING,TEN,THREE
169,COPYRIGHT,CYTOKINES,LTD
169,ALK,COPYRIGHT,III,INC
169,AUTHORS,HENCE,KDR,KNOCKDOWN,LTD,MALIGNANT,NOVEL,PTY,PUBLISHING,SCIENCE,SUNITINIB,WILEY
169,231,233,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,WCC
169,COPYRIGHT,INC,METASTASES,REGIONS
169,AKT,APOPTOSIS,BACKGROUND,BAX,BCL,CASPASE,CHINESE,COPYRIGHT,DECREASED,ERK,HDW,INDUCTION,IRELAND,LABEL,LTD,MATERIALS,METHODS,MMP,MTT,PROTEIN,RELEVANCE,RESULTS,RUBIACEAE,THESE,U87,WESTERN,WILLD
100,169,BACKGROUND,BRAIN,COPYRIGHT,DERIVED,EMT,INCREASING,LABEL,LTD,METHODS,PCR,RESULTS,TARGETING,THESE,WESTERN,WHILE
169,COPYRIGHT,HNSCC,LTD,NGF,PERINEURAL,THESE,TRK
001,169,AUTHORS,COPYRIGHT,GVP,INC,MSS,MVP,PFS,PUBLISHED,THERE,VCS,VGS,VMS
169,COPYRIGHT,FDG,INC,PET,STRUCTURAL
169,325,339,ADDITIONAL,AIM,CONCLUSION,COPYRIGHT,COX,GBM,HRS,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WHILE
011,06YEARS,169,177,29YEARS,CONCLUSION,COPYRIGHT,GBM,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,TURKISH
169,AMONG,CENTRAL,COPYRIGHT,FALLS,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OLDER,OTHER,RESULTS,REVIEWS,SEVERAL,SYSTEMATIC
102,169,195,956,ADDITIONAL,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,TBI
169,945,946,ALLYL,ATE,BROMINATED,COPYRIGHT,HOWEVER,LAT,LTD,PSA,THESE,THREE,WESTERN
169,177,BBB,COPYRIGHT,DGL,LIM,LIMK2,LNP,LTD,MECHANISM,MTT,NPS,PEG,PLASMID,SUCCESSFUL
169,ASPSCR1,COPYRIGHT,INC,THESE
002,169,183,292,AMONG,CLINICO,COPYRIGHT,GPA,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,WHILE
001,005,014,126,169,193,339,ACCORDING,BETWEEN,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PCI,RESULTS
169,COPYRIGHT,FINALLY,MDSCS,THEREFORE
121,169,COPYRIGHT,LEUCINE,PCR,WESTERN
169,611,BRAIN,CONCLUSION,FACBC,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTEEN,SOCIETY,UNLABELLED
123,150,169,714,AMONG,BECAUSE,CONCLUSION,DPA,GBM,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIX,SOCIETY,SPECT,UNLABELLED,VOLUMES
169,BACKGROUND,LABEL,METHODS,MMP,MT1,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,USING
169,FVB,SFK,SRC
169,18A,BTB,COPYRIGHT,FINALLY,HRP,INC,MEANWHILE,RUNX1,TAKEN,U87MG
169,447,455,AUC,BIOMEDICAL,CHINESE,CHO,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MAY,METHODS,MRS,NAA,OBJECTIVE,PURPOSE,RESULTS,SEN,SPE,STUDIES
070,169,279,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SIR,USING
100,120,169,BECAUSE,COMMISSION,COPYRIGHT,ESTIMATED,HOWEVER,PROTECTION,PUBLISHED,SAS
007,100,169,670,946,BACKGROUND,COPYRIGHT,DISCUSSION,INC,LABEL,METHODS,RESULTS,SALMONELLA
169,COPYRIGHT,WHILE
169,COPYRIGHT,FUS,FUSED,PARKINSON,SARCOMA
169,AIM,AKT,COPYRIGHT,ERK,LABEL,LTD,MEK,METABOLIC,METHODS,OBJECTIVE,RAF,RESULTS
001,017,036,100,124,169,310,809,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,RESULTS,T790M,THERE,TKI
169,231,233,COPYRIGHT,DRESS,PUBLISHED,SAS
169,392,860,CENTRAL,CHILDHOOD,COX,DESPITE,FINNISH,HRS,OUTCOME,POPULATION
169,COPYRIGHT,CURRENT,DESPITE,LTD,MOLECULAR,MRI,PET
169,231,233,AFTER,COPYRIGHT,PUBLISHED,SAS,VERTEBRAL
005,111,150,169,177,320,CLINICALLY,COPYRIGHT,CROWN,DCE,FUNCTIONAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PARAMETRIC,PUBLISHED,RESULTS,ROI,TDA
AFTER,DELAYED,FLAIR,FURTHER,MRI,RADIATION,SRS,WMC
169,AGGRESSIVE,COPYRIGHT,SINCE,THESE,USING,WHILE
169,CNS,COPYRIGHT,DMD,HOWEVER,INC,STUDIES
169,ALTOGETHER,ATP,COPYRIGHT,CXCL8,LPS,MCP,MRS2578,U87MG
169,945,AM281,CB1,CB2,COPYRIGHT,ELISA,INC,KEY,LABEL,METHODS,OBJECTIVE,PRO,RESULTS,TNF
169,COPYRIGHT,GROWING,PCR,PUBLISHED
169,946,COPYRIGHT,FURTHER,GBM,HOWEVER,IRELAND,LTD,PUBLISHED,REPRESSION,STAT3,TAKEN
169,180,210,916,BECAUSE,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,PDCD5
ANP,BRAIN,CPP,NOW,PTX,THEREFORE
022,023,111,160,169,AFTER,AMONG,BACKGROUND,BMS,CLINICIANS,CONCLUSION,COPYRIGHT,COX,CRC,INC,INCREASED,JANUARY,JAPAN,KINKI,LABEL,LOG,MATERIALS,METHODS,MST,RESULTS,THERE,UNIVERSITY
169,177,COPYRIGHT,DUE,FIRST,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PHANTOM,PURPOSE,REGARDING,RESULTS
169,ADULT,ASSESSMENT,BETWEEN,BRAIN,COPYRIGHT,FIFTY,FUNCTIONAL,GTV,HOWEVER,INC,INDIVIDUAL,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PARTS,PTV,PURPOSE,RESULTS,SECONDARY,SRS,STATE,THERAPY,THREE,TRAIL
116,127,169,COPYRIGHT,GBM,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RADIATION,RESULTS,TMZ
008,010,160,169,ACADEMY,BACKGROUND,COPYRIGHT,DIVERSE,III,INC,LABEL,MEDLINE,METHODS,MKP,MUP,OBJECTIVE,PUBLISHED,RESULTS
169,BACKGROUND,COPYRIGHT,ENGLISH,FEMALES,INC,LABEL,METHODS,PROGNOSIS,PUBLISHED,RESULTS,SCHOLAR
231,524,CA2,CCB,ERK,HOWEVER,KCL,MDA,NIFEDIPINE,SILENCING
000,001,025,ASA,BACKGROUND,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SPECIAL
169,946,CBS,COPYRIGHT,GAPDH,H2S,INC,INDUCTION,PSD95
169,COPYRIGHT,INC
BACKGROUND,BETWEEN,DISCUSSION,GIVEN,LABEL,METHODS,RESULTS
100,COLLEGE,FURTHER,GAMMA,GKS,KNIFE,LABEL,METHODS,OBJECTIVE,OCTOBER,RATES,RESULTS,UNIVERSITY
168,AMONG,BEIJING,GAMMA,GKS,KNIFE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TIANTAN
011,137,162,ACCEPTABLE,AFTER,AMONG,GAMMA,GENERAL,GKS,HOWEVER,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SUCCESSFUL,THERE
100,GAMMAPLAN,HOWEVER,LABEL,LEKSELL,METHODS,OBJECTIVE,RESULTS,TCP,TREATMENT
141,BRAIN,CHILD,CLASS,GAMMA,GKS,GROUP,HCC,KARNOFSKY,KNIFE,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,SCALE,SIXTY,THERAPY,UNIVARIATE
100,BECAUSE,GAMMA,GKS,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PER,RESULTS,SUBSEQUENT
009,110,289,AVERAGE,CRITICS,DESPITE,KARNOFSKY,KPS,LABEL,MAY,MEIER,METHODS,MVA,OBJECTIVE,OVERALL,RESULTS,SALVAGE,SCALE,SRS,TREATMENT
008,012,024,CLASS,COX,DISTANT,FOLLOWING,GAMMA,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SALVAGE,SRS,WHILE
003,006,110,625,817,ACCORDING,ACTUARIAL,COX,FACTORS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OPTIMAL,PENDING,RESULTS,SCALE,SHERBROOKE,SRS,UNIVARIATE
215,CNS,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,WHOLE
176,227,270,403,AFTER,AGAIN,AVERAGE,BETWEEN,BRAIN,CGI,DIGITAL,FINALLY,GAMMA,GAMMAPLAN,GKP,IMAGING,KNIFE,LABEL,LIPPITZ,METHODS,METRICS,MRI,OBJECTIVE,PADDICK,PERFEXION,PHILIPS,RESULTS,SEVEN,THESE,VELOCITYAI
001,157,241,449,701,924,AUDITED,FOLLOWING,GAMMA,INSTITUTE,JAMES,KNIFE,LABEL,METHODS,OBJECTIVE,PADDICK,PCI,PEI,RESULTS,THROUGH,WHITNEY
134,176,178,204,219,268,302,305,318,355,382,749,792,825,ACCORDING,BASIC,BRAIN,HOWEVER,LABEL,LORENZONI,METASTASES,METHODS,MRI,NPS,OBJECTIVE,RESULTS,SCORE,SRS,SUBGROUPS
DISEASE,END,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SRS,TEXAS,UNIVERSITY
073,112,133,138,181,319,360,425,469,541,554,560,607,649,720,732,739,771,870,974,990,994,BECAUSE,COMPETING,GAMMA,GAMMAHOUSE,GROUP,KARNOFSKY,KATSUTA,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SRS,THESE,ULTIMATELY
169,COPYRIGHT,CURRENTLY,LTD,THERE,THEREFORE
950,965,AKRIB10,B10,BRAIN,BRSK2,CERTAIN,CYTOSCAPE,EWSR1,EXPRESSION,GSE9508,MCODE,OMNIBUS,SMO
ANNEXIN,DHF,HOWEVER,MTS,SP1,TAKEN
100,215,303,623,798,902,926,942,ADC,ANOVA,AUC,DWI,FORTY,PARAMETERS,ROC
PREVIOUSLY,RIGHT
ECC,UNDER
GIVEN,RECURRENCE
122,197,714,BARTHEL,CONTROL,END,EOL,GBM,INDEX,KARNOFSKY,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,PARTICULAR,RESULTS,SCALE,STATE
101,150,AFTER,AFTERWARD,COX,GROUP,GTR,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,PFS,PROLONGED,RESULTS,SCALE,STUPP,TMZ,VOLUMETRIC
EARLY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SUBSEQUENT,THEREFORE
LABEL,METHODS,OBJECTIVE,RESULTS,S1013,THESE
500,956,ALA,CONTINUOUS,CST,LABEL,MEP,METHODS,MOTOR,MRI,OBJECTIVE,RESECTION,RESULTS
LABEL,METHODS,OBJECTIVE,RAS,RECURRENCE,RECURRENT,RESULTS,THERE
FURTHER,GBM,KTS,WILMS,WT1
DIFFUSE,MUTATIONS
THERE
BECAUSE,HENCE,HGF,MET
AMONG
945,946,DTX,GLYCINE,PEG,PLA,RGD,RGDYK,U87MG
CHEMOKINES,ENDOTHELIN
AMONG,BASED,BVZ,COMPARISON,HGG,IMAGING,MRI,THERE
5TH,7TH,8TH,AFTER,MRI,REVIEWING,REZ,SURGERY
169,BIOLOGY,GBM,RESISTANCE,SOCIETY
169,ABL,AES,LABEL,NOTCH,RAC,RHO,THESE,TYR,UNLABELLED
001,160,AMONG,CONCLUSION,DSS,FDG,III,INITIAL,LABEL,METHODS,MORTALITY,NAC,OBJECTIVE,PET,PURPOSE,RESULTS
169,COPYRIGHT,DISCUSSION,INC
169,AFTER,CENTRAL,COPYRIGHT,HOWEVER,INC
169,COPYRIGHT,INC,THESE
169,CNS,COPYRIGHT,INC,OTHER
169,CENTRAL,CNS,COPYRIGHT,INC,OPTIMAL
169,COPYRIGHT,INC,TREATMENT
160,169,AFTER,COPYRIGHT,GAMMA,HOWEVER,INC,KNIFE,MRI
169,COPYRIGHT,INC,SRS
169,CENTRAL,COPYRIGHT,DUE,INC,SRS
169,COPYRIGHT,INC,MONRO,SVZ,THESE
169,CENTRAL,COPYRIGHT,INC,SEVERAL
169,CENTRAL,COPYRIGHT,INC,INITIAL,MONRO,MRI
169,BECAUSE,CENTRAL,CNS,COPYRIGHT,INC,OPTIMAL,RADIOLOGIC,TYPICAL
169,COPYRIGHT,INC
169,BCL2L11,BH3,BIM,GBM,MEK,TKI
DESPITE,SIMILAR
169,BIOLOGISTS,COMPANY,CURRENT,GBM,GEM,GRADE,HOWEVER,LTD,ORTHOTOPIC,PRIMARY,PUBLISHED,THESE
AKT,GBM,RH2
169,260,340,440,946,AKT,BACKGROUND,CNS,CONCLUSION,INHIBITION,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVERSITY
172,177,945,CCG,CENTRAL,GROUP,HGG,HISTOLOGY,HOWEVER,LGG,MIB,PFS,UNIVARIATE
BROAD,HOWEVER,PEPTIDE
CAJAL,NUCLEAR
176,947,CONCLUSION,DOSES,KNOWN,LABEL,METHODS,OAR,OBJECTIVE,PREVIOUSLY,PTV,PURPOSE,RESULTS
160,169,ALIKE,BIOLOGY,BRAIN,CHROMATIN,COMMONS,EXPRESSION,HOWEVER,LICENSE,LUO,MDK,MIDKINE,MOLECULAR,NEOPLASIA,REPOSITORY,SHARE,SOCIETY,SP1,XIA
169,COPYRIGHT,GALANIN,OTHER,PKA,SOCIETY,THESE
ALZHEIMER,BACKGROUND,C26,CONCLUSION,FATTY,LABEL,METHODS,OBJECTIVE,RBC,RESULTS,SEVERAL,STATE
100,129,141,150,152,155,167,19Q,405,AMONG,BASED,DIFFUSE,FOLLOWING,FURTHER,H3F3A,HAARLEM,IDH,III,ISN,MOLECULAR,NOA,R132H
009,436,THEREFORE
AC133,CAR,CD133,CSC,GBM,HOWEVER,SCS,THEREFORE
169,300,946,ADVERSE,ANTITUMOR,BNP,DOPPLER,FHD,LABEL,LY2157299,MACDONALD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,SMALL,TGF,THEREFORE
004,005,013,169,ADVERSE,FORTY,IHC,IL4,IL6,IL8,INK4A,LABEL,METHODS,MUTATIONS,OBJECTIVE,PFS,PURPOSE,RESULTS,SCCHN,SCREENING,TEN,THOSE,TNF
169,286,945,947,COHORTS,CONCLUSION,ELISPOT,EPHA2,GAA,HLA,IFN,IL13R,ISA,LABEL,LGG,METHODS,MONTANIDE,OBJECTIVE,PFS,PURPOSE,RES,RESULTS,SYNTHETIC,THESE,WT1
169,1970S,1980S,INC,MUTATIONS,PALLISTER,PHS,WILEY
T12,TREATMENT
001,006,DENSELY,IGF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,THERE
945,BECAUSE,HIF,LABEL,MET,METHODS,MIB,OBJECTIVE,OSMOTIC,RESULTS,U87,USING
GRADE,STR,USING
THERMOPSIS,THESE
FOXP2,MENDELIAN,MUTATIONS,SEVERAL
003,169,946,ADULT,BACKGROUND,EARLY,LABEL,METHODS,RESULTS,SIXTY,SOCIETY
CHALLENGES,CPG,EPIGENETIC,GBM,HTB,K27,KIF23,LOX,PBK,THERE
ALA,DELAYED,FCM,HOWEVER,PREVIOUSLY,ROS,THESE
180,511,FIRST,GFP,HGG,HOWEVER,RRV,RVV
169,EFFECTIVE,INC,THESE,WILEY
AIM,BACKGROUND,LABEL,METHODS,MONRO,RESULTS,THREE,TREATMENT,TSC
EPH,THEIR
169,GROWING,INC,MINIMAL,PD0332991,WILEY
LIMITED,MICROBEAM,MRT
005,BLACK,CNR,CONCLUSION,DIAGNOSTIC,FOM,FPS,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,VISIBLE
BTSCS,MOLECULAR,NSC
020,121,215,606,858,921,ADC,CONCLUSION,DIFFUSION,DWI,LABEL,METHODS,MINIMUM,OBJECTIVE,PURPOSE,RESULTS
160,THESE
169,BIOLOGY,HOMOZYGOUS,SOCIETY
BACKGROUND,CONCLUSION,CYBERKNIFE,GENERATING,LABEL,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS,SRS
CONVERSELY,FUNCTIONAL,MRI
AMONG,GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,R132H,RESULTS,THERE,UNIVERSITY,USING
004,005,008,019,026,102,135,CNS,COX,EFFECTS,HOWEVER,LABEL,METHODS,MORTALITY,OBJECTIVE,PATIENT,RESULTS,SURGERIES,THERE,THESE
120,132,AFTER,GRADE,III,METHODS,RESULTS,SINCE,THEREFORE
GLYCOLYTIC,LIN28,ODC,PET,POLYAMINES,SMS
105,116,296,584,767,CLASSICAL,HOWEVER,MICRORNAS,PRONEURAL,SECONDARY,TAKEN
100A6,169,AHNAK,CNS,COMBINING,ELISA,ESI,FGR,MGS,QUITE,RAS,SEVERAL,TOF,VCH,WILEY,WNT
169,INC,SEVERAL,SPECIAL,WILEY
065,096,145,177,215,223,271,703,835,ADC,ASSESSMENT,EVALUATION,NGGCT,TEN,THERE
001,003,037,057,110,132,169,ANY,CENTRAL,CNS,COPYRIGHT,COX,FACTORS,FIFTEEN,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,SRS
169,COPYRIGHT,GBM,GYE,HOWEVER,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SIX,SOCIETY,TREATMENT
169,ACTUARIAL,ACUTE,ADVERSE,COPYRIGHT,DEFINITIVE,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SEPTEMBER,SIX,SMALL,SOCIETY,THREE
APART,INCREASING
370,624,BETWEEN,CENTRAL,THERE,TPN,TREATMENTS
ACC,BACKGROUND,CONCLUSION,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS
003,ADVERSE,CNS,IMPORTANCE,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,RELEVANCE,RESULTS,SETTING,THERAPY
EQUALLY,GALEN,TAKEN
GLIOMAS,HOWEVER,TLR
100,400,ABL,AES,AFTER,ARM,BOSUTINIB,HOWEVER,PFS,SEVEN,SRC,THEREFORE
000,001,008,014,177,ATHYMIC,BLOOD,BUN,CISPLATIN,DECREASING,DELAYED,MED,NAC,PHASE,THESE
ATLAS,EPH,THESE
169,177,AMONG,BASED,CUSHING,PCR,SOCIETY
CURRENT,OUTCOME,YET
MRI
169,BACKGROUND,COMMITTEE,CONCLUSION,END,FT4,JOINT,LABEL,METHODS,PRESS,RESULTS,SERUM,TSH
ACRYLAMIDE,GATEKEEPER,H1975,L858R,MICHAEL,NSCLC,SW620,T790M,THESE
AVERAGE,CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,PRE,PURPOSE,RESULTS
DTI,MRI,NEC,USING
BASED,CNS,DLT,GRADE,THERAPY,TID,TLAST
169,HISTOLOGIC,SEZ,THROUGH
MICRORNAS,THESE
SUPPORTIVE
HOWEVER,K63,PARKINSON,UBC13,UBIQUITIN,UCH,UEV1A
AFTER,CED,CURRENT,GBM,HOWEVER,MRI,PET
115,169,215,CONCLUSION,LABEL,METHODS,OBJECTIVE,PTCH1,PURPOSE,RESULTS,SOCIETY
169,ANATOMICAL,DES,MEYER,ORS,SIX,SOCIETY
945,CSNK1,EPH,EPHA7,FINALLY,HOWEVER,MYC,PCTAIRE,PCTK1
GSKJ4,H3K27,JMJD3,K27,PEDIATRIC
169,BACKGROUND,DIAGNOSTIC,INC,LABEL,METHODS,PARENTS,PROCEDURE,RESULTS,SCREENING,WILEY
100,169,835,AMONG,FREQUENCY,INC,INTERPHONE,MHZ,RADIO,SAR,TALAIRACH,THEIR,THEREFORE,WILEY
169,17P,22Q,CNV,MELANOMAS,MELANOTIC,SOCIETY

160,946,LHX,PCR,POTENTIAL,QRT,WNT
169,2HG,DROSOPHILA,EXPRESSION,HEMATOLOGY,IDH,R132H,R140Q,R163Q,R195H,SOCIETY,THESE,UAS
GBM,GSC,HGG,HOWEVER,MES,METABOLIC,SIMILAR
003,514,AFRICAN,AFTER,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,OBJECTIVE,RESULTS,THESE,WORSE
100,450,CSF,FIFTY,GIVEN,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
CLASS,ENGEL,GRADE,GROSS,LABEL,METHODS,OBJECTIVE,OPERATIONS,PMT,RESULTS,THESE
141,222,CSF,FIFTY,FOXL1,POU,SP1,THESE
001,078,161,594,CTX,FURTHER,GCT,IPFSG,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SALVAGE
HOWEVER,PROGNOSIS
100,BID,FOUNDATION,GNF,INSTITUTE,IRINO,LABEL,METHODS,NBS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,TMZ,TRK
FASLG,MECHANISM,MTT,PCR,TARGETSCAN
169,COPYRIGHT,GBM,HOT,LTD,MRS,PRESS,WILEY
AFTER,DKK,EMD121974,PCR,REDUCED,THESE
142,169,211,255,334,363,365,588,775,AFTER,ALDRYCH,AML,APRIL,BACKGROUND,BETWEEN,CGD,CONCLUSION,HLH,INC,INFANTS,LABEL,MARCH,METHODS,NBL,PROCEDURE,RESULTS,SAA,SEVENTEEN,THEIR,TORONTO,WILEY,WISCOTT
035,103,AMONG,BACKGROUND,LABEL,METHODS,RESULTS
169,COPYRIGHT,CUTANEOUS,FIRST,MODULATION,SOCIETY
002,GROSS,GTR,LABEL,MEIER,METHODS,OBJECTIVE,PFE,PFS,PURPOSE,RESULTS,STE,XRT
ALA,BACKGROUND,FOLLOWING,GROUP,LABEL,METHODS,MRI,RESULTS
001,EXPRESSION,III,PCR,SIMILARLY,STUDIES,THESE,TRX,TRXR1,TUNEL,WORLD
001,005,007,023,026,027,036,133,189,19Q,354,381,AMONG,AOA,PCV,TMZ
ODN,PHASE,SIMILARLY,THESE
ALZHEIMER,BACH1,BVR,SINCE
169,EFFECTIVE,FORETINIB,MECHANISMS,MET,SHH,TAKEN
177,1ST,2ND,322,3RD,DESPITE,III,MRI,PFS,SIXTY,VEGFR
169,177,328,578,819,944,BACKGROUND,FURTHER,HEART,INC,KIM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING,WMH
AMONG
169,946,ANXIETY,DEPRESSION,FATIGUE,FRACTAL,HOWEVER,HURST,INC,SLEEP,STRESSFUL,WILEY,WORRY
215,875,BONFERRONI,CHINESE,FURTHER,HAN,HGG,LGG,NMI,TAKEN
169,AUTHORS,INC,INSTEAD,SOCIETY,THEREFORE,WILEY
006,028,042,045,046,049,CNS,COX,DEPARTMENT,EVN,MIB,SIMILAR,TOTAL,WORLD
GBM,HOWEVER,METASTASIS,MTSS1,THESE
CNS,GBM,MRI
250,600,ALZHEIMER,LASER,LCM,USING
AMONG,DESPITE,FINALLY,GBM,GSC,OLIG2
ERK,LTP,MEK,RAS,THESE
CONCLUSION,LABEL,MATERIALS,METHODS,PURPOSE,RESULTS,UNLABELLED
BACKGROUND,CONCLUSION,LABEL,METHODS,MRI,POPULATION,RESULTS,SWEDISH,THREE,WAITING
169,INC,PEDIATRIC,WILEY
169,INC,PCR,WILEY
000,169,181,200,316,400,431,AMONG,CCNB1,CDC20,MRT,PLK,PTTG1,TRIB3
169,CONCLUSION,KNOWN,LABEL,LTD,MEK,METHODS,OBJECTIVE,SUMMARY,V600E,V600M,V600R,WILEY
BECAUSE,TREATMENT
169,BACKGROUND,BRCA2,CONCLUSION,FANCONI,FEW,INC,LABEL,METHODS,PHENOTYPIC,PROCEDURES,RESULTS,SEVEN,SOLID,WILEY
AUSTRALIAN,RESOURCES,TOOLS
214,301,381,437,659,ABO,CSF,ENDOSCOPIC,ETV,ITH,LABEL,METHODS,OBJECTIVE,PEDIATRIC,REESH,RESULTS,SEVEN,SIX,THERE,UNIVERSITY,UTH
149,BETWEEN,EOR,GRADE,JANUARY,LABEL,METHODS,OBJECTIVE,PCMIS,RESULTS,THERE
100,LABEL,MEDTECH,METHODS,OBJECTIVE,RESULTS,ROBOTIC,SIX
000,169,BACKGROUND,BRAIN,CNS,CONCLUSION,LABEL,METHODS,PFS,PRESS,RESULTS
001,009,169,624,BACKGROUND,DURAL,HEART,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PARESIS,PURPOSE,RESULTS,SCALE,SINUS,THREE,THROMBOSIS
045,215,738,815,AGILENT,CONCLUSION,GBM,LABEL,METHODS,MICROARRAY,OBJECTIVE,OBJECTIVES,PATHWAY,POTENTIAL,RESULTS,VOLCANO
036,169,245,271,298,307,407,453,507,672,699,870,897,BACKGROUND,COLORECTAL,DESPITE,INCIDENCE,INPATIENT,LABEL,METHODS,NATIONWIDE,RESULTS,SOCIETY
169,945,AKT,HOWEVER,MIG,TAKEN,TRANSGENIC
ATS,BACKGROUND,BETWEEN,LABEL,METHODS,RESULTS,THREE,TREATMENT
169,AKT,APLYSIN,BIOLOGY,HOWEVER,INCREASING,SOCIETY,WESTERN
169,BECAUSE,SMO,SMOOTHENED
169,5ENVE,BRAIN,FINALLY,TREATMENT
106,110,151,156,201,250,307,BACKGROUND,CONTEXT,CPS,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SIR,SMR,SWEDISH,THERE
020,030,040,BACKGROUND,GBM,LABEL,METHODS,RESULTS,TMZ,U87MG
100,EGFR2,INHIBITING,PRL,WESTERN
208,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SIGNS,VOLUMETRIC
FIRST,MRI
AKT,CCK,CONSISTENT,EDU,FINALLY,HIPPO,HOWEVER,MAMMALIAN,MEANWHILE,TAKEN,THEREFORE
MRI,WHILE
001,120,466,MEIER,NSCLC,ROC,THESE
947,TMZ,WHILE

HOWEVER,PCR,VEGFR
CSF,MNI,MRI,SEVERAL
001,177,DCE,DSC,MRI,SEVEN
169,945,GBM,HOWEVER,LABEL,LIVIN,METHODS,OBJECTIVE,PURPOSE,RESULTS,TAT,THESE,WESTERN
169,ADR,ECTOPIC,HOWEVER,MEMBERS
169,BA6,BROCA,INC,MNS,WILEY
000,001,003,005,009,012,013,018,026,030,148,177,201,206,230,288,360,406,417,458,563,733,800,861,911,BASED,BETWEEN,CSF,GTR,HGG,OSS,PEDIATRIC,PFS
006,22981,232,26981,EORTC,GBM,PFS,PPS,TMZ
947,ANOTHER,ELISPOT,GBM,OTHER,SIX,THERE,TMZ

ASPECTS,BRAIN,GUIDELINE,PATIENT,PEDIATRIC
240,ADULT,BRAIN,GUIDELINE,PATIENT
DESPITE,HOWEVER,LABEL,OBJECTIVE,OTHER,POC,POPULATION,PURPOSE,RESULTS,SINCE,STILL,SUMMARY
169,CD4,CD8,CSF,GBM,SINCE,THESE,WHILE
169,LTD,PUBLISHED,THESE,WILEY
169,THESE
946
177,ACUTE,AFTER,CNS,DBF,FIFTEEN,GROSS,JANUARY,MAY,PBS,PEDSQOL,PFS,QOL,RBE,SIX
WHOLE
000,040,120,141,304,655,884,BEIJING,FORTY,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,THREE,TIANTAN,UNIVARIATE
CARMINE,FDA,FRAMELESS,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,WHITE
AFFYMETRIX,ARRAY,CANDIDATE,CDH19,CURRENT,GBM,GSC,LABEL,METHODS,NSC,OBJECTIVE,RESULTS,U87,WESTERN
ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,RESULTS
GBM,SALL4
050,109,205,961,CET,DCE,FURTHER,GIVEN,MRI,PFS,PRE,THEREBY,VWR
000,001,003,006,014,024,168,999,ADULT,BRAIN,EPENDYMOMA,ESTIMATED,REPORTS,SPINE
100,169,215,BACKGROUND,BETWEEN,BMS,CONCLUSION,GOV,LABEL,MEDICAL,METHODS,MRI,ORR,PFS,PRESS,PUBLISHED,RESULTS,SECONDARY,SOCIETY,TMZ,TREATMENT,UNIVERSITY
002,169,III,NEURO,PCV,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,7TH,8TH,9TH,CSF,INC,WILEY
015,020,022,028,169,CDR,DTC,HERC5,NSCLC,PCR,QRT,SEVEN,STAGE
DESPITE,ECM,GBM,MSC
INHIBITION,JNK,JUN,NH2
169,ATM,ATR,CONSISTENT,GBM,INITIAL,MMR,TMZ
203,300,CNTN2,DIFFUSE,EXPRESSION,GBM,GSE9385,OMNIBUS,PPI
BACKGROUND,CONCLUSION,CONTEXT,LABEL,METHODS,PITUITARY,THERE
160,CYTOTOXIC,DAU,DU145,III,THESE
001,007,ADC,ADC10,CEL,COX,GBM,HAZARDS,PFS,PHASE,T2L
001,014,021,032,160,III,MTD,MTT,PCR,POZ,THESE,TRANSWELL
946,AKT,HOWEVER,LIQ,THESE,TMZ
001,113,169,945,CONCLUSION,CONFORMAL,DELAYED,HOPKINS,INTENSITY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,REVISED,SOCIETY
001,055,069,174,177,186,417,821,99M,COX,GBM,SPECT,TECHNETIUM
079,169,177,263,331,495,808,946,EFFECTIVE,TGF,TREATMENT,USING
169,300,34A,ACTIVATION,MIR,ND2,SHH,SIRT1,SMOA1,STRATEGIES,THESE
SHH,WNT
169,ACADEMY,BIOLOGICAL,BIOLOGY,CHINESE,EDITORIAL,HOWEVER,INSTITUTE,INSTITUTES,PRESS,PUBLISHED,SILENCING,U87MG,UNIVERSITY
945,AKT,HIF,HOWEVER,OCT
169,247,458,AMONG,ANY,CBT,CIS,COMPELLING,HOWEVER,ORS,OVERALL,STATE,USING,VITAMIN,WASHINGTON
845,DASATINIB,EGF,ERLOTINIB,GBM,GEFITINIB,SRC,THESE,TYR
169,GBM,MOLECULAR,PRESS
032,100,105,169,533,599,BACKGROUND,GBM,GMB,INC,LABEL,METHODS,PXA,RESULTS,SEGAS,THR599DUP,V600E,WILEY
002,007,009,109,125,169,CYBERKNIFE,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,SRS,SRT,UNIVERSITY
003,024,120,19Q,PCV,PFS
002,163,758,GBM,HOWEVER,KARNOFSKY,KPS,LOW,OVERALL,PRE,SCALE
AKT,CASPASE,DEPLETING,GBM,GSC,GSK3B,INCREASING,MALIGNANT,PI3KINASE
BASED,MTA,SIMILAR
169,AKT,BIOLOGY,EMBRYONIC,FOXO3,HOWEVER,INC,MNSOD,MOLECULAR,SOCIETY
169,ADAM9,FIRST,HYPOXIA,KNOCKDOWN,OVERALL,RAV,THEREFORE
ASSESSMENT,GROUP,HOWEVER,III,NEURO,PHASE,RADIATION,SUCCESSFUL,THERAPY,TREATMENT
362,CENTERS,LABEL,METHODS,OBJECTIVE,REASONS,RESULTS,SIX
CSF,MONRO,THESE
PCR,TOTAL
169,FAR,GBM,LGG,PRESS
178,956,BRAIN,DELAYED,FIFTY,INFANTS,LABEL,LEUCOVORIN,METHODS,MRI,MTX,OBJECTIVE,POPULATION,PURPOSE,RESULTS
001,002,003,015,018,063,AMONG,BACKGROUND,CONCLUSION,COX,DCD,HOWEVER,LABEL,MEIER,METHODS,NETWORK,ORGAN,PRIMARY,PSC,RESULTS,SHARING
169,232,786,FETAL,HOWEVER,INC,PROGRAM,SERVICE,STILLBIRTH,THERE,WILEY,WISCONSIN
001,009,019,215,600,740,ADC,BACKGROUND,LABEL,METHODS,MRI,RESULTS
ANNEXIN,MTT,NOTCH,P21
169,CPC,CPP,CPT,DISCUSSION,EFS,LABEL,METHODS,MOLECULAR,OBJECTIVE,PURPOSE,RESULTS,SOMATIC
169,17Q24,945,BIALLELIC,CNC,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,PRKAR1A,REDUCED,RESULTS,S251LFSX16,SOCIETY
169,ONCOLYTIC,THESE,USING,WHILE
000,001,005,169,197,273,439,500,689,CNS,GENERAL,RRS,THERE
18F,AMINO,BRAIN,FDG,HOWEVER,LABEL,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SUMMARY
004,034,177,CONCLUSION,DYNAMIC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
128,136,252,946,AII,AIIIS,EMT,III,MALIGNANT,NBT,STUDIES,TGF,TGFB1I1
169,945,946,AMP,ATP,COPYRIGHT,SOCIETY
001,003,160,177,AUC,CONCLUSION,EVALUATION,FET,III,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,TAC,TBR,TIS
169,372,BRAIN,BRESLOW,CLARK,COX,HOWEVER,LEVEL,RECURRENCE,SEVENTY,STAGE,THESE
THERE
DESPITE,ECTOPIC,FINALLY,INK4A,NOTABLY,NR2E1,NSC,OVERALL,TLX

AREAS,BACKGROUND,COVERED,CURRENTLY,DCS,DENDRITIC,GBM,LABEL,METHODS,OPINION,SUCCESSFUL,TARGETING
DIFFUSE,GBM,HSPGS,SULF1,SULF2
300,AMONG,FUNCTIONAL,PRIDE,PXD001398,SUCCESS
BACKGROUND,CONCLUSION,DIFFUSION,FOLLOWING,LABEL,METHODS,RESULTS,VOXEL
100,1ST,2ND,AMONG,ANOTHER,BARTHEL,FORTY,GROSS,INDEX,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SIX,THREE
100,105,121,124,249,257,260,282,302,381,CSF,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,UNIVERSITY
ANALYZING,CNS,DERMOID,MRI
132,172,945,ANOTHER,H09,IDH,MSMAB,MUTATIONS,R132G,R132H,R132L,R132S,R172G,R172M,R172S,THESE
001,169,COX,GBM,MICRORNAS,PRESS,PUBLISHED,SCORE,UNIVERSITY
CONFIRMING,FOLLOWING,GBM,THESE
CHICAGO,ENDOCRINE,JANUARY,MEETING,PITUITARY,SOCIETY
169,BRAIN,MOLECULAR,NOVEL,PRESS,PUBLISHED,REASONS,UNIVERSITY,WHOLE
169,CHANGES,GBM,INSTEAD,MRI,OVERALL,TMZ
169,C57BL,CRANIAL,III,MRI,PYP,RADIATION,SOD,THESE
146,169,BACKGROUND,EAN,ISOCITRATE,LABEL,LOW,MEIER,METHODS,MUTATIONS,OBJECTIVE,PURPOSE,RESULTS,VOXEL
GRN,IMPORTANCE,LABEL,METHODS,MUTATIONS,OBJECTIVE,RELEVANCE,WML
169,INC,MOLECULAR,MRI,PDT,PLASMONICS,PTT,RAMAN,SEVERAL,TPL,WILEY
169,ALZHEIMER,AMERICANS,BASED,CHALLENGES,COPYRIGHT,ISSUE,SEVERAL,SPECIAL,THERE,WHILE
001,160,177,215,517,ALT,DUE,SOMATIC,THESE
945,946,DHT,FINALLY,GBM,HOWEVER,SMAD3,TAKEN,TGF,U87
001,014,169,BMS,CD3,CD8,DENSITY,FORTY,FOXP3,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,TIL,V600E,WILEY
AMONG,III,LABEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY
AGE,BENEFIT,CURRENT,HOWEVER,LABEL,OBJECTIVE,PCNSL,PURPOSE,RESULTS,STILL,SUMMARY
169,AKT,APPROACHES,BLI,GBM,IHC,NT113,RESULTS,THESE,WESTERN
169,EMT,GBM,GTP,NANOG,RAD,RAS,STAT3,THESE
26951,288,C30,CONCLUSION,COX,EORTC,EVERY,HRQOL,LABEL,METHODS,OBJECTIVE,PCV,PURPOSE,QLQ,RESULTS,THEREFORE,TREATMENT
169,BECAUSE,COPYRIGHT,GYRBE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SEVENTEEN,THEREFORE
160,169,215,647,ALEXA,AUTHORS,IGG,LTD,PTY,PUBLISHING,SCIENCE,SPR,THEREFORE,WILEY
169,946,COPYRIGHT,EXPRESSION,INC,PATHOLOGY,PUBLISHED,SIGNALING,SOCIETY
HCC,HOWEVER,SYK
001,150,169,COPYRIGHT,CPS,INC,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,REDUCED,RESULTS,THERE,THINNED
100,169,53BP1,947,ACETYLATED,ADDITIONAL,ATM,BCL,CHEK2,COPYRIGHT,HDACI,INCUBATION,IRELAND,LTD,MS275,PPV,RTX,SCRIPTAID,VPA
120,169,33342,CA4,COMBRETUM,COPYRIGHT,HOECHST,IRELAND,LTD
132,15A,169,COPYRIGHT,EMT,EPITHELIAL,FINALLY,HOWEVER,IRELAND,LTD,MIR,TRANSITION
015,016,046,049,050,084,177,BACKGROUND,BRAIN,GCS,GLASGOW,KARNOFSKY,LABEL,METHODS,RESULTS,SCALE
945,AGE,ALZHEIMER,FINALLY,HIF,YET
138,169,967,ACT,AMONG,APT,BACKGROUND,BETWEEN,COPYRIGHT,FIFTEEN,INC,JANUARY,LABEL,MDCTA,METHODS,PFO,PUBLISHED,RESULTS,TROUSSEAU
003,022,044,048,469,ATLAS,ENGEL,EXPRESSION,HOWEVER,LABEL,LGG,METHODS,OBJECTIVE,PURPOSE,RAD50,RESULTS,RINT1
169,947,ATM,ATR,BRCA1,CLONOGENIC,COPYRIGHT,CURRENT,F02,GM05849,IRELAND,LTD,PHOSPHO,STALLED,UCN,USING
169,176,180,COPYRIGHT,CSF,DSC,LTD,MRI,WILEY
GROUP,KCNA1,SAMPLES,SFRP1,SHH,THESE,WNT
946,956,AKT,AS2O3,AS4O6,ATO,FURTHER,GSK,LABEL,LN428,LOCAL,METHODS,MMP,MT1,OBJECTIVE,RESULTS,SUBSEQUENT,TAO,THESE,U87MG,WESTERN
169,5A1,6A1,COPYRIGHT,GLC,IRELAND,LTD,OATP4A1,OATP5A1,OATP6A1,OATPS,SCLCS,TREATMENT,WESTERN
160,ADH,III,SERUM
107,AGE,CHOROID,COX,CPC,CPP,DESPITE,DUE,END,GROSS,GTR,ICD,INSTITUTE,MEIER,PROGRAM,RESULTS,SIXTY
ABC,ABCG2,BMJ,GLI,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEVENTY,SHH,SONIC,WESTERN
ALZHEIMER,CHALLENGES,DUE,PARKINSON
130,140,143,945,AFTER,BACKGROUND,BRIEN,EMERGENCE,FAILURE,FIFTY,FLEMING,HOWEVER,LABEL,METHODS,RESULTS,SBP
169,APT,BASED,COPYRIGHT,FITTING,GIVEN,INCREASED,LORENTZIAN,LTD,MRI,MRS,NOE,OVERHAUSER,WILEY
169,945,AKT,DSB,FAK,HIF,INC,INHIBITION,M059J,M059K,SRC,THESE,WILEY
169,945,946,947,948,CD3,CD4,CD5,CD7,CD8,CENTRAL,CNS,DESPITE,LTD,PET,PRIMARY,PUBLISHED,TCR,WILEY
169,EPIGENETIC,GBM,INC,NOTCH,THERE,THESE,WILEY,WNT
001,028,149,160,169,717,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,INC,KARNOFSKY,KPS,LABEL,METHODS,NEITHER,RESULTS,TREATMENT
ALK,CNS,CTLA4,FGFR1,MEDICAL,METASTASES,NETWORK,RAS,SOCIETY
143,169,956,BIOLOGICAL,COPYRIGHT,CRK,FDR,GBM,HOWEVER,LABEL,LLL12,PARK7,PGAM1,RESULTS,STAT3,THROUGH,TPI,U87,UNASSIGNED,UNLABELLED
946,EMT,HOWEVER,INCREASED,INHIBITION,MICRORNAS,SMAD7,TAKEN,TGF
160,BRAIN,LABEL,METHODS,MRI,OBJECTIVE,PEDIATRIC,PURPOSE,RESULTS,THERE
169,954,983,AMONG,CLDN9,COPYRIGHT,CURRENTLY,INC,PITUITARY,THESE,WESTERN
169,174,300,578,COPYRIGHT,CPG,FEWER,HOWEVER,KIT,SIMILAR,TISSUES,TSM
100,1799T,600,AMSTERDAM,BACKGROUND,BMJ,CRC,FINDINGSS,GROUP,GUIDELINES,INITIAL,LABEL,LIMITED,LYNCH,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,SCREENING,SELECTION,UNASSIGNED,VAL600GLU
AFTER,DIAGNOSES,EEG,ENGEL,FDG,III,LABEL,METHODS,MRI,OBJECTIVE,OLE,PET,PURPOSE,RESULTS
169,721,945,COPYRIGHT,DEX,GCS,LPS,LTD,MDD,PHA,TNF
169,BRCA1,GBM,GFP,KNOCKDOWN,REMBRANDT,SPERMIDINE
169,AUTOIMMUNE,CD8,CPG,DESPITE
18F,BRAIN,FDG,MRI,PET,TCC
AFTER,MRI,PET
169,BACKGROUND,BMS,BRAIN,CONCLUSION,CTCAE,DL0,DL1,DL2,DL3,DLS,GRADE,IDENTIFIER,LABEL,MEDICAL,METHODS,NCI,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,TRIALSGOV,UNASSIGNED,UNIVERSITY
BRAIN,CNS,IPILIMUMAB,RATES,THERE,TREATMENT,WHOLE,WORLD
160,946,ADULT,CD133,EXOGENOUS,FAS,GAMMA,GSC,IL6,IL8,MEDIA,NPC,NSC,TGF,TRAIL,U87MG,USING,WHILE
141,200
169,657,760,BACKGROUND,CBV,CONCLUSION,FOUNDATION,HOWEVER,LABEL,MET,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
120,177,203,349,CHOROID,CPC,CPP,CSS,END,GTR,HISTOLOGY,OLDER,PATIENT,RESULTS
947,CMV,LDH,OVERALL,RING1,SEL,SYTXV
ASPSCR1,METASTATIC
LABEL,LANGERHANS,MOLECULAR,OBJECTIVE,PURPOSE,RAF,RESULTS,SUMMARY,V600E
169,BRAIN,CLINICIANS,NEURO,PRESS,PUBLISHED,SOCIETY,SRS,UNIVERSITY
HOWEVER,MTT,PCR,RHO,ROCK1,TRANSWELL,WESTERN
160,300,405,854,967,EGGER,JANUARY,OPN,SIXTEEN
013,PROTRACTED,TORONTO
169,FAK,FEDERATION,HOWEVER,LTD,SEVERAL,SOCIETIES,WILEY
169,192,277,443,BIVARIATE,CALIFORNIA,FLORIDA,HYPOTHESIS,INC,INSURANCE,LABEL,LEVEL,MAJOR,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,SOCIETY,THERE
169,AFTER,BACKGROUND,BBB,BICNU,CED,COMPARISON,CONCLUSION,CONVECTION,COPYRIGHT,DISSOLVING,E98FM,LABEL,METHODS,RESULTS,SINCE,THESE
169,900,GSM,INC,LATIN,LHS,MANNEQUIN,MHZ,SAM,SAR,SAR10,WILEY
169,177,INC,TRANSIENT,UNDERGOING,WILEY
120,169,215,AAT,AMINO,BACKGROUND,COPYRIGHT,DU145,INC,LABEL,MB468,MDA,METHODS,PET,RESULTS,SIMILAR,SKOV3,THESE,U87
169,SOCIETY
ATLAS,BACKGROUND,CA9,CONCLUSION,COX,LABEL,MEIER,METHODS,MYC,PROTEIN,RESULTS
169,AGE,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,STUDIES,TURKU,UNIVERSITY,WILEY
169,BIOLOGY,BMI,FEDERATION,REDUCTION,THESE
169,APOPTOSIS,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,LABEL,METHODS,PDT,RESULTS,THESE,WHILE,WST
118,155,19Q,1P19Q,200,250,574,641,738,917,EOR,GIIGS,HOWEVER,THERE
169,3MONTHS,6MONTHS,ABSTRACTS,AUTHORS,CAB,CONSORT,COPYRIGHT,DIFFERENT,ITEMS,KNOWLEDGE,LIBRARY,MEDLINE,PREFERRED,PUBLISHED,REPORTING,REVIEWS,ROUTINE,SYSTEMATIC,THERE,WEB
001,039,169,215,550,COPYRIGHT,FERRATA,FOUNDATION,HODGKIN,THESE
ANATOMICAL,EXTENSIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
009,591,AMONG,ANALYZING,LABEL,METHODS,OBJECTIVE,OVERALL,POPULATION,RESULTS,RRS
001,006,1306C,1575G,LABEL,METHODS,MMP,OBJECTIVE,RESULTS,THERE,TIMP2,TIMPS
100,974,AUC,CNS,CSF,FDG,PET,ROC,THESE
AFFYMETRIX,EFNA1,EFNA3,EFNA4,EFNB1,EPH,EPHA2,EPHA8,EPHB4,FUNCTIONAL,SHH,THESE,YET
622,FUNCTIONAL,KNOCKDOWN,MALIGNANT,MICRORNAS,TARGETING
APOPTOSIS,AREAS,BACKGROUND,CASPASE,COVERED,HOWEVER,LABEL,METHODS,OPINION,SINCE,THEREFORE,VARIETY
AMONG,BACKGROUND,CONCLUSION,GAMMA,GROSSLY,KNIFE,KNOSP,LABEL,MEIER,METHODS,OBJECTIVE,RATES,RECURRENT,RESULTS,SEVERAL,THERE

BARTHEL,BLOCK,BOX,FORTY,FURTHER,INDEX,LABEL,METHODS,MEYER,OBJECTIVE,RESULTS,VIRTUAL
BACKGROUND,CONCLUSION,CONTEXT,ICD,LABEL,METHODS
169,GBM,SOCIETY,THESE
MIB,MITOSES,PAPILLARY,WORLD
CENTRAL,CEREBELLAR,NERVOUS
292,338,AFTER,BACKGROUND,CLUSTER,CONTEXT,CROSS,IGF,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,THESE
167,ANXIETY,FCS,HOWEVER,IL1,IL1R2,LABEL,METHODS,NFKB2,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,USING,VARIATIONS
ALA,BACKGROUND,GERMANY,GLIOLAN,III,LABEL,METHODS,MRI,PNETS,RECURSIVE,RESULTS,RPA,THESE,WEDEL
CPU,DEFORMABLE,PATCH,RATIO,TRE
100,120,395,541,573,BACKGROUND,CNS,CONCLUSION,FIRST,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,SIXTY,TKI
169,DESPITE,HARNESSING,HOWEVER,NEURO,NEWER,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,174,200NM,COPYRIGHT,INC,LTD,MATERIALIA,PUBLISHED,THESE
520,609,BACKGROUND,DCS,GIVEN,LABEL,METHODS,RESTING,RESULTS
AV100,BACKGROUND,GAMMA,KNIFE,LABEL,LEKSELL,MATERIALS,METHODS,PERFEXION,RESULTS,THESE
143,BACKGROUND,CSF,FAVORABLE,FINALLY,GROSS,LABEL,METHODS,PERMANENT,RADICAL,RESULTS,SIXTY
169,COPYRIGHT,HODGKIN,SAS,THERE,TREATMENT
118,473,AKT,ANNEXIN,GBM,MMP
169,945,946,CONVERSELY,FINALLY,GBM,HIF,III,SEVERAL,THESE,TUBB3,UTR
001,104,169,312,315,375,997,CENTRAL,CRC,JANUARY,RECORDS,SEPTEMBER,SIR,SMR,SOUTH,USA,VITAL
946,954,AKT,CNS,EMT,EPITHELIAL,FAK,HOWEVER,PREVIOUSLY,THEREFORE,U87
169,COPYRIGHT,MRI,SINCE,SUBSEQUENT
AKT,HOWEVER,MICROARRAY,NOTABLY,THEREFORE,USING
FINALLY,SHH,SONIC,THEREFORE,THESE,TREATMENT
945,946,CD133,CD49F,CK2,GBM,INHIBITION,INITIAL,NANOG,U87
GATHERING,TAILORING
169,CLEAR,COPYRIGHT,LTD,RIGHT
169,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,PRIOR,PUBLISHED,RESULTS,SAS
169,COPYRIGHT,DESPITE,ISSUE,OXYGENATED,SPECIAL,THERE,THESE
169,COPYRIGHT,GBM,INC,LABEL,SGT,THESE,TMZ,U87,UNASSIGNED,UNLABELLED,USING
037,043,155,169,BACKGROUND,IDENTIFIER,LABEL,METHODS,NEURO,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,TREATMENT,UNASSIGNED,UNIVERSITY
AFTER,BACKGROUND,EVERY,LABEL,METHODS,REMOVAL,RESULTS
009,HOWEVER,IHC,LABEL,METHODS,OBJECTIVE,RESULTS
100,ACROMEGALY,CAVERNOUS,GRADE,KNOSP,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SIXTEEN,TOTAL,TSH
946,ABC,ABCG2,AMONG,ATP,FDA,SINCE
ARL,BBB,CONCLUSION,LABEL,METHODS,OBJECTIVE,OWING,PURPOSE,RESULTS,TFR,THERE,TRANSWELL
001,009,012,113,132,160,177,448,543,857,936,KPS,MEIER,PCR
169,IMPAIRMENT,MYOMETRIAL,PRESS,PUBLISHED,THESE,UNIVERSITY
BRAIN,INO
CONCLUSION,FET,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
006,027,132,160,309,355,356,372,394,427,428,437,469,513,524,526,537,562,640,698,743,804,892,ASIAN,BASED,CAUCASIAN,CHI,CIS,EGGER,EPIGENETIC,GBM,HOWEVER,PFS
REGUCALCIN
125,169,EGF,INJECTION,L1CAM,MAB,RESULTS,RET,SIMILAR
021,045,102,151,169,183,GEORG,MRI,PRL,STUTTGART,WHETHER
BECAUSE,FINALLY,LABEL,OPINION,RADIATION,STATEMENT,UNASSIGNED
169,AUTHORS,BRAIN,DESPITE,INC,MAPPING,PUBLISHED,THERE,THESE,WILEY
169,GBM,HOWEVER,LDA,MET,PHA665752,SU11274,THREE,VCH,WILEY
5XFAD,ALZHEIMER,ASIDE,FMEC1,PRESENTLY
002,169,778,CHANGES,DUTCH,GHD,HBA1C,HORMONE,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY,SOCIETY,TREATMENT
156,169,207,BMI,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,SIADH,SIXTY,SOCIETY,TSS
CONCLUSION,CPA,EXCLUDING,IAC,LABEL,METHODS,MRI,OBJECTIVE,OPTIMAL,OUTCOME,RESULTS,SETTING,THERE
11C,18F,BECAUSE,DESPITE,FDG,MALIGNANT,MRI,PET
169,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,INTENSIVE,LABEL,METHODS,MRI,RESULTS,ROYAL,TREATMENT,ZEALAND
169,COPYRIGHT,INC,STAT3
007,169,2003_VS,2005_VS,2006_VS,2012_VS,428,64_VS,BESIDES,COX,EINDHOVEN,HRMALE_VS,HROTHER_VS,NSCLC,_2001,_2010,_FEMALE
169,ALZHEIMER,COPYRIGHT,GIVEN,LTD,PARKINSON
BIMODAL,DEPARTMENT,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RADIATION,RESULTS,ROCHESTER,SEPTEMBER
152,169,252,COPYRIGHT,GBM,IRELAND,LTD,MEANWHILE,RESTORING,TAKEN
169,AKT,COPYRIGHT,FURTHER,GOLGI,HOWEVER,IRELAND,LTD,PROTEIN,TAKEN
177,198,215,480,565,CNS,IRANIAN,JCV,PCR,WBC
169,COPYRIGHT,IRELAND,LTD
001,BRAIN,EMT,FURTHER,H1915,HOWEVER,METASTASIS,NSCLC,PCR,THEREFORE
004,155,297,526,CNS,III,IOL,PCNSL,PFS,SG1
001,104,109,171,177,210,467,875,918,989,DESPITE,LABEL,MEP,METHODS,OBJECTIVE,PERMANENT,RESULTS,SEP
001,003,050,105,126,149,169,176,281,286,287,291,BACKGROUND,CEA,COG,COGNITIVE,CRC,DEFICIT,FATIGUE,GDS,III,LABEL,MEDICAL,METHODS,PRESS,PRIMARY,PUBLISHED,QOL,RESULTS,SOCIETY,TEN,TRIAL,UNIVERSITY,USING,WOMEN
005,GBM,GSC,THESE,U87
169,BACKGROUND,INC,INCREASING,LABEL,LGG,MARCH,MAXIMUM,METHODS,NEURO,PITTSBURGH,PRE,PROCEDURE,PROGRAM,RESULTS,WILEY
HOWEVER,IRE,NDRG1,REMARKABLY,THEREFORE
169,494,AMONG,BACKGROUND,CNS,CONCLUSION,CONVERSELY,CSF,DESPITE,INC,LABEL,MEDICAL,METHODS,PROCEDURE,RESULTS,ROUTINE,TORONTO,WHILE,WILEY
169,BRAIN,DESPITE,INC,PEDIATRIC,WILEY
ADDISON,CONCLUSION,CONTEXT,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,SCN,SLEEP,VFD
FURTHER,HISTOLOGY,MENDELIAN,SEVERAL,THESE
02425,03386,121,159,282,397,ADC,C10,C90,HISTOGRAM,IDH
RIGID,THERE
121,169,500,817,827,AMIGO,IMAGE,OPERATING,SOCIETY
169,CONVERSELY,COPYRIGHT,CXCR1,CXCR2,FINALLY,GSC,HOWEVER,INC,NTS,NTSR1,SR48692,STAT3,TAKEN
124,FOLLOWING,GBM,HSV,INSTEAD,ONCOLYTIC,THESE,UTR
DESPITE,FOLLOWING,LABEL,MRI,OPINION,PRECISION,REGARDLESS,STATEMENT,UNASSIGNED
169,AFTER,COPYRIGHT,GRAVE,IRELAND,LTD,THYROID,TSH
002,004,010,037,102,128,129,165,177,CONCLUSION,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN,TESLA
GBM,HOWEVER,ROMO1,ROS,THEREFORE
003,007,009,160,212,225,250,336,413,431,685,784,812,848,977,987,997,ADULT,GBM
169,ALDH1,CD133,COPYRIGHT,CSC,FINALLY,GBM,INC,NOTCH,STAT3,THESE,TRANSIENT,TRMP7,TRPM7
169,BIOMARKERS,CHILDHOOD,EPIDEMIOL
001,045,141,160,AFTER,DBC,FREEDOM,HOWEVER,LMD,LOCAL,MEIER,SRS
054,104,111,160,170,185,946,CALIFORNIA,CNS,ELEVATION,FRANCISCO,IQR,PFS,SAN,THREE,UNIVERSITY,WBI,WVI,XRT
169,CAD,COPYRIGHT,IGS,SEVERAL,SOLUTIONS,THESE
236,HSP75,HSP90,KARNOFSKY,KPS,THESE,TRAP1,WORLD
ADC,ADCMEAN,EIGHT,LABEL,MAXIMUM,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVMEAN,THERE
169,DESPITE,GBM,HOWEVER,PRESS,TRAIL
CCM,CHINESE,PCR
169,GSH,HMOX1,INDUCTION,INHIBITORS,LABEL,ROS,TSC,UNLABELLED,USING
AFTER,CENTRAL,CNS,CONCLUSION,DORFMAN,LABEL,LIBRARY,METHODS,OBJECTIVE,RDD,RESECTION,RESULTS,ROSAI
001,004,027,044,100,160,644,807,COX,KARNOFSKY,MRI,PET,PFS
BKGRMAX,CONCLUSION,DEFINITIVE,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,SEVERAL,SUVLMAX
956,CD206,MEIER,MRI,OVERALL,PFS
169,VCH,WILEY
160,945,AMP,HOWEVER,RAS,RCC
100,160,AFTER,EARLY,FAVOURABLE,HDC,HIT97,III,MRI,PFS,PNETS,RESPONDERS,THERE,TREATMENT
169,CBF,CBV,COPYRIGHT,DCE,DSC,EPI,FOURIER,INC,MRI,PERFUSION,SENSE,VOXEL
160,169,235,238,500,BORON,CAPTURE,CELLS,CONTROL,COPYRIGHT,INT,LTD,NEUTRON,NON,NSCLC,PUBLISHED,SINCE,SMALL,TCP,THERAPY,TREATMENT
169,5MC,AUTHORS,BEADCHIPS,COPYRIGHT,HOWEVER,INC,PUBLISHED,SUPPORTED
169,AFTER,GROSS,INC,WILEY
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OCT,PURPOSE,RESOLUTION,RESULTS,THREE
013,100,114,177,BACKGROUND,GTR,LABEL,METHODS,MRI,NFA,RESULTS,SEVENTY
169,COPYRIGHT,DESPITE,GBM,THESE
108,169,ADVERSE,BACKGROUND,BRITISH,ECG,EEG,ELECTRICAL,EXCLUSION,IRE,JOURNAL,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,UNIVERSITY,VAS
945,BORON
169,326,BACKGROUND,FEW,LABEL,METHODS,NEURO,PCR,PRESS,PUBLISHED,RESULTS,SMO,SOCIETY,UNIVERSITY,WESTERN
ANOTHER,AVAGLIO,FURTHER,HOWEVER,III,LABEL,MEANWHILE,OPINION,PFS,PHASE,REGARDLESS,STATEMENT,UNASSIGNED
GUIDELINES,LABEL,OPINION,STATEMENT,SYMPTOM,THERE,THESE,UNASSIGNED
169,COPYRIGHT,INC
LOCAL,MRI,YOUNGER
169,700,AHNAK,COPYRIGHT,INC,SEVERAL,VARIOUS
169,COPYRIGHT,INC,PUBLISHED
177,BACKGROUND,BLOOD,DIAGNOSIS,DISORDERS,HASSENFELD,LABEL,LANGONE,MEDICAL,METHODS,NYU,TREATMENT
106,117,235,260,ADOLESCENT,DEPARTMENT,EARLY,GRADE,GUSTAVE,JANUARY,PEDIATRIC,PHASE,UNION
169,ESRP1,ESRP2,HOWEVER,LTD,MBM,OVERALL,PRM,PTBP1,PUBLISHED,STAGE,U2AF2,WILEY
946,947,EMT,MET,NSCLC,SIGNALING,TGF,THESE
169,GLUCOSE,HOWEVER,III,IRS,SOCIETY,TAKEN,WHILE
160,595,ESTIMATED,GIVEN,HOWEVER,LMD,THERE,THEREFORE
BACKGROUND,CENTRAL,CONTEXT,ENGLISH,FGA,FSH,GIVEN,LABEL,METHODS,RESULTS,SYNTHESIS,SYSTEMATIC,THEIR,THERE
169,BRAIN,CHANTILLY,COMMITTEE,GIVEN,GROUP,MALIGNANCY,NEURO,PRESS,PUBLISHED,SEPTEMBER,SOCIETY,THERAPIES,UDVAR,UNIVERSITY,WORKING
169,INHIBITION,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,946,ALK,ATLAS,BACKGROUND,EXOGENOUS,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SMAD1,SMAD2,SMAD3,SMAD5,SOCIETY,TGF,THERE,UNIVERSITY
160,169,896,931,AUTHORS,COHORTS,COX,EIGHT,LABEL,LTD,MEIER,OVERALL,RESULTS,SEPTEMBER,SRS,UNLABELLED,WILEY
CURRENT,DDP,ENDOXAN,GBM,III,TEMODAL
ERP
160,177,FALSE,FINAL,FORTY,LABEL,METHODS,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,STUDENT,SUV
000,100,169,AGE,APC,AUTHORS,BACKGROUND,BRAIN,CENTRAL,HODGKIN,INC,LABEL,METHODS,RESULTS,SOCIETY,STATISTICS,WILEY
169,ALTOGETHER,BACKGROUND,EXPRESSION,GBM,INHIBITION,LABEL,METHODS,NEURO,NOTABLY,PRESS,PUBLISHED,RESULTS,SOCIETY,THEREFORE,UNIVERSITY
005,118,169,BACKGROUND,LABEL,MEIER,METHODS,MUT,RESULTS,RFS,SOCIETY
ASPIRATION,HOWEVER,SEVEN,SUBSEQUENT,THESE
ASL,BLAND,CBF,CBV,DSC,GRADE,MEIER,MRI,NORMALIZED,ROC,SEVERAL,SIXTY,THERE,TTR,YET
003,037,160,793,845,AFRICAN,AFTER,BLACK,CARIBBEAN,COX,ENGLAND,EPISODE,ETHNICITY,KINGDOM,OTHER,PAKISTANI,RECEIPT,SOUTH,STATISTICS,STUDIES,THESE,WHITE
009,019,025,029,165,189,262,393,447,464,514,579,586,645,651,704,743,801,873,898,948,953,965,ADDITIONAL,AFTER,BACKGROUND,CCCCC,CONCLUSION,HAPLOTYPES,HAPLOVIEW,HOWEVER,LABEL,METHODS,OCCURRENCE,RESULTS,SEVEN,UNIVARIATE,UTR
103,125,160,201,BETWEEN,CALCULATED,GBM,KARNOFSKY,LOW,PFS,PROCEDURE,SBT,TREATMENT
032,160,178,DISEASE,EOL,HGG,OVERALL,QOC,SOMNOLENCE
790,BRAIN,DIFFUSE,III,NORTHEAST
013,017,021,026,031,160,ARCHIVE,AUTOMATIC,COX,FLAIR,GBM,IMAGING,MRI,UNIVARIATE
169,COPYRIGHT,INC,PTENMUT,SNB19,U87
098,160,741,ACS,AGE,COLLEGE,DVT,NSQIP,PRE,PROJECT,QUALITY,TOTAL,UNIVARIATE,UTI,VTE
ESC,INHIBITION,KNOWLEDGE,NANOG,SMARCA4,SNF,SWI
169,BRITAIN,COPYRIGHT,GREAT,IRELAND,LTD,NF2,PUBLISHED,SMARCE1,SOCIETY,TESTING,THREE,WILEY
CD3,ENG,EPHA2,HOWEVER,WHILE
BACKGROUND,BMI,CONCLUSION,HOWEVER,LABEL,METHODS,NON,PAEDIATRIC,RESULTS,SEVEN,WHITNEY
148,389,730,810,BACKGROUND,CONCLUSION,EXCLUSION,FOLLOWING,GRADE,ITEMS,LABEL,LOCAL,MARCH,MEDLINE,METHODS,OVERALL,PREFERRED,RCC,REPORTING,RESULTS,REVIEWS,SYSTEMATIC,THERE,TREATMENT
CYBERKNIFE,MRI,PET
169,BACKGROUND,CNS,CONCLUSION,LABEL,METHODS,NEURO,PATIENT,PRESS,PUBLISHED,RESULTS,SMO,SOCIETY,THERE,THESE,UNIVERSITY
19Q,CLASS,CLEARLY,HOWEVER,LABEL,LGG,LOW,MAXIMAL,OPINION,PCV,RADIATION,STATEMENT,SURGERY,THESE,TYPICALLY,UNASSIGNED
001,025,111,169,BACKGROUND,GBM,IGFBP,LABEL,METHODS,RESULTS,RHO,SOCIETY,THEIR,THERE,YKL
169,INC,UDS,WILEY
150,160,200,DIFFUSE,FIFTEEN,GRADE,HOWEVER,KPS,MRI,PFS,TEN,TMZ
CONVERSELY,GBM,HOWEVER,RSI,SIX,THESE
169,FK1,FK506,INC,KNOCKDOWN,SIMILARLY,TDO,TRYPTOPHAN,WILEY
BRCA1,ERBB2,OVARIAN,TAKEN,THESE
BRAIN,NPY,THEREFORE,THESE,Y2R,Y5R
100,169,ALERTED,BACKGROUND,CHILDHOOD,CONCLUSION,ENDOCRINE,FIRSTLY,INC,LABEL,METHODS,PROCEDURES,RESULTS,THEREFORE,WILEY
000,040,169,177,372,508,937,960,AUC,CONCLUSION,COPYRIGHT,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SYSTEMATIC,WEB
169,AUSTRALIA,AUSTRALIAN,METASTASES
169,24H,APE,COPYRIGHT,DSPES,GBM,GNR,HOWEVER,INC,LUC,LUCANTHONE,MCF,PEG,TEM
000,160,574,THERE
160,DESPITE,EIGHT
169,COPYRIGHT,EXTENSIVE,INC,MICRORNAS,PUBLISHED
100,103,113,365,AMONG,BACKGROUND,LABEL,METHODS,MULTIMODAL,RECURRENCE,RESULTS
169,BAX,BCL,FURTHER,GDC,NOTABLY,THEREFORE,THESE
1425EPN,160,177,ALT,BXD,IMETELSTAT,PEDIATRIC,TELOMERASE,THESE,TIC
100,140,169,384,COPYRIGHT,FRACTURES,INC,INCREASED,LABEL,METASTASES,METHODS,OBJECTIVE,PHYSICIANS,RESULTS
001,169,557,961,ALA,BACKGROUND,COPYRIGHT,DIFFERENT,ESPECIALLY,FGS,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMPSON
504,945,946,AKT,CD133,HOWEVER,HSP90,IPI,THESE
031,045,048,160,164,237,ASSESSMENT,BRAIN,CHRONIC,COX,FACIT,FATIGUE,FUNCTIONAL,GENERAL,HGG,III,ILLNESS,KPS,QOL,QUALITY,SEVENTY,THERAPY,USING
160,169,CONCERNING,COPYRIGHT,ECLIPSE,GTV,LABEL,LTD,MATERIALS,METHODS,MUS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,V10
AKT,SEVERAL
169,946,A315E,ALS,EFFECTS,NMR,NUCLEAR,OVERHAUSER,PRESS,PUBLISHED,SEQUENTIAL,TDP,UNIVERSITY
169,COPYRIGHT,INC,PALINOPSIA
153,170,BACKGROUND,BECAUSE,FATIGUE,LABEL,METHODS,PROCEDURE,RESULTS,SLEEP
001,002,003,005,008,009,124,160,177,COX,KARNOFSKY,KPS,MEIER,PCR,PFS
169,MRI,SOCIETY
THEREFORE,TREATMENT,TSS
100,169,177,BREATHING,CO2,EPR,HYPOXIA,MRI,TREATMENT
169,BRAIN,FHL,GLY132ARG,INC,LABORATORY,WILEY
001,169,804,AMONG,ASSESSMENT,BASIC,BRAIN,COPYRIGHT,GPA,HOWEVER,INC,INDEX,LABEL,METASTASES,METHODS,MST,OBJECTIVE,OBJECTIVES,PROGNOSTIC,RECURSIVE,RESULTS,RPA,SCORE,SIR,SRS,THERE
100,109,160,CTE,HOWEVER,MAY,SCT,VOD
169,COPYRIGHT,GIVEN,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,COPYRIGHT,INC,THROUGH,UNTIL
169,693,BASED,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SEVERAL,SLE,THESE
ACADEMY,BRACKMANN,CHS,CPA,EIGHT,HOUSE,IAC,LABEL,MEASURE,METHODS,NEITHER,OBJECTIVE,OUTCOME,PRIMARY,RESULTS,SURGERY,TEN,THREE
169,177,204,COPYRIGHT,GROUP,III,INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,RPA,SARCOMA,SCALE,SIXTEEN,THERAPY
THERE
231,BEH,BRAIN,OPT,TREATMENT
CONCLUSION,HOWEVER,LABEL,METHODS,MRI,MRS,NAA,OBJECTIVE,PAS,PILOCYTIC,PURPOSE,RESULTS
946,ALZHEIMER,LTP,STZ
169,BACKGROUND,CNSCS,CONCLUSION,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RAS,RESULTS,SIRT1,SOCIETY,THESE,U87,UNIVERSITY
390,860,ACC,ADRENAL,BACKGROUND,CONCLUSION,JANUARY,LABEL,MEIER,METASTASES,METASTATIC,METHODS,NETWORK,OPERATIVE,RESULTS,SEX
BACKGROUND,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPARING,THESE
169,BACKGROUND,CSF,LABEL,METHODS,RESULTS,SOCIETY
169,ADULT,AFTER,ALREADY,ATM,CED,CONSISTENT,GIC,HEALTHY,KU60019,PEDIATRIC
169,CONCLUSION,HISTOLOGY,INC,LABEL,METHODS,OBJECTIVE,RESULTS,WILEY
165,945,CNS,HSC,IDUAC,IDUAE,MPS,THESE
169,253,277,288,BRIGHAM,COPYRIGHT,EXCLUDING,FRAME,INC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SERIOUS,VARIABLES,WOMEN,YOUNG
169,945,946,COPYRIGHT,GAMMA,INC,KNIFE,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS
946,FURTHER,GBM,HENCE,HOWEVER,HUR,III,MK2,TAKEN
MIXED,MUCORALES
169,446,946,BACKGROUND,CONCLUSION,CONVERSELY,GBM,HOWEVER,LABEL,METHODS,NEURO,POMGNT1,PRESS,PUBLISHED,RESULTS,SOCIETY,SUBSEQUENT,THESE,UNIVERSITY
169,AMD3100,ANOTHER,BACKGROUND,CONCLUSION,CXCR4,GBM,GSC,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,SVZ,TAKEN,U87MG,UNIVERSITY
169,COPYRIGHT,CROWN,III,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,WORLD
169,NEURO,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
150,169,AUDIT,BACKGROUND,BRITISH,DEVIATIONS,FINALLY,FIRST,JOURNAL,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SUPPORT,THESE,UNIVERSITY
001,004,007,008,027,037,100,105,116,19Q,237,C228T,C250T,CONSISTENT,HOWEVER,IDH,III,ISOCITRATE,MEIER,MUTATIONS,PFS,RECURRENT,SIMILARLY
037,076,337,467,840,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,RFS,THERE,UNIVERSITY
003,036,169,177,BACKGROUND,COMPARING,LABEL,METHODS,OVERALL,RESULTS,SIMILAR,SOCIETY,THERE
945,CCRCC,FSH,METASTASES
001,183,275,ABCB1,ABCC2,ABCG2,BMS,HOWEVER,LLCPK,MDR1A,PGP,PPI,PROTEIN,RESISTANCE,RESULTS
169,2HG,APRIL,ENGLISH,IDH,III,INC,ISOCITRATE,JANUARY,REFERENCES,SCIENCE,WEB,WILEY
007,049,160,AIM,CGH,CIC,ETV,HIF,MAP,PCR,V600E,V600K,V6OOE,WESTERN
183,AGE,BACKGROUND,CONCLUSION,COX,DUE,FURTHER,GCA,GEORG,LABEL,METHODS,RESULTS,STUTTGART,TREATMENT
001,177,193,231,305,BACKGROUND,CONCLUSION,CST,DIFFUSION,JANUARY,LABEL,METHODS,NAVIGATED,OBJECTIVE,OCTOBER,RESULTS,THESE
PITUITARY
169,COPYRIGHT,CYTOTOXIC,GBM,GLUCOSE,IRELAND,LTD,METABOLIC,PUBLISHED,THERAPIES,THESE
169,219,241,288,306,312,628,798,850,CENTRAL,CNS,COSTS,EASTERN,EVERY,HODGKIN,PREMATURE,STOMACH,THESE,WESTERN,YEARS
169,ALK,ANAPLASTIC,CENTRAL,COPYRIGHT,HOWEVER,PUBLISHED,SPECIALIST
160,169,947,ATM,COPYRIGHT,DDR,HENCE,PIGCT,PUBLISHED,SUBSETS,TGCTS
007,135,169,298,COPYRIGHT,COX,FORTY,GAMMA,HOWEVER,KARNOFSKY,KNIFE,KPS,LTD,MBT,MEIER,OVERALL,STOCKHOLM
000,001,032,053,060,089,169,209,372,470,553,593,838,COPYRIGHT,EGGER,FURTHER,HOWEVER,KNOWLEDGE,LTD,SYSTEMATIC,TEN,WEB
169,COPYRIGHT,LTD,OTHER,OVERALL,PILOCYTIC
17P,233,243,ARRAY,BLUEGNOME,BRACHMANN,CAMBRIDGE,CGH,DISCUSSION,FURTHER,GTG,HIMFG,KARYOTYPES,LABEL,LABORATORY,LANGE,METHODS,MYBBP1A,OBJECTIVE,PELP1,PURPOSE,RESULTS,SINCE,SPNS2
160,528,940,AGAINST,ITALIAN,ITALY,LABEL,OBJECTIVE,RESULTS,UNLABELLED
169,215,929,ADC,BACKGROUND,FLAIR,LABEL,METHODS,MRI,NEURO,PRESS,PUBLISHED,REGIONS,RESULTS,SOCIETY,UNIVERSITY
169,IMAGING,LTD,THERE,WILEY
002,013,015,021,104,AMSTERDAM,BACKGROUND,BESIDES,BMJ,FOCAL,GROUP,HAGUE,LABEL,LGG,LIMITED,MCH,METHODS,MRI,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEIZURE,TMZ
050,169,BACKGROUND,CONCLUSION,DCA,EFFICACIES,F98,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THEIR,TMZ,U87,UNIVERSITY,XRT
001,008,169,172,ALK,BACKGROUND,LABEL,METHODS,NEURO,NSCLC,OVERALL,PRESS,PUBLISHED,RECEIPT,RESULTS,SOCIETY,SUBSEQUENT,UNIVERSITY
100,169,49503,945,946,AGS,BACKGROUND,CELLS,CHRONIC,ELISA,HP60190,INDUCTION,LABEL,LTD,MATERIALS,METHODS,MKN28,PCR,RESULTS,WILEY
AUC,CONCLUSION,DXR,HOWEVER,LABEL,METHODS,NPL,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SINCE,U87
169,190,269,490,COPYRIGHT,EDUCATION,FIRST,INC,ITALIAN,LABEL,MATERIALS,METHODS,MSKCC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL

169,BRAIN,CLDN1,TAKEN
169,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
169,BECAUSE,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PARENTS,RESULTS,WILEY
001,011,028,169,853,967,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,COX,ENHANCING,INC,LABEL,MEIER,METHODS,PMGCT,PMNSGCT,PRIMARY,RESULTS
001,169,177,946,BACKGROUND,COPYRIGHT,DVL,HOWEVER,INC,IRS,LABEL,MATERIALS,METHODS,RESULTS,WESTERN,WNT
518,CCND1,NF2,THESE
169,EGF,GSC,INC,S1P,THESE,USING,WILEY
169,7Q33Q34,DNT,FAM131B,NF1,SNP,SOCIETY
169,183,945,946,DEPARTMENT,IST,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,RESULTS,RTH,TRH,TSH,TSHOMAS,WILEY
169,CK7,HOWEVER,MALIGNANT,PREVIOUSLY,SOCIETY
169,COPYRIGHT,CTC,EARLY,SEVERAL,SOLID
012,169,548,ACCORDING,ASSESSMENT,BACKGROUND,BASED,LABEL,METHODS,NEURO,PRESS,PSP,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,CALIFORNIA,COPYRIGHT,FRANCISCO,GBM,GCG,GIANT,HOWEVER,LTD,OVERALL,PFS,SAN,THESE,UNIVERSITY
001,003,009,169,183,2MONTHS,COPYRIGHT,COX,GTR,LTD,MEIER,PFS,PRESENTING
CNS,INVENTORY,SITUATION,VOCATIONAL
169,215,AUTOPSY,COPYRIGHT,MRI
001,107,160,169,195,203,673,AMONG,BACKGROUND,CNS,COPYRIGHT,IBC,III,INC,LABEL,METHODS,NETWORK,OVERALL,RESULTS
BECAUSE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,WHOLE
169,410,BACKGROUND,HOWEVER,LABEL,LGG,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
115,169,19Q,ALGORITHMS,BACKGROUND,COX,CPG,HM450,IDH,LABEL,MEIER,METHODS,MOLECULAR,NEURO,NOA,PCR,PRESS,PUBLISHED,RESULTS,SOCIETY,STP27,UNIVERSITY,WORLD
169,COLLEGE,COPYRIGHT,HNC,LTD,NCF,PUBLISHED,RADICAL,ROYAL
169,COPYRIGHT,DESPITE,INC,MOSBY
000,036,041,215,248,BASED,BETWEEN,CLPTM1L,GOVERNMENT,PRESS,PUBLISHED,UNIVERSITY
001,004,169,BACKGROUND,BRAIN,CLEAR,CONCLUSION,COPYRIGHT,COX,INC,KETTERING,LABEL,MEIER,METHODS,MSKCC,NEUROLOGIC,RCC,RESULTS,SLOAN
160,CSF,TREATMENT
169,BACKGROUND,CONCLUSION,ELONGATION,GTP,LABEL,METHODS,NEURO,PCR,PRESS,PUBLISHED,RESULTS,SEREX,SOCIETY,THESE,U87MG,UNIVERSITY,WESTERN
169,181,BACKGROUND,LABEL,MEASURABLE,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SERUM,SOCIETY,TRIAL,UNIVERSITY
169,BACKGROUND,CALCULATED,DOTATOC,FIFTEEN,HOWEVER,LABEL,LATER,METHODS,MRI,NEURO,OVERALL,PET,PRESS,PUBLISHED,RESULTS,RUV,SINCE,SOCIETY,UNIVERSITY
169,231,AKT,BACKGROUND,BRAIN,GAP,LABEL,MDA,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
001,130,169,BACKGROUND,EPWORTH,FATIGUE,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SCALE,SLEEPINESS,SOCIETY,UNIVERSITY
MALIGNANT,MEANWHILE,THERE
464,ADDISON
ACCORDING,BASED,IRONICALLY,NATURAL,THEREFORE
001,FIFTY,FORTY,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RAPID,RESULTS,VANCOUVER,VARIABLES
945,946,ALA,ARG,ASP,ATWLPPR,FAL,GLY,LABEL,LEU,METHODS,NEUROPILIN,NRP,OBJECTIVE,PRO,PROCEDURES,PURPOSE,RESULTS,RGD,RGDYK,THR,TRP,U87MG
169,BECAUSE,COPYRIGHT,HOWEVER,INC,THESE
160,CURRENT,DESPITE,GBM
169,ABSENCE,BACKGROUND,CPG,GBM,H3F3A,IDH,LABEL,METHODS,NEURO,PEDIATRIC,PRESS,PUBLISHED,RESULTS,ROS,SOCIETY,UNIVERSITY
169,231,946,COPYRIGHT,EMT,FEDERATION,MCF,MDA,PUBLISHED,SNAIL,SOCIETIES,STUDIES,TAKEN,TGF,ZEB
LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,GROSS,LABEL,METHODS,OBJECTIVE,RESULTS,SAMII,TRIGEMINAL
169,AFTER,COPYRIGHT,HOWEVER,IMAGING,INTRADURAL,LTD,MPNST
BACKGROUND,CONCLUSION,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,PITUITARY,RESULTS,SELLA
THREE
100,150,169,200,AUSTRALIAN,BACKGROUND,CENTRAL,COLLEGE,CONCLUSION,GBM,LABEL,METHODS,RESULTS,ROYAL,SEVENTEEN,TMZ,ZEALAND
169,CSF,HOWEVER
946,FRK,FYN,HOWEVER,MEANWHILE,SRC,U87
160,169,231,BACKGROUND,BESAN,CONCLUSION,DEPARTMENT,DIAGNOSIS,DISCUSSION,LABEL,METHODS,PHACE,REPORTS,SIX,SOCIETY,THESE
160,ABCB1,ABCG2,ADP,BACKGROUND,KO143,LABEL,OBJECTIVE,ONGOING,PURPOSE,RESULTS,RUCAPARIB,TRANSPORT
000,169,240,CMV
020,022,025,169,1P19Q,ANAPLASTIC,BACKGROUND,CD133,DIAGNOSIS,HOWEVER,IDH,III,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
124,945,ADAPTATION,HOWEVER,SERP1,TEAD1
001,006,104,169,BACKGROUND,BMD,BMI,CONTEXT,COPYRIGHT,CROSS,HOWEVER,INC,IRANIAN,LABEL,METHODS,NEITHER,OBJECTIVE,OUTCOME,PATIENT,PREVIOUSLY,PURPOSE,RESULTS,SCI,SETTING,TOTAL,UNTIL
000,169,244,756,COSTS,HEALTHCARE,HYPOTHESIS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PROJECT,QALYS,RESULTS,SOCIETY
001,137,244,DISCUSSION,EARLY,GCC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCT,RESULTS,VFD
169,ATTACHMENT,COPYRIGHT,GTR,HENCE,INC,LABEL,METHODS,OBJECTIVE,RESULTS,STR,THIRD
001,054,177,630,ADOLESCENT,CHILDHOOD,QOL
169,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,LABEL,METHODS,RESULTS,ROYAL,ZEALAND

102,116,118,145,195,231,472,489,MALIGNANT,MANAGEMENT,USA
001,169,177,183,AGHDA,BACKGROUND,BDI,CONCLUSION,EDE,EPQ,EPWORTH,EUROQOL,FEV,FKB,HOWEVER,LABEL,LTD,METHODS,NORMATIVE,OBESITY,QOL,RESULTS,SCALE,SLEEPINESS,TPQ,WILEY
169,COPYRIGHT,CSF,INC,LABEL,METHODS,NSF,OBJECTIVE,OCTOBER,RESULTS
169,177,AUSTRALIAN,BACKGROUND,COLLEGE,GROUP,LABEL,LINAC,METHODS,MUS,OAR,RADIATION,RESULTS,ROYAL,THERAPY,THERE,ZEALAND
169,AKT,BCL,BECLIN1,CNS,ERBB1,ERBB2,EXPRESSION,FDA,GFP,INC,KNOCK,LAMP2,LC3,LC3II,SIMILAR,TREATMENT,WILEY
135,169,888,ABT,ADP,BACKGROUND,LABEL,METHODS,MTD,NEURO,PAR,PBMCS,PRESS,PUBLISHED,RESULTS,RP2DS,SOCIETY,TMZ,UNIVERSITY,VELIPARIB
07728,134,169,177,BACKGROUND,BETWEEN,COMMISSION,CONCLUSION,CRT,DISRUPTED,HGG,JANUARY,LABEL,METHODS,NEURO,PRESS,PUBLISHED,RADIATION,RESULTS,SOCIETY,UNITS,UNIVERSITY
AKT,CSF,ERK,MO3,SINCE,USING
BACKGROUND,CONCLUSION,IGCTS,LABEL,METHODS,MRI,PRIMARY,SEVEN
BMJ,CMV,GROUP,LIMITED,PUBLISHED,PUBLISHING,SINCE,VILHELM
169,316,AGE,BACKGROUND,COX,GERMANY,LABEL,METHODS,MRI,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY,VALIDATION
26951,26981,368,573,C30,COMPARISON,DESPITE,EORTC,HRQOL,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,QUITE,RESULTS,THREE,TREATMENT
169,945,946,ASCL1,EGF,EXPRESSION,GBM,ICAM1,IL8,ITGA9,NG2,OLIG2,PDGFR,PRESS,REMARKABLY,SMA,SNAI2,THESE,VCAM1
169,ACR,ALBERTA,BACKGROUND,BESIDES,BMS,CONCLUSION,KCR,LABEL,LOW,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,954,CONCLUSION,DCE,DSC,HISTOGRAM,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC
BECAUSE,SCHMAHMANN,SHERMAN,THEREAFTER
BMJ,DIAGNOSIS,GROUP,HGG,HSE,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PROGNOSIS,PUBLISHED,PUBLISHING,RESULTS
GBM,GDSCS,PCR,SINCE,THEREFORE,TREATMENT,TSA,VPA
169,COPYRIGHT,HOWEVER,INC,MRI,THERE,THESE
FDG,MRI,PET,PITUITARY
169,945,BCL,BECAUSE,COPYRIGHT,EFFECTIVE,GLIOMAS,HIF,LTD
002,008,045,255,498,804,CHICAGO,ELLIPSE,III,INC,LEF,PROTEIN,SINCE,TCF,USA
ALTOGETHER,ERK
169,181,COPYRIGHT,EEG,FCD,FEDERATION,IRELAND,LABEL,LTD,MEG,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SMALL
043,183,ALA,DISCUSSION,HDR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,SEVERAL
169,18F,COPYRIGHT,FDG,LTD,PET,WILEY
169,COPYRIGHT,MRI

ANAPLASTIC,CNS,EPENDYMOMA,THESE
DAS,MEDICAL,WHILE
945,BACKGROUND,CONCLUSION,EIGHT,GENOMES,KYOTO,LABEL,MATERIALS,METHODS,MICROARRAY,PHASE,PRIMARY,RESULTS,SECONDARY,TARGETING
CALIFORNIA,FRANCISCO,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAN,SCO,UNIVERSITY
002,009,169,183,751,956,AFTER,AIM,APPRAISAL,BACKGROUND,BASED,CHILD,COPYRIGHT,IGF,LABEL,LIBRARY,LITERATURE,METHODS,NEUROLOGY,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SEVERAL,SHORT,SOCIETY,SSA,SYNTHESIS
2ND,8TH,ALK,CAUCASIAN,CD163,CNS,DIAGNOSIS,IMAGING
BORON
166,183,CNS,IHC,MIB,RAPID
ALA,GBM,MRI

ABCG2,ATM,BRCA1,CD133,CURRENT,GBM,RAD51,THESE,TMZ,XRCC1
156,169,AUSTRALIA,CONCLUSION,COPYRIGHT,GAD,HOWEVER,LABEL,LTD,MDD,METHODS,OBJECTIVE,PCA,RESULTS,THESE,WILEY
169,PRESS,PUBLISHED,PULMONARY,SURGERY,UNIVERSITY
169,AFM,COPYRIGHT,ELISA,INC,LABEL,THROUGH,UNASSIGNED,UNLABELLED
169,19P,22Q,AMONG,CHROMOSOME,NF2,ORBITAL,SNP,SOCIETY,SPH,WORLD
088,126,247,275,304,469,576,824,COX,GREEK,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
DIFFUSE,FURTHER,GNT,H09,IDH,OLIG2
031,10P12,295,606,646,FUNCTIONAL,SIMILAR
169,172,190,FIFTEEN,GRADE,MPP,PARTIAL,PERCIST,PFS,SUCCINATE,THERE,TMZ
169,MMP,USING
160,ASSESSMENT
176,APPROACHES,ERBB2,FINALLY,FRESHLY,HTS
160,491,ARF,ATLAS,BCL,GBM,HOWEVER,INK4A,MIR,SMALL,THEREFORE
C620Y,C624F,C628Y,C636Y,EGF,FOLLOWING,THESE
946,ALZHEIMER,BECAUSE,IGVL5D3
013,022,100,BACKGROUND,COMPLETION,INITIAL,JANUARY,KARNOFSKY,LABEL,METHODS,MTX,OVERALL,PCNSL,RESULTS,THEIR,WHILE
A10,ANP,AS2,BACKGROUND,BRAINSTEM,BSG,CONCLUSION,GRADE,LABEL,MATERIALS,METHODS,RESPONDING,RESULTS,SEVENTEEN,SIX
100,169,946,CD133,CLAUDIN,CONSISTENT,MIB,SOCIETY,THESE,THREE,WHOLE
169,BAYES,CAR,CARLO,HOWEVER,LAPLACE,MONTE,PQL,SPAIN,THESE
177,732,783,827,ENDOCRINE,MEDICAL,MRI,PRL,SIX,THEREFORE,THESE
BACKGROUND,CONCURRENT,LABEL,METHODS,RESULTS,WHILE
106,20A,CD133,CSC,GSC,HOWEVER,KNOCKDOWN,MICRORNAS,NORDY,U87,UTR
26A,E2F,HOWEVER,KAP,ROCK2
164,169,CNS,NMOSD
177,956,AFTER,CMRO2,CONCLUSION,CSF,HOWEVER,LABEL,LARGE,MATERIALS,METHODS,MRI,OBJECTIVE,PVC,RESULTS
CUSHING,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,QOL,RESULTS
AGS,AKT,CELASTROL,CHINESE,S6K,TAKEN,YCC
3T3,947,AMONG,FOLLOWING,MEYER,OTHER,PANAX,PCR,PPD,PPT,REVERSE,THEREFORE
HOWEVER
945,AIP,BASED,MEF
163,FDG,MRI,PET,PIB,THESE
169,902,COPYRIGHT,DESPITE,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THYROID,TSH
GRADE,III,LITERATURE
945,AKT,CONVERSELY,CXCR4,GROUP,MICROARRAY,THESE
169,BESIDES,COPYRIGHT,CURRENTLY,IRELAND,LTD
DESPITE,FINALLY,GBM,THESE
CONVERSELY,PCR,TSA
160,AIM,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROS,U87
169,CSC,HOWEVER
169,CLINICIANS,INC,WILEY
156,209,237,446,ADDITIONAL,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
169,COPYRIGHT,HUS,SOCIETY
169,HISTOLOGY,INC,PILOMYXOID,PMA,ROSENTHAL,SLENDER,WILEY
169,947,COPYRIGHT,DESPITE,E2F,HEXOKINASE,HK2,IRELAND,LTD,SIMILARLY,THESE
AIM,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,169,902,BEGINNING,CONCLUSION,CONTROL,COPYRIGHT,HOWEVER,INC,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
FURTHER,HOWEVER,TNBCS,USING
INS,LOH,STRIKINGLY,THESE
BACKGROUND,DISCUSSION,LABEL,METHODS,MRI,SECUENCIAL,THERE
001,021,133,169,BACKGROUND,BMI,COPYRIGHT,DESPITE,FAT,FFM,LABEL,LTD,METABOLISM,METHODS,NUTRITION,OBJECTIVE,RESULTS,SDS,SOCIETY,THEREFORE,UNDER
169,BIOLOGY,COPYRIGHT,INC,MOLECULAR,SOCIETY
897,AKT,DIFFUSE,DISRUPTION,EFNA1,EFNA3,EFNA4,EPHA2,GBM,GSC,TAKEN,TKO,USING
061,169,BACKGROUND,CENTRAL,CONCLUSION,DWI,FDG,FOUNDATION,IMAGE,JANUARY,LABEL,METHODS,MIB,OBJECTIVE,PET,PURPOSE,RESULTS,T1W,T2W
169,ORTHOTOPIC,OVERALL
HOX,LABEL,MALAT,METHODS,NFPAS,OBJECTIVE,PURPOSE,RESULTS,THERE
946,APOPTOSIS,ASC,CRE,EGL,HOWEVER,ND2,P20,P60,SMAD3,SMOA1,SMOM2,SMOOTHENED,SONIC,TAKEN
018,028,169,599,AUTHORS,BJU,COGNITIVE,CONCLUSION,CPG,DREYFUS,HOWEVER,LABEL,METHODS,OBJECTIVE,RAS,RESULTS,THERE,VINCI,WHILE
001,003,005,015,039,061,846,967,HCC,LABEL,LITERATURE,METHODS,OBJECTIVE,PITUITARY,PURPOSE,RESULTS
BACKGROUND,DISCUSSION,FSH,LABEL,METHODS,PITUITARY,RESULTS,THEIR,THREE,TSH
160,945,946,CNS,CSF,MMS,ORR,PDGFR,PFS,RET,SECONDARY,SIMON,SUNITINIB,VEGFR
169,172,954,BACKGROUND,BRITISH,FUNCTIONAL,LABEL,OPIOIDS,SOCIETY,THESE,UNLABELLED
ATLAS,GBM,ID1,ID2,ID3,ID4,THESE
160,169,215,638,772,830,930,ADC,CHO,CONCLUSION,COPYRIGHT,DWI,HPC,III,LABEL,METHODS,MRS,NAA,OBJECTIVE,PUBLISHED,RESULTS,SAS,THREE
945,AMONG,CONCLUSION,FURTHER,GFR,GLIAL,IHC,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
BACKGROUND,CHILDHOOD,HEART,HOWEVER,JAPAN,LABEL,METHODS,NETWORK,ORS,RESULTS
169,BACKGROUND,BROCA,CONCLUSION,COPYRIGHT,DTI,LABEL,MATERIALS,METHODS,OBJECTIVE,PEAKS,PURPOSE,RESULTS,SAS,SMA,USING
AKT,BACKGROUND,CUSHING,IGF,INSULIN,LABEL,METHODS,OBJECTIVE,PCR,PI3,RESULTS,RHO,WESTERN
001,169,289,551,818,946,949,AFTER,AMERICA,BACKGROUND,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,THROUGH,UNIVERSITY,WOMEN
002,187,195,302,308,388,690,BACKGROUND,COX,CRC,HOWEVER,LABEL,MEIER,METHODS,RESULTS,USING
169,AFTER,FRACTAL
CONSISTENT,EGF,EPIDERMAL,GBM,MET
946,BACKGROUND,CD133,EARLY,LABEL,MATERIALS,METHODS,OVERALL,PAPCP,PCR,PROMININ1,RESULTS,TSC,WNT
169,AVM,BRAGG,JAMES,LINDA,MEDICAL,TREATMENT,UNIVERSITY,WHILE
005,009,169,INC,MYC,U87MG,WESTERN,WHILE,WILEY
164,AUSTRALIA,CONCLUSION,DEPRESSION,DSM,LABEL,MDD,METHODS,OBJECTIVE,PCA,QUEENSLAND,RESULTS,SCALE,THERE,THESE,TREATMENT
129,818,935,953,AUC,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESENTING,PUBLISHED,RESULTS,ROC,THESE,UNIVARIATE,USING
169,674,CSI,CTV,DAILY,LOCAL,PTV,SET,THERE,USING
177,CONCLUSION,DOSIMETRIC,LABEL,METHODS,OBJECTIVE,PEPTIDE,PURPOSE,RESULTS,THERE,TREATMENT
AFTER,CUTANEOUS,LANGERHANS,LCH,MRI,TREATMENT,WHITE
169,FEW
169,BACKGROUND,CHO,COPYRIGHT,DTI,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PARAMETRIC,PURPOSE,RESULTS,SOCIETY,THESE,WHOLE
ACTUARIAL,CUSHING,INITIAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SRS,TLN
4TH,GAMMA,PITUITARY,SEVEN
AUROC,FURTHER,GLX,HOWEVER,NAA,PERSISTENT,PRIOR,ROC,USING
MRI
169,615,CPG,EPIGENETIC,INC,MEDIP,NIMBLEGEN,THERE,THEREFORE,THESE,USING,WILEY
169,ANEURYSMS,BACKGROUND,COPYRIGHT,DOPPLER,INC,LABEL,MEP,METHODS,RESULTS,VARIOUS,VOLUNTARY
100,COMBINING,DSC,HGG,LABEL,METHODS,MRI,NPV,OBJECTIVE,PCNSL,PPV,PRIMARY,PURPOSE,RESULTS,ROC
169,APRIL,BASED,CONCLUSION,COPYRIGHT,CRANIAL,INC,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,BRAIN,CLEVELAND,LABEL,MATERIALS,METHODS,MRI,NEURO,RESULTS,THERE,TREATMENT,USING
METASTATIC
153,BACKGROUND,CLEVELAND,COX,HOWEVER,KARNOFSKY,KPS,LABEL,METHODS,PCNSL,PROGNOSTIC,RECURSIVE,RESULTS
LABEL,LARGE,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SRS
183,945,946,GEORG,STUTTGART
135,240,BRAIN,COX,EMORY,KARNOFSKY,KPS,LABEL,LDH,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SRS,UNIVERSITY
169,CASES,COPYRIGHT,CSF,FORTY,INC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,WORLD
108,129,169,188,ACTUARIAL,COPYRIGHT,DBF,DISTANT,FIFTY,FREEDOM,INC,LABEL,LBF,LOCAL,METHODS,OBJECTIVE,RESULTS,SEVENTY
009,111,122,201,AGE,CCI,COMPLIANCE,ELDERLY,GBM,INDEX,INSTITUTE,KARNOFSKY,KPS,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TMZ
169,COPYRIGHT,CURRENT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
